5th edition › sites › nrf › shared documents... · 5th edition...

106

Upload: others

Post on 30-Jun-2020

31 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ
Page 2: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

5th Edition

ชอหนงสอ รปแบบเภสชภณฑวตถออกฤทธและยาเสพตดใหโทษภาษาไทย ประเทศไทย 2556

ชอภาษาองกฤษ PNDEX THAILAND 2013 (Psychotropics & Narcotics Index 2013)

ISBN 974-244-092-1

จดท�าและ กองควบคมวตถเสพตด ส�านกงานคณะกรรมการอาหารและยารวบรวมโดย กระทรวงสาธารณสข โทร/โทรสาร 0 2590 7346 อเมล : [email protected]

เรยบเรยงและ บรษท ทมส (ประเทศไทย) จ�ากดจดพมพโดย ชน 2 อาคารผดงเกยรต 27, 29 ซอยสขมวท 62 ถนนสขมวท แขวงบางจาก เขตพระโขนง กรงเทพฯ 10260 โทร 0 2741 5354 โทรสาร 0 2741 5360

All rights reserved.สงวนลขสทธตามพระราชบญญต

Page 3: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

OBJECTIVESวตถประสงค

1. สาหรบใชเปนคมอของเจาหนาทสาธารณสขในการพสจนเอกลกษณ และรปพรรณ (Identification) ของวตถออกฤทธ และยาเสพตดใหโทษ กรณทเกดอาการไมพงประสงคจากการใชยา หรอการใชยาเกนขนาด

2. สาหรบใชเปนคมอของเจาหนาทปองกนและปราบปรามดานวตถเสพตดในการพสจนเอกลกษณ และรปพรรณ (Identification) ของวตถออกฤทธ และยาเสพตดใหโทษ กรณทมการกระทาฝาฝนกฎหมาย

3. ใชเปนคมออางองหรอใชประโยชนอนๆ ในทางการแพทย

คณะผจดทา

ทปรกษา

นพ.บญชย สมบรณสข เลขาธการคณะกรรมการอาหารและยานพ.ปฐม สวรรคปญญาเลศ รองเลขาธการคณะกรรมการอาหารและยาภก.วชระ อาพนธ เภสชกรเชยวชาญดานระบาดวทยาของวตถเสพตด

คณะทางาน

นายประพนธ อางตระกล ผอานวยการกองควบคมวตถเสพตดนางจนทนา ธรรมวระพงษ เภสชกรชานาญการพเศษนางสาวธรธร มโนธรรม เภสชกรชานาญการนางสาวฐปนย เจรญสน เภสชกรชานาญการนางสาวกมลชนก สรยกล ณ อยธยา เภสชกรชานาญการนางสาวจตตไพจตร มงเกยรตสกล เภสชกรชานาญการนางสาววณา ทนงคงสวสด เภสชกรปฏบตการ

Page 4: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

CONTENTSสารบญ

OBJECTIVES : วตถประสงค 2HOW TO USE : วธการใชหนงสอ 4PRODUCT IDENTIFICATION SEQUENCE : ลาดบการจดภาพยาเมดดวยส รปราง และขนาด 9

PRODUCT IDENTIFICATION CHARTหมวดรปภาพเภสชภณฑ

10-40

สขาว 10 สเหลอง 14 สสม 16สแดง 17

สชมพ 17สมวง 20สฟา/นาเงน 20สเขยว 22

สนาตาล 24สเทา/ดา 24หลายส 24

PINK PAGESหมวดหนาสชมพ

41-63

THAI NARCOTICS ACT B.E. 2522 (1979) พระราชบญญตยาเสพตดใหโทษ พ.ศ. 2522 41

THAI PSYCHOTROPIC SUBSTANCES ACT B.E. 2518 (1975)พระราชบญญตวตถทออกฤทธตอจตและประสาท พ.ศ. 2518

43

CLASSIFICATION OF PSYCHOTROPICS AND NARCOTICSการจดประเภทของวตถออกฤทธและยาเสพตดใหโทษทขนทะเบยนในประเทศไทย

44-45

NATIONAL LIST OF ESSENTIAL MEDICINE (FOR PSYCHOTROPICS AND NARCOTICS)

วตถออกฤทธและยาเสพตดใหโทษในบญชยาหลกแหงชาต46-48

IMPORTANT DRUG NOTESขอมลทสาคญของตวยาทมการขนทะเบยนหรอเคยขนทะเบยนในประเทศไทย

49-63

INDEXหมวดดชนตางๆ

64-98

CONTROLLED SUBSTANCE CLASS INDEXดชนเภสชภณฑเรยงตามประเภทกลมยา และชอตวยาจาก A-Z

64-70

MANUFACTURER’S INDEXดชนเภสชภณฑเรยงตามชอผผลต

71-79

BRAND & GENERIC NAME INDEXดชนรวมชอการคาและชอสามญของยา จดเรยงตาม A-Z

80-98

LIST OF PRODUCT SOLD BY FDAรายการยาทจาหนายโดยกลมเงนทนหมนเวยนยาเสพตด

99-104

Page 5: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

HOW TO USEวธการใชหนงสอ

1 ทราบตวอยาง รปพรรณ เอกลกษณ หรอลกษณะของยา

9

PRODUCT IDENTIFICATION SEQUENCEÅíҴѺ¡ÒèѴÀÒ¾ÂÒàÁç´

9

หมายเหต:

สทปรากฏในหนงสออาจคลาดเคลอนกบสจรงของเมดยาแนะนาใหตรวจดวยคณลกษณะอนรวมดวยเชนขนาดสญลกษณ

AW_PNdex front 20100402.indd 9 2/4/2553 13:57:09

PRODUCT IDENTIFICATION SEQUENCEการจดลาดบยาเมดดวยส รปราง ขนาด ... หนา 9

PRODUCT IDENTIFICATION CHARTคนหารปภาพเภสชภณฑ ... หนา 10-40

DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 5 mg P4 [190.2 mg]

402

POBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4

403

WINOPAM (ÅÔÇÔ¹à¹ÍÃ�¿ÒÃ�ÁÒ) diazepam 5 mg XP4

404

MODURAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]

chlordiazepoxide hydrochloride 5 mg

405

CEBARAX † (ÁÒ«Òáź) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]

406

CHLORDIBRAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4

407

CLINOPRONT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg N3 [283.31 mg]

408

LIBRAX † (âÍÅÔ¤) chlordiazepoxide 5 mg P4 [299 mg]

chlordiazepoxide 5 mg

409

LICON † (äÅ¿Š ¤Í¹à«Ô¹) chlordiazepoxide hydrochloride 5 mg XP4

410

UTORAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4

411

ZEPOBRAX † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) chlordiazepoxide hydrochloride 5 mg XP4

412

DIRAX † (ÊËá¾·Â�àÀÊѪ) chlordiazepoxide 5 mg P4 [200 mg]

413

DIAPINE TABLET (á͵ᏵԤ) diazepam 10 mg P4 [320 mg]

414

TERCO-C † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 10 mg N3 [591.1 mg]

415

CODEE-C † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 10 mg N3 [345.02 mg]

416

SECO † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) codeine phosphate 10 mg N3 [331.56 mg]

417

TOCODYL † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) codeine phosphate 10 mg XN3 [325.82 mg]

418

CODESIA † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 10 mg N3 [350 mg]

419

RADIBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4

420

ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 1 mg P2 [259 mg]

421

CODENOL † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 15 mg N3

422

ROHYPNOL (âê/ÍÂ.) fl unitrazepam 1 mg P2 [175 mg]

423

PARAMED-CO † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 15 mg XN3 [601.1 mg]

424

VASON (ÁÔÅÅÔàÁ´) diazepam 2 mg P4 [110 mg]

425

CELIUM (ÂÙâ·à»‚œÂ¹) medazepam 5 mg P4 [110 mg]

426

GREEN Capsule

EUHYPNOS 20 (ÍÒÃ� ¾Õ àªÍàÃÍÃ�/ÍÂ.) temazepam 20 mg P2 [868.96 mg]

[868.96 mg]

427

TUMAX † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) chlordiazepoxide hydrochloride 5 mg P4 [180 mg]

428

ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 2 mg XP4

429

POSENE (ÊÂÒÁàÁ´Ôá¤Ã�) clorazepate dipotassium 10 mg XP4

430

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 23 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 23 8/6/2013 2:03:57 PM

*OPIUM TINCTURE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) morphine 1% x 450 mL N2

585

*ORAMORPH (àºÍÃÔ§à¡ÍÃ� ÍÔ¹à¡ÅäÎÁ�/ÍÂ.) morphine sulfate 10 mg/5 mL x 250 mL N2

586

*ORAMORPH (àºÍÃÔ§à¡ÍÃ� ÍÔ¹à¡ÅäÎÁ�/ÍÂ.) morphine sulfate 20 mg/mL x 30 mL N2

587

*P-CODYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 60 mL XN3

588

*P-CODYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 120 mL XN3

589

*PERCIDYL COUGH † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 100 mL XN3

590

*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 60 mL XN3

591

*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 500 mL XN3

592

*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 1000 mL XN3

593

*PHENOBARB ELIXIR (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) phenobarbital sodium 20 mg/5 mL x 60 mL XP4

phenobarbital sodium 20 mg/5 mL x 60 mL

594

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 30 mL XP4

phenobarbital sodium 20 mg/5 mL x 30 mL

595

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 60 mL XP4

596

†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

32 PRODUCT IDENTIFICATION CHART PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 32 8/6/2013 2:04:06 PM

หมายเหต : ยาทเคยขนทะเบยนในประเทศไทย แตปจจบนไมไดขนทะเบยนแลว ใชสญลกษณ X นาหนา class เดม เชน XP3, XP4, XN3

ชอผผลต (Manufacturer’s name) •

ชอการคา (Trade name) •

ชอสามญ (Generic name) •

ประเภทวตถออกฤทธ หรอยาเสพตดใหโทษ •

(Controlled Substance Class)

นาหนกของเมด (Weight) •

ภาพเมดยา จะมขนาดเทาของจรง •

ภาพผลตภณฑทไมใชเมดยา จะเปนขนาดยอ •

หมายเลขของภาพ (Frame No.) •

Page 6: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

2

3

ทราบชอการคาหรอชอสามญของวตถออกฤทธ

หรอยาเสพตดใหโทษ

คนหาวตถออกฤทธหรอยาเสพตดใหโทษในบญชยาหลกแหงชาต

บญช ก ร�ยก�รย�ม�ตรฐ�นทใชในก�รปองกนและแกไขปญห�สขภ�พทพบบอยมหลกฐ�นชดเจนทสนบสนนก�รใชมประสบก�รณก�รใชในประเทศไทยอย�งพอเพยงและเปนย�ทควรไดรบก�รเลอกใชเปนอนดบแรกต�มขอบงใชของย�นน

บญช ข ร�ยก�รย�ทใชสำ�หรบขอบงใชหรอโรคบ�งชนดทใชย�ในบญชกไมไดหรอไมไดผลหรอใชเปนย�แทนย�ในบญชกต�มคว�มจำ�เปน

บญช ค ร�ยก�รย�ทตองใชในโรคเฉพ�ะท�งโดยผชำ�น�ญหรอผทไดรบมอบหม�ยจ�กผอำ�นวยก�รของสถ�นพย�บ�ลนนๆโดยมม�ตรก�รกำ�กบก�รใชซงสถ�นพย�บ�ลทใชจะตองมคว�มพรอมตงแตก�รวนจฉยจนถงก�รตดต�มผลก�รรกษ�เนองจ�กย�กลมนเปนย�ทถ�ใชไมถกตองอ�จเกดพษหรอเปนอนตร�ยตอผปวยหรอเปนส�เหตใหเกดเชอดอย�ไดง�ยหรอเปนย�ทมแนวโนมในก�รใชไมตรงต�มขอบงชหรอไมคมค�หรอมก�รนำ�ไปใชในท�งทผดหรอมหลกฐ�นสนบสนนก�รใชทจำ�กดหรอมประสบก�รณก�รใชในประเทศไทยอย�งจำ�กดหรอมร�ค�แพงกว�ย�อนในกลมเดยวกน

บญช ง ร�ยก�รย�ทมหล�ยขอบงใชแตมคว�มเหม�ะสมทจะใชเพยงบ�งขอบงใชหรอมแนวโนมจะมก�รสงใชย�ไมถกตองหรอเปนร�ยก�รย�ทมร�ค�แพงจงเปนกลมย�ทมคว�มจำ�เปนตองมก�รระบขอบงใชและเงอนไขก�รสงใชย�ก�รใชบญชย�หลกแหงช�ตไปอ�งองในก�รเบกจ�ยควรนำ�ขอบงใชและเงอนไขก�รสงใชไปประกอบในก�รพจ�รณ�อนมตก�รเบกจ�ยจงจะกอประโยชนสงสดทงนย�ในบญชงจำ�เปนตองใชสำ�หรบผปวยบ�งร�ยแตอ�จทำ�ใหเกดอนตร�ยตอผปวยหรอกอปญห�เชอดอย�ทร�ยแรงก�รสงใชย�ซงตองใหสมเหตผลเกดคว�มคมค�สมประโยชนจะตองอ�ศยก�รตรวจวนจฉยและพจ�รณ�โดยผชำ�น�ญเฉพ�ะโรคทไดรบก�รฝกอบรมในส�ข�วช�ทเกยวของจ�กสถ�นฝกอบรมหรอไดรบวฒบตรหรอหนงสออนมตจ�กแพทยสภ�หรอทนตแพทยสภ�เท�นนและโรงพย�บ�ลจะตองมระบบก�รกำ�กบประเมนและตรวจสอบก�รใชย�(DrugUtilizationEvaluation,DUE)โดยตองมก�รเกบขอมลก�รใชย�เหล�นนเพอตรวจสอบในอน�คตได

บญช จ(1) ร�ยก�รย�สำ�หรบโครงก�รพเศษของกระทรวงทบวงกรมหรอหนวยง�นของรฐทมก�รกำ�หนดวธก�รใชและก�รตดต�มประเมนก�รใชย�ต�มโครงก�รโดยมหนวยง�นนนรบผดชอบและมก�รร�ยง�นผลก�รดำ�เนนง�นตอคณะอนกรรมก�รพฒน�บญชย�หลกแหงช�ตเปนระยะต�มคว�มเหม�ะสมเพอพจ�รณ�จดเข�ประเภทของบญชยอยอนในบญชย�หลกตอไปเมอมขอมลเพยงพอ

บญช จ(2) ร�ยก�รย�สำ�หรบผปวยทมคว�มจำ�เปนเฉพ�ะใหเข�ถงย�ไดอย�งสมเหตผลและคมค�ซงมก�รจดกลไกกล�งเปนพเศษในกำ�กบก�รใชย�ภ�ยใตคว�มรบผดชอบรวมกนของระบบประกนสขภ�พซงดแลโดยกรมบญชกล�งกระทรวงก�รคลงสำ�นกง�นประกนสงคมกระทรวงแรงง�นสำ�นกง�นหลกประกนสขภ�พแหงช�ตและหนวยง�นอนๆทเกยวของโดยมแนวท�งกำ�กบก�รใชย�ต�มภ�คผนวก3

“ร�ยก�รย�สำ�หรบผปวยทมคว�มจำ�เปนเฉพ�ะ”ต�มบญชจ(2)หม�ยคว�มว�ย�ทจำ�เปนตองใชสำ�หรบผปวยเฉพ�ะร�ยโดยย�มคว�มเหม�ะสมทจะใชเพยงบ�งขอบงใชหรอมแนวโนมจะมก�รสงใชย�ไมถกตองหรอเปนย�ทตองอ�ศยคว�มรคว�มชำ�น�ญเฉพ�ะโรคหรอใชเทคโนโลยขนสงและเปนย�ทมร�ค�แพงม�กหรอสงผลอย�งม�กตอคว�มส�ม�รถในก�รจ�ยทงของสงคมและผปวยจงตองมระบบกำ�กบและอนมตก�รสงใชย�(authorizedsystem)ทเหม�ะสมโดยหนวยง�นสทธประโยชนหรอหนวยง�นกล�งทไดรบมอบหม�ยทงนเพอใหเปนไปต�มขอบงใชและเงอนไขก�รสงใชย�จงจะกอประโยชนสงสดโรงพย�บ�ลจะตองมระบบก�รกำ�กบประเมนและตรวจสอบก�รใชย�และมเกบขอมลก�รใชย�เหล�นนเพอใหตรวจสอบโดยกลไกกล�งในอน�คตได

NATIONAL LIST OF ESSENTIAL MEDICINES (NLEM)วตถออกฤทธและย�เสพตดใหโทษในบญชย�หลกแหงช�ต

บญชย�หลกแหงช�ต พ.ศ.2555 มจดประสงคเพอสร�งเสรมระบบก�รใชย�อย�งสมเหตผล

ย�ทอยในบญชย�หลกแหงช�ตนจะแสดงร�ยก�รย�โดยใชชอส�มญของย�ทงในรปเบสเกลอหรอเอสเทอรของย�โดยจะระบคณสมบตเฉพ�ะต�งๆไดแกรปแบบผลตภณฑคว�มแรงขน�ดบรรจ(บ�งร�ยก�ร)ย�ทมคณสมบตครบต�มขอกำ�หนดดงกล�วเท�นนจงจดเปนย�ในบญชย�หลกแหงช�ตทงนสำ�หรบย�ทมเงอนไขหรอมหม�ยเหตจะตองใชต�มเงอนไขและหม�ยเหตทแสดงไวในร�ยละเอยดของย�แตละชนดกอนเสมอ

ก�รจดแบงกลมย�เปนสวนหนงในก�รสงเสรมใหย�ในบญชย�หลกแหงช�ตใชอย�งเหม�ะสมและคมค�โดยมหลกก�รแบงต�มระดบคว�มรคว�มส�ม�รถและคว�มเชยวช�ญของแพทยและผประกอบวช�ชพด�นสขภ�พทจะใชย�แบงเปน5บญชยอยคอบญชก.ข.ค.ง.และจ.โดยแบงยอยอกเปนจ(1)และจ(2)

ย�แตละชนดจะส�ม�รถจดอยในบญชยอยไดม�กกว�1บญชโดยขนกบขอบงชรปแบบและร�ยละเอยดต�งๆทกำ�หนดไว

PINK PAGES 2013-FINAL-July31.indd 46 8/7/2013 1:43:10 PM

BRAND & GENERIC NAME INDEXดชนรวมชอการคาและชอสามญ ... หนา 80-98

PRODUCT IDENTIFICATION CHARTคนหารปภาพเภสชภณฑ ... หนา 10-40

• คนตามหมายเลขภาพมมลางซาย

NATIONAL LIST OF ESSENTIAL MEDICINEขอกาหนดบญชยาหลกแหงชาต ... หนา 46-48

(เฉพาะวตถออกฤทธและยาเสพตดใหโทษ)• คนตามชอสามญ เรยงลาดบชอ A-Z

VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 5 mg XP4 [70.02 mg]

239

ALPRALAN (âÍÅѹ-à¤ÁàÁ´) alprazolam 0.5 mg P2 [157.28 mg]

240

PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 2 mg XP4

241

DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 5 mg P4 [145.6 mg]

242

DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 2 mg P4 [130 mg]

243

LORA (á͵ᏵԤ) lorazepam 2 mg P4 [200 mg]

244

MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 60 mg N2

245

S.CO ZEPAM (àÍÊ â¤ ¿ÒÃ�ÁÒ) diazepam 5 mg XP4

246

BELLADONNA ALKALOIDS W/ PHENOBARBITAL † (ÊÒÁѤ¤ÕàÀÊѪ) phenobarbital sodium 16.2 mg XP4 [160 mg]

247

CENTRODINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 10 mg N3 [205.2 mg]

248

DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 10 mg XP4 [233 mg]

249

DIZEPAM (ÁÒ«Òáź) diazepam 2 mg P4 [170 mg]

250

KENSPA † (हÂÒ¡Ø) chlordiazepoxide hydrochloride 5 mg P4 [246 mg]

251

TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 50 mg XP3

252

LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 2 mg P4 [200 mg]

253

LEXOTAN (âê) bromazepam 3 mg P4 [200 mg]

254

PHENOCON (ÁÒ«Òáź) phenobarbital sodium 60 mg XP4

255

ANAX (ÁÔÅÅÔàÁ´) alprazolam 0.5 mg P2 [130 mg]

256

ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 0.5 mg P2 [132.5 mg]

257

ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 0.5 mg P2 [130 mg]

258

ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 0.5 mg P2 [130 mg]

259

ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 0.5 mg P2

260

ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 1 mg P2

261

DIZOLAM (á͵ᏵԤ) alprazolam 0.5 mg P2 [130 mg]

262

FARZOLAM (¿ÒÃ�ÁÕ¹‹Ò) alprazolam 0.5 mg P2

263

MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [130 mg]

264

MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 0.5 mg P2 [130 mg]

265

MOXINAX (âÁà´ÍÃ�¹áÁ¹Ù) alprazolam 0.5 mg P2 [130 mg]

266

PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [131.9 mg]

267

PRAZOL (हÂÒ¡Ø) alprazolam 0.5 mg P2 [216.36 mg]

268

SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 0.5 mg P2 [125.75 mg]

269

XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2

270

XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 0.5 mg P2 [110 mg]

271

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

18 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 18 8/6/2013 2:03:48 PM

BRAND & GENERIC NAME INDEX 81PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient xIndicates brand may be off-market ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient xIndicates brand may be off-market

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

- xSIAMPRAXOL 0.5 mg - 269

- xSIAMPRAXOL 1 mg - 315

- xSUNAX 0.25 mg - 120

- xSUNAX 0.5 mg - 279

- xXALAM 0.25 mg - 112

- xXALAM 0.5 mg - 270

- xXALAM 1 mg - 316

- XANACINE 0.25 mg - 113

- XANACINE 0.5 mg - 271

- XANACINE 1 mg - 317

- XANAX 0.25 mg - 114

- XANAX 0.5 mg - 272

- XANAX 1 mg - 318

- XANAX XR 0.5 mg - 372

- XANAX XR 1 mg - 079

- xXANAX XR 2 mg - 381

- xXIEMED 0.25 mg - 121

- xXIEMED 0.5 mg - 280

- xXIEMED 1 mg - 323

- xZOLAM 0.25 mg - 115

- xZOLAM 0.5 mg - 273

- xZOLAM 1 mg - 319

ALPRAZOLAM FRX 0.25 mg - 122

ALPRAZOLAM FRX 0.5 mg - 282

AMA† P2A 20/55 159

amobarbital:

- AMA† P2A 20/55 159

- AMYTAL 0.5 g - 674

AMYTAL 0.5 g - 674xANAX 0.25 mg - 097xANAX 0.5 mg - 256ANCORIL 0.5 mg P1A 14/51 209xANPRESS 0.25 mg - 102xANPRESS 0.5 mg - 274xANPRESS 1 mg - 309ANTA 0.5 mg P1A 36/53 330ANTA 1 mg P1A 12/54 018ANTA 2 mg P1A 29/52 138ANXENE 5 mg - 455ANXENE 10 mg - 288xANXIELAX 5 mg - 486ANXIRA 0.5 mg P1A 24/52 327ANXIRA 1 mg P1A 25/52 021xANZION 0.25 mg - 098xANZION 0.5 mg - 257xANZION 1 mg - 306xATIVAN 0.5 mg - 332xATIVAN 1 mg - 023xATIVAN 2 mg - 141

xATRACTIL 75 mg - 505xAZEPAM 2 mg - 219xAZEPAM 5 mg - 326A-ZERAX 2 mg P1A 37/52 479A-ZERAX 5 mg P1A 38/52 489

BBELLADONNA ALKALOIDS W/

PHENOBARBITAL† - 247xBELLERGAL† - 232xBELLOID† - 139xBENADRYL CD†

60 mL - 533xBENADRYL CD†

1000 mL - 534xBENERA† - 433BENPINE 5 mg P1A 32/54 435BENPINE 10 mg P1A 17/54 526BENPINE 25 mg P1A 1/49 218BENYLIN CD† 60 mL - 535BLUCO† - 383xBLUCON† - 360BONADINE CD† 60 mL - 536

bromazepam:

- LEXOTAN 1.5 mg P1C 26/55 080

- LEXOTAN 3 mg P1C 27/55 254xBROMTUSSIA DC†

60 mL - 537BRONPECT† - 325BROWN MIXTURE

GPO† 180 mL N2A 15/45 538BROWN MIXTURE

GPO† 450 mL N2A 15/45 539BROWN MIXTURE

OSOTH INTERLAB† 180 mL N2A 13/53 540

buprenorphine hydrochloride:

- xBUPRINE 0.2 mg - 001

- xTEMGESIC 0.3 mg/mL x 1 mL - 666

- xTEMGESIC 0.2 mg - 007xBUPRINE 0.2 mg - 001

butobarbital:

- xBELLOID† - 139

CCALMIPAM 2 mg - 388CALMIPAM 5 mg - 302CALYPSOL

50 mg/mL x 10 mL - 675CAMPHORATED

OPIUM TINCTURE GPO 1000 mL N2A 6/53 541

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug1.indd 81 8/7/2013 12:57:34 PM

90 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient xIndicates brand may be off-market

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

FENTANYL HEXAL 12 mcg/hr - 689

FENTANYL HEXAL 25 mcg/hr - 690

FENTANYL HEXAL 50 mcg/hr - 691

FENTANYL JANSSEN-CILAG 0.05 mg/mL x 2 mL - 635

FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL - 636

FENTANYL SANDOZ 0.05 mg/mL x 2 mL - 637

FENTANYL SANDOZ 500 mcg/10 mL - 676

FENTANYL-HAMELN 50 mcg/mL x 2 mL - 638

FENTANYL-HAMELN 50 mcg/mL x 10 mL - 639

FENTANYL-SNS 50 mcg/mL x 2 mL - 640

FLULIUM 5 mg P1A 28/55 467FLULIUM 10 mg - 300

flunitrazepam:

- ROHYPNOL 1 mg - 423

flurazepam hydrochloride:

- xDALMADORM 15 mg - 512xFORTWIN

30 mg/mL x 1 mL - 641FREXENE 5 mg - 441FREXENE 10 mg - 445FRISIUM 5 mg P1C 12/53,

P1B 13/53 038FRISIUM 10 mg - 039

GxGARDENAL

200 mg/4 mL P1C 1/50 677GAXENE 5 mg - 474GRANDAXIN 50 mg P1C 27/53 058

HHALCION 0.25 mg - 378HAWKCOPAX 0.5 mg P1A 7/55 348HAWKCOPAX 1 mg - 393xHISEDYL† 60 mL - 557xHISEDYL† 120 mL - 558

IINZOLAM 0.25 mg - 118INZOLAM 0.5 mg - 277INZOLAM 1 mg - 321

KKAPANOL 20 mg - 133KAPANOL 50 mg - 134KAPANOL 100 mg - 135KEMORA 0.5 mg P1A 48/54 434KEMORA 1 mg P1A 49/54 024KENSPA† P2A 36/52 251xKETA-HAMELN

50 mg/mL x 10 mL - 678KETALAR

50 mg/mL x 10 mL - 679

ketamine hydrochloride:

- CALYPSOL 50 mg/mL x 10 mL - 675

- xKETA-HAMELN 50 mg/mL x 10 mL - 678

- KETALAR 50 mg/mL x 10 mL - 679

LxLAYLIUM-10

10 mg/2 mL x 2 mL - 642LEXOTAN 1.5 mg P1C 26/55 080LEXOTAN 3 mg P1C 27/55 254LIBRAX† P2A 3/55 409LICON† - 410LIZAVAN 0.5 mg - 333LIZAVAN 1 mg - 025LOMOTIL† N2A 12/53 004LONZA 0.5 mg P1A 1/54 339LONZA 1 mg P1A 2/54 020LORA 0.5 mg P1A 28/54 397LORA 1 mg P1A 29/54 040xLORA 2 mg P1A 30/54 244LORAMED 0.5 mg - 334LORAMED 1 mg - 026LORAMED 2 mg P1A 50/54 237LORAMET 1 mg - 105LORA-P 0.5 mg - 347LORA-P 1 mg - 013LORA-P 2 mg - 137xLORAPAM 0.5 mg - 336xLORAPAM 1 mg - 027xLORAPAM 2 mg - 142LORAPINE 0.5 mg - 340LORAPINE 1 mg - 033LORAVAN 0.5 mg P1A 22/50 329LORAVAN 1 mg - 028LORAZE 1 mg P1A 31/51 044xLORAZENE 0.5 mg - 328xLORAZENE 1 mg - 014xLORAZENE 2 mg - 143

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug1.indd 90 8/7/2013 12:57:35 PM

5

Page 7: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

CONTENTSสารบญ ... หนา 3

4 ทราบประเภทของทะเบยนวตถออกฤทธหรอยาเสพตดใหโทษ

CLASSIFICATION OFPSYCHOTROPICS & NARCOTICS

การจดกลมประเภทและสาระตามกฎหมาย ... หนา 44-45• สาระสาคญในการควบคมตามกฎหมาย• รายชอตวยา (ชอสามญ) ของวตถออกฤทธและ

ยาเสพตดใหโทษจดตามกลม/ประเภท ตามกฎหมาย

CONTENTSสารบญ

OBJECTIVES : วตถประสงค 2HOW TO USE : วธการใชหนงสอ 4PRODUCT IDENTIFICATION SEQUENCE : ลาดบการจดภาพยาเมดดวยส รปราง และขนาด 9

PRODUCT IDENTIFICATION CHARTหมวดรปภาพเภสชภณฑ

10-40

สขาว 10 สเหลอง 14 สสม 16สแดง 17

สชมพ 17สมวง 20สฟา/นาเงน 20สเขยว 22

สนาตาล 24สเทา/ดา 24หลายส 24

PINK PAGESหมวดหนาสชมพ

41-63

Thai Narcotics Act B.E. 2522 (1979) พระราชบญญตยาเสพตดใหโทษ พ.ศ. 2522 41

Thai Psychotropics Act B.E. 2518 (1975)พระราชบญญตวตถทออกฤทธตอจตและประสาท พ.ศ. 2518

43

CLASSIFICATION OF PSYCHOTROPICS AND NARCOTICSการจดประเภทของวตถออกฤทธและยาเสพตดใหโทษทขนทะเบยนในประเทศไทย

44-45

NATIONAL LIST OF ESSENTIAL MEDICINE (FOR PSYCHOTROPICS AND NARCOTICS)

วตถออกฤทธและยาเสพตดใหโทษในบญชยาหลกแหงชาต46-48

IMPORTANT DRUG NOTESขอมลทสาคญของตวยาทมการขนทะเบยนหรอเคยขนทะเบยนในประเทศไทย

49-63

INDEXหมวดดชนตางๆ

64-98

CONTROLLED SUBSTANCE CLASS INDEXดชนเภสชภณฑเรยงตามประเภทกลมยา และชอตวยาจาก A-Z

64-70

MANUFACTURER’S INDEXดชนเภสชภณฑเรยงตามชอผผลต

71-79

BRAND & GENERIC NAME INDEXดชนรวมชอการคาและชอสามญของยา จดเรยงตาม A-Z

80-98

LIST OF PRODUCT SOLD BY FDAรายการยาทจาหนายโดยกลมเงนทนหมนเวยนยาเสพตด

99-104

ส�ระสำ�คญในก�รควบคมต�มกฎหม�ยวตถออกฤทธในประเภท 1 (P1)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท1ยกเวนกระทรวงส�ธ�รณสขหรอผซงไดรบมอบหม�ยจ�กกระทรวงส�ธ�รณสข

วตถออกฤทธในประเภท 2 (P2)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท2ยกเวนกระทรวงส�ธ�รณสขหรอผซงไดรบมอบหม�ยจ�กกระทรวงส�ธ�รณสขทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมทข�ยใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงทข�ยเฉพ�ะสำ�หรบใชกบสตวทตนบำ�บดหรอปองกนโรคหรอข�ยโดยกระทรวงทบวงกรมสภ�ก�ช�ดไทย

วตถออกฤทธในประเภท 3 และ 4 (P3, P4)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท3หรอ4หรอนำ�ผ�นวตถออกฤทธทกประเภทเวนแตไดรบอนญ�ตทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมทข�ยใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงทข�ยเฉพ�ะสำ�หรบใชกบสตวทตนบำ�บดหรอปองกนโรคและไมใชบงคบในก�รผลตข�ยนำ�เข�หรอสงออกโดยกระทรวงทบวงกรมสภ�ก�ช�ดไทยองคก�รเภสชกรรม

ยาเสพตดใหโทษในประเภท 1 (N1)ห�มมใหผใดผลตนำ�เข�สงออกจำ�หน�ยหรอมไวในครอบครองซงย�เสพตดใหโทษในประเภท1เวนแตรฐมนตรไดอนญ�ตเฉพ�ะในกรณจำ�เปนเพอประโยชนของท�งร�ชก�ร

ยาเสพตดใหโทษในประเภท 2 (N2)ห�มมใหผใดผลตนำ�เข�หรอสงออกย�เสพตดใหโทษในประเภท2เวนแตไดรบอนญ�ตในกรณจำ�เปนเพอประโยชนของท�งร�ชก�รในกรณจำ�หน�ยหรอมไวในครอบครองตองไดรบอนญ�ต

ยาเสพตดใหโทษในประเภท 3 (N3)ห�มมใหผใดผลตนำ�เข�สงออกจำ�หน�ยหรอมไวในครอบครองเพอจำ�หน�ยซงย�เสพตดใหโทษในประเภท3เวนแตไดรบอนญ�ตทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมจำ�หน�ย/ครอบครองใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงจำ�หน�ย/ครอบครองสำ�หรบใชกบสตวทตนบำ�บด

ยาเสพตดใหโทษในประเภท 4 และ 5 (N4 & N5)ห�มมใหผใดผลตจำ�หน�ยนำ�เข�สงออกหรอมไวในครอบครองซงย�เสพตดใหโทษในประเภท4หรอในประเภท5เวนแตรฐมนตรจะไดอนญ�ตโดยคว�มเหนชอบของคณะกรรมก�รควบคมย�เสพตดใหโทษเปนร�ยๆไป

1. ชอส�มญของวตถออกฤทธในประเทศไทย (ชอทเปนตวหน�หม�ยถงเปนวตถออกฤทธทยงคงมตำ�รบย�ในประเทศไทยถงเดอนพฤษภ�คม2556)

วตถออกฤทธในประเภท 1 (P1)

วตถออกฤทธในประเภท 2 (P2)

วตถออกฤทธในประเภท 3 (P3)

วตถออกฤทธในประเภท 4 (P4)

Cathinone Alprazolam Pemoline Amobarbital Allobarbital MedazepamDET Amfepramone

(Diethylpropion)Phencyclidine Butalbital Barbital Mefenorex

DMHP Phendimetrazine Cyclobarbital Benzphetamine MethyphenobarbitalDMT Amineptine Phenmetrazine Glutethimide Bromazepam MethyprylonEtryptamine Aminorex Phentermine Meprobamate Butobarbital Nordazepam

(Nordiazepam)GHB Brotizolam Phenylpropanolamine Pentazocine CamazepamMethcathinone Buprenorphine Pipradrol Pentobarbital Chloral hydrate and

its adductsOxazepam

Mescaline Butorphanol Pseudoephedrine OxazolamMescaline derivatives Cathine (D-Norpseu-

doephedrine)Quazepam Chlodiazepoxide Perlapine

Mescaline analog e.g. Escaline

Secobarbital Chlophentermine PhenobarbitalEphedrine Temazepam Clobazam Pinazepam

Isoproscaline Estazolam Triazolam Clonazepam PrazepamProscaline Fencamfamin Zalepron Clorazepate Propylhexedrine4-Thiomescaline or 4-TM Fenethylline Zipeprol Clortermine Pyrovalerone4-Thioescaline or 4-TE Flunitrazepam Zopiclone Clotiazepam Secbutabarbital4-Thiooproscaline or 4-TP Flurazepam Zolpidem Cloxazolam SPA (Lefetamine)3- Thiomescaline or 3-TM Haloxazolam Diazepam Tetrazepam3-Thioescaline or 3-TE Ketamine Delorazepam Tofisopam3-Thiometaescaline or 3-TME Loprazolam Ethchlorvynol Vinylbital4-Methylaminorex Lormetazepam EthinamateParahexyl Mazindol Ethyl loflazepatePCE Methylphenidate FenproporexPHP(PCPY) Mesocarb FludiazepamPsilocine Midazolam HalazepamPsilocybine N-Ethylamphetamine Inorganic bromideTCP Nimetazepam KetazolamTetrahydrocannabinol Nitrazepam Lorazepam

CLASSIFICATION OF PSYCHOTROPICS & NARCOTICSประเภทของวตถออกฤทธและย�เสพตดใหโทษในประเทศไทย

PINK PAGES 2013-FINAL-July31.indd 44 8/7/2013 1:43:09 PM

ÄRegistration expired

IMPORTANT DRUG NOTESขอมลสำ�คญของตวย�วตถออกฤทธและย�เสพตดใหโทษ

Provides Useful Information On Significant Contraindications, Precautions, Adverse Reactions And Interactions Of Drugs, Presented According To The Psychotropic & Narcotic Drugs List Of Thailand Note: I: Indications; CI: Contraindications; SP: Precautions; AR: Adverse Reactions; DI: Drug Interactions.

P2 - Psychotropic Substance Schedule 2

• Alprazolam •

ลดอ�ก�รวตกกงวลและอ�ก�รตนตระหนก

I: Management of anxiety and panic attacks.

CI: Acute narrow-angle glaucoma, pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.

SP: Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal func-tion; arteriosclerosis; obesity; depression particu-larly suicidal tendency; chronic pulmonary insuf-ficiency. May impair ability to drive or operate machinery. Children <18 yr.

AR: Psychological & physical dependence, with-drawal syndrome; drowsiness, sedation, vertigo, headache, visual disturbances, photosensitivity, GI disturbances, jaundice; fatigue, muscle weakness, ataxia, seizures, delirium, dizziness, confusion & depression. Blood dyscrasias. Mania & hypomania.

DI: Potentiates action of alcohol & CNS depressants. Reduced conc w/ cigarette smoking by 50%. Cimeti-dine & fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine & desip-ramine. Decreased metabolism w/ CYP3A4 inhibitors.

• Amfepramone • (diethylpropion)

ลดคว�มอย�กอ�ห�รในก�รรกษ�ผทมนำ�หนกเกนกว�ปกต

I: Obesity.

CI: Advanced arteriosclerosis. Hyperthyroid-ism. Hypersensitivity. Glaucoma. Agitated states. History of drug abuse. Pulmonary HTN or severe hypertension. Heart murmur or valvular disorders. Emotional instability. History of psychiatric illness. Concomitant use w/ other anorectic agents. MAOI

therapy or w/in 2 wk of discontinuation. Pregnancy & lactation. Childn & elderly.

SP: Increased risk of developing primary pulmonary HTN (PPH). HTN & severe CV disease. Prolonged use may induce dependence w/ withdrawal symp-toms on cessation of therapy; do not use for more than 3 months. May increase convulsions in some epileptic patients. Toxic psychosis. Peptic ulceration. Prostatic hyperplasia. Diabetes mellitus. May impair ability to perform hazardous activities w/c requires mental alertness or physical coordination.

AR: CV & CNS disturbances; GI effects; allergic reactions; impotence; changes in libido, gyneco-mastia, menstrual upset; hematopoietic effects; dyspnea, hair loss, muscle pain, dysuria, increased sweating, polyuria.

DI: Hypertensive risk w/ MAOIs. b-blockers, guanethidine, TCAs, urinary alkalinisers or acidifiers, sibutramine. Alters antidiabetic drug requirements.

• ÄBuprenorphine •

บรรเท�ปวดระดบป�นกล�งถงปวดรนแรงสำ�หรบใชในก�รผ�ตด

I: As a perioperative analgesic supplement. Moder-ate to severe pain. Premedication before anaesthe-sia. Management of opiate dependence. Reversal of fentanyl-induced anesthesia.

CI: Acute alcoholism; convulsive disorders; head injuries; increased intracranial pressure; comatose patients; resp depression & obstructive airway disease; patients on established opioid agonists.

SP: Hepatic or renal disease; pregnancy, lactation; hypothyroidism; adrenocortical insufficiency; asthma; prostatic hyperplasia; shock; hypotension; inflam-matory or obstructive bowel disorders; myasthae-nia gravis; infants/neonates. Reduce dose in elderly & debilitated patients. May precipitate withdrawal symptoms in narcotic addicts. Pulmonary impair-ment. Patients w/ delirium tremens, toxic psycho-ses, kyphoscoliosis, prostatic hypertrophy, urethral stricture, increased intracranial pressure, seizure disorder, dysfunction of biliary tract, hypokalemia. May impair ability to perform hazardous activities w/c requires mental alertness or physical coordination.

PINK PAGES 2013-FINAL-July31.indd 49 8/15/2013 9:50:49 AM

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

P2

alprazolam

ALCELAM 0.25 mg 100ALCELAM 0.5 mg 259ALCELAM 1 mg 308ALLAM 0.25 mg 116ALLAM 0.5 mg 275ALLAM 1 mg 320ALNAX 0.25 mg 099ALNAX 0.5 mg 258ALNAX 1 mg 307ALPAZAM 0.25 mg 101ALPAZAM 0.5 mg 260ALPAZAM 1 mg 261ALPRALAN 0.25 mg 036ALPRALAN 0.5 mg 240ALPRAMED 0.25 mg 276ALPRAMED 0.5 mg 117ALPRAMED 1 mg 421ALPRAX 0.25 mg 161ALPRAX 0.5 mg 195ALPRAX 1 mg 052ALPRAXOL 0.25 mg 017ALPRAXOL 0.5 mg 235ALPRAZOLAM FRX

0.25 mg 122ALPRAZOLAM FRX

0.5 mg 282ANAX 0.25 mg 097ANAX 0.5 mg 256ANPRESS 0.25 mg 102ANPRESS 0.5 mg 274ANPRESS 1 mg 309ANZION 0.25 mg 098ANZION 0.5 mg 257ANZION 1 mg 306DIZOLAM 0.25 mg 103DIZOLAM 0.5 mg 262DIZOLAM 1 mg 324FARZOLAM 0.25 mg 104FARZOLAM 0.5 mg 263FARZOLAM 1 mg 310INZOLAM 0.25 mg 118INZOLAM 0.5 mg 277INZOLAM 1 mg 321

MANEX 0.25 mg 106MANEX 0.5 mg 264MANEX 1 mg 311MARZOLAM 0.25 mg 107MARZOLAM 0.5 mg 265MARZOLAM 1 mg 312MITRANAX 0.25 mg 119MITRANAX 0.5 mg 278MITRANAX 1 mg 322MOXINAX 0.25 mg 108MOXINAX 0.5 mg 266PHARNAX 0.25 mg 109PHARNAX 0.5 mg 267PHARNAX 1 mg 313PRAZOL 0.25 mg 110PRAZOL 0.5 mg 268PRAZOL 1 mg 314SIAMPRAXOL 0.25 mg 111SIAMPRAXOL 0.5 mg 269SIAMPRAXOL 1 mg 315SUNAX 0.25 mg 120SUNAX 0.5 mg 279XALAM 0.25 mg 112XALAM 0.5 mg 270XALAM 1 mg 316XANACINE 0.25 mg 113XANACINE 0.5 mg 271XANACINE 1 mg 317XANAX 0.25 mg 114XANAX 0.5 mg 272XANAX 1 mg 318XANAX XR 0.5 mg 372XANAX XR 1 mg 079XANAX XR 2 mg 381XIEMED 0.25 mg 121XIEMED 0.5 mg 280XIEMED 1 mg 323ZOLAM 0.25 mg 115ZOLAM 0.5 mg 273ZOLAM 1 mg 319

buprenorphine hydrochloride

BUPRINE 0.2 mg 001TEMGESIC

0.3 mg/mL x 1 mL 666TEMGESIC 0.2 mg 007

cathine

D-NORPSEUDOEPHEDRINE SR OSMOPHARM 20 mg 517

MIRAPRONT N 20 mg 516

diethylpropion hydrochloride

DIETIL RETARD 75 mg 096

PREFAMONE 75 mg 191

REGENON RETARD 75 mg 130

REGENON RETARD 75 mg 504

diethylpropion resinate

ATRACTIL 75 mg 505

ephedrine hydrochloride

EPHEDRINE GPO 30 mg/mL x 1 mL 632

flunitrazepam

ROHYPNOL 1 mg 423

flurazepam hydrochloride

DALMADORM 15 mg 512

ketamine hydrochloride

CALYPSOL 50 mg/mL x 10 mL 675

KETA-HAMELN 50 mg/mL x 10 mL 678

KETALAR 50 mg/mL x 10 mL 679

lormetazepam

LORAMET 1 mg 105

CONTROLLED SUBSTANCE CLASS INDEX

ดชนเภสชภณฑจดเรยงตามกลม/ประเภทของทะเบยน

Controlled Substance Class-Aug13.indd 64 8/14/2013 2:43:23 PM

DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 5 mg P4 [190.2 mg]

402

POBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4

403

WINOPAM (ÅÔÇÔ¹à¹ÍÃ�¿ÒÃ�ÁÒ) diazepam 5 mg XP4

404

MODURAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]

chlordiazepoxide hydrochloride 5 mg

405

CEBARAX † (ÁÒ«Òáź) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]

406

CHLORDIBRAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4

407

CLINOPRONT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg N3 [283.31 mg]

408

LIBRAX † (âÍÅÔ¤) chlordiazepoxide 5 mg P4 [299 mg]

chlordiazepoxide 5 mg

409

LICON † (äÅ¿Š ¤Í¹à«Ô¹) chlordiazepoxide hydrochloride 5 mg XP4

410

UTORAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4

411

ZEPOBRAX † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) chlordiazepoxide hydrochloride 5 mg XP4

412

DIRAX † (ÊËá¾·Â�àÀÊѪ) chlordiazepoxide 5 mg P4 [200 mg]

413

DIAPINE TABLET (á͵ᏵԤ) diazepam 10 mg P4 [320 mg]

414

TERCO-C † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 10 mg N3 [591.1 mg]

415

CODEE-C † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 10 mg N3 [345.02 mg]

416

SECO † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) codeine phosphate 10 mg N3 [331.56 mg]

417

TOCODYL † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) codeine phosphate 10 mg XN3 [325.82 mg]

418

CODESIA † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 10 mg N3 [350 mg]

419

RADIBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4

420

ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 1 mg P2 [259 mg]

421

CODENOL † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 15 mg N3

422

ROHYPNOL (âê/ÍÂ.) fl unitrazepam 1 mg P2 [175 mg]

423

PARAMED-CO † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 15 mg XN3 [601.1 mg]

424

VASON (ÁÔÅÅÔàÁ´) diazepam 2 mg P4 [110 mg]

425

CELIUM (ÂÙâ·à»‚œÂ¹) medazepam 5 mg P4 [110 mg]

426

GREEN Capsule

EUHYPNOS 20 (ÍÒÃ� ¾Õ àªÍàÃÍÃ�/ÍÂ.) temazepam 20 mg P2 [868.96 mg]

[868.96 mg]

427

TUMAX † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) chlordiazepoxide hydrochloride 5 mg P4 [180 mg]

428

ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 2 mg XP4

429

POSENE (ÊÂÒÁàÁ´Ôá¤Ã�) clorazepate dipotassium 10 mg XP4

430

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 23 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 23 8/6/2013 2:03:57 PM

IMPORTANT DRUG NOTESขอมลสาคญของตวยา ... หนา 49-63• คนตามชอสามญ จาก A-Z ในแตละกลม

CONTROLLED SUBSTANCECLASS INDEX

ดชนกลม/ประเภทของทะเบยน ...หนา 64-70

• คนตามชอสามญ เรยงลาดบชอ A-Z ในแตละกลม

6

Page 8: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

5

6

คนหา ขอหาและโทษ จากพระราชบญญตฯ ทเกยวของ

คนหาจากชอบรษทผผลต

THAI NARCOTICS ACTพระราชบญญตยาเสพตดใหโทษ ... หนา 41

THAI PSYCHOTROPIC SUBSTANCES ACT

พระราชบญญตวตถทออกฤทธตอจตและประสาท ... หนา 43

ตารางบนทกขอหาและบทกำาหนดโทษ ทมา : บนทก ป.ป.ส. 2556 สำานกงาน ป.ป.ส. กระทรวงยตธรรม

ขอหา ยาเสพตดใหโทษประเภท 1

ผลตนำาเขาสงออก(ม.15, 65)

•จำ�คกตลอดชวตและปรบ1ล�น-5ล�นบ�ท•ถ�กระทำ�เพอจำ�หน�ยประห�รชวตถ�ปรม�ณตอไปนขนไปใหถอว�ผลตนำ�เข�สงออกครอบครองเพอจำ�หน�ยแอลเอสดส�รบรสทธ0.75มลลกรมหรอ15หนวยก�รใชหรอนำ�หนกสทธ300มลลกรม(หนวยก�รใช=เมด,ซอง,ขวดหรอหนวยอย�งอนททำ�ขนโดยปกตสำ�หรบก�รใชเสพหนงครง)ยาบาส�รบรสทธ375มลลกรมหรอ15หนวยก�รใชหรอนำ�หนกสทธ1.5กรมยาเสพตดใหโทษประเภท 1 อนๆส�รบรสทธ3กรม•ถ�เปนก�รผลตโดยก�รแบงบรรจหรอรวมบรรจจำ�คก4-15ปหรอปรบ80,000-300,000บ�ทหรอทงจำ�ทงปรบถ�กระทำ�เพอจำ�หน�ยจำ�คก4ป-ตลอดชวตและปรบ400,000-5ล�นบ�ท

จำาหนายครอบครองเพอจำ�หน�ย(ม.15, 66)

•จำ�คก4-15ปหรอปรบ80,000-300,000บ�ทหรอทงจำ�ทงปรบ•ถ�มส�รบรสทธปรม�ณตอไปนแอลเอสด0.75มลลกรม-20กรมหรอย�บ�375มลลกรม-20กรมหรอย�เสพตดใหโทษประเภท1อนๆ3-20กรมจำ�คก40ป-ตลอดชวตและปรบ400,000-5ล�นบ�ท•ถ�มส�รบรสทธเกน20กรมจำ�คกตลอดชวตและปรบ1ล�นบ�ท-5ล�นบ�ทหรอประห�รชวต

ครอบครอง(ม.15, 67)

•จำ�คก1-10ปหรอปรบ20,000-200,000บ�ทหรอทงจำ�ทงปรบ

เสพ(ม.57, 91)

•จำ�คก6เดอน-3ปหรอปรบ10,000-60,000บ�ทหรอทงจำ�ทงปรบ

หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)

•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป–ตลอดชวตและปรบ300,000-5,000,000บ�ทถ�เปนเฮโรอนตองระว�งโทษเปนสองเท�และถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะประห�รชวต

ขอหา ยาเสพตดใหโทษประเภท 2

ผลตนำาเขาสงออก(ม.16, 68)

•จำ�คก1-10ปและปรบ100,000-1ล�นบ�ท•ถ�เปนมอรฟนฝนหรอโคค�อนจำ�คก20ป-ตลอดชวตและปรบ2ล�น-5ล�นบ�ท

จำาหนายครอบครองเพอจำาหนาย(ม.17, 69)

•จำ�คก1-10ปหรอปรบ20,000บ�ท-200,000บ�ทหรอทงจำ�ทงปรบ•ถ�เปนมอรฟนฝนหรอโคค�อนปรม�ณส�รบรสทธไมถง100กรมจำ�คก3-20ปหรอปรบ60,000-400,000บ�ทหรอทงจำ�ทงปรบถ�มส�รบรสทธ100กรมขนไปจำ�คก5ป-ตลอดชวตและปรบ500,000-5ล�นบ�ท

ครอบครอง(ม.17, 69)

•จำ�คกไมเกน5ปหรอปรบไมเกน100,000บ�ทหรอทงจำ�ทงปรบ

เสพ(ม.58, 91)

•จำ�คก6เดอน-3ปหรอปรบ10,000-60,000บ�ทหรอทงจำ�ทงปรบเวนแตเปนก�รเสพเพอรกษ�โรคต�มคำ�สงของแพทยทไดรบใบอนญ�ต

หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)

•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ300,000–5,000,000บ�ทถ�เปนมอรฟนหรอโคค�อนตองระว�งโทษเพมขนอกกงหนงและถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะจำ�คกตลอดชวตและปรบ1,000,000–5,000,000บ�ท

Thai Narcotics Act B.E. 2522 (1979)พระร�ชบญญตย�เสพตดใหโทษพ.ศ.2522

PINK PAGES 2013-FINAL-July31.indd 41 8/7/2013 1:43:09 PM

ตารางบนทกขอหาและบทกำาหนดโทษ ทมา : บนทก ป.ป.ส. 2556 สำานกงาน ป.ป.ส. กระทรวงยตธรรม

ขอหา ประเภท 1 (P1) ประเภท2(P2) ประเภท 3 (P3) ประเภท 4 (P4)

ผลตนำ�เข�สงออกข�ย

•จำ�คก5-20ปและปรบตงแต100,000-400,000บ�ท(ม.13,13ทว,89)

•จำ�คกไมเกน5ปและปรบไมเกน100,000บ�ท(ม.16,90)

นำ�ผ�น •จำ�คกไมเกน5ปและปรบไมเกน100,000บ�ท(ม.16,90)

ครอบครองใชประโยชน •จำ�คก1-5ปและปรบ20,000-100,000บ�ท(ม.62,106)•ถ�ปรม�ณเกนทกำ�หนดในประก�ศกระทรวงส�ธ�รณสข(ปจจบนคอฉบบพ.ศ.2555)จำ�คก5-20ปและปรบ100,000-400,000บ�ท(ม.62,106ทว)

•จำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ(ม.62,106)

เสพ •จำ�คก1-5ปและปรบ20,000-100,000บ�ท(ม.62ทว,106ตร)

•จำ�คก1-5ปและปรบ20,000-100,000บ�ทเวนแตเสพต�มคำ�สงแพทย(ม.62ตร,106ตร)

•ไมมคว�มผด

จงใจชกนำ�ยยงสงเสรมใชอบ�ยหลอกลวงขเขญใหผอนเสพ

•จำ�คก2-10ปและปรบ40,000-200,000บ�ท(ม.62จตว�,106จตว�)•ถ�กระทำ�ตอหญงหรอบคคลไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�คว�มผดท�งอ�ญ�หรอเพอประโยชนแกตนเองหรอผอนในก�รกระทำ�คว�มผดอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ60,000-500,000บ�ท(ม.62จตว�,106จตว�)

Thai Psychotropic Substances Act B.E. 2518 (1975)พระร�ชบญญตวตถทออกฤทธตอจตและประส�ทพ.ศ.2518

PINK PAGES 2013-FINAL-July31.indd 43 8/16/2013 3:28:00 PM

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

2M (Med-Maker)2 เอม (เมด-เมเกอร)

ANPRESS 0.25 mg 102ANPRESS 1 mg 309CONVULSIL 2 mg 070XIEMED 0.5 mg 280

a N H Productsเอ เอน เอช โปรดคส

COMOBEN 5 mg 390COMOBEN 10 mg 510COMODINE COUGH†

60 mL 550DIVOPAN 2 mg 056DIVOPAN 5 mg 166

acdHoNแอคดอน

CHLORDIAZEPOXIDE ACDHON 10 mg 529

DIADON 5 mg 377DIAZEPAM

ACDHON 2 mg 498LORAZEPAM

ACDHON 0.5 mg 344LORAZEPAM

ACDHON 1 mg 034PHENOBARBITAL

ACDHON 15 mg 384PHENOBARBITAL

ACDHON 30 mg 136PHENOBARBITAL

ACDHON 60 mg 030PHENOBARBITAL

ELIXIR ACDHON 20 mg/5 mL x 30 mL 595

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL 596

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 120 mL 597

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL 598

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL 599

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL 600

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL 601

TRANADON-S 5 mg 475

all PlaNtsออลแพลนทส

PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL 655

alPHaPHarM/Fdaอลฟาฟารม/อย.

ALODORM 5 mg 090

TRIALAM 0.25 mg 185

aNtigeN/Fdaแอนตเจน/อย.

FENTANYL ANTIGEN 0.05 mg/mL x 2 mL 633

FENTANYL ANTIGEN 0.05 mg/mL x 10 mL 634

asiaN PHarMเอเชยนฟารมาซตคล

ALPRAXOL 0.25 mg 017

ALPRAXOL 0.5 mg 235

A-ZERAX 2 mg 479

A-ZERAX 5 mg 489

BROMTUSSIA DC† 60 mL 537

CODENOL† 15 mg 422

CODESIA† 419

CODESIA† 60 mL 542

DIPOT 5 mg 459

DITROPINE† 008

LORAZEP 0.5 mg 337

LORAZEP 1 mg 005

LORAZEP 2 mg 385

PHENOTAL ELIXIR 20 mg/5 mL x 60 mL 606

asiaN PHarM/Fdaเอเชยนฟารมาซตคล/อย.

PSEUDOEPHEDRINE ASIAN PHARM 30 mg 158

PSEUDOEPHEDRINE ASIAN PHARM 60 mg 048

PSEUDOEPHEDRINE ASIAN PHARM 30 mg/5 mL x 60 mL 616

atlaNtic labแอตแลนตค

AMA† 159BENPINE 5 mg 435BENPINE 10 mg 526BENPINE 25 mg 218DIAPINE

5 mg/mL x 1 mL 625DIAPINE

10 mg/2 mL x 2 mL 626DIAPINE CAPSULE

2 mg 499DIAPINE CAPSULE

5 mg 506DIAPINE TABLET

2 mg 011DIAPINE TABLET

5 mg 183DIAPINE TABLET

10 mg 414DIZOLAM 0.25 mg 103DIZOLAM 0.5 mg 262DIZOLAM 1 mg 324LORA 0.5 mg 397LORA 1 mg 040LORA 2 mg 244PHENOBARBITAL

ATLANTIC 16.25 mg 234PHENOBARBITAL

ATLANTIC 32.5 mg 436PHENOBARBITAL

ATLANTIC 65 mg 015PHENOBARBITAL

ATLANTIC 100 mg 303

aveNtisอเวนตส

FRISIUM 10 mg 039

MANUFACTURER’S INDEX

ดชนเภสชภณฑจดเรยงตามชอผผลต

MNF INDEX CLASS-FINAL-Aug13.indd 71 8/14/2013 2:48:37 PM

MANUFACTURER’S INDEXดชนรวมชอผผลต ... หนา 71-79

PRODUCT IDENTIFICATION CHARTคนหารปภาพเภสชภณฑ ... หนา 10-40

• คนตามหมายเลขภาพมมลางซาย

VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 5 mg XP4 [70.02 mg]

239

ALPRALAN (âÍÅѹ-à¤ÁàÁ´) alprazolam 0.5 mg P2 [157.28 mg]

240

PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 2 mg XP4

241

DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 5 mg P4 [145.6 mg]

242

DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 2 mg P4 [130 mg]

243

LORA (á͵ᏵԤ) lorazepam 2 mg P4 [200 mg]

244

MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 60 mg N2

245

S.CO ZEPAM (àÍÊ â¤ ¿ÒÃ�ÁÒ) diazepam 5 mg XP4

246

BELLADONNA ALKALOIDS W/ PHENOBARBITAL † (ÊÒÁѤ¤ÕàÀÊѪ) phenobarbital sodium 16.2 mg XP4 [160 mg]

247

CENTRODINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 10 mg N3 [205.2 mg]

248

DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 10 mg XP4 [233 mg]

249

DIZEPAM (ÁÒ«Òáź) diazepam 2 mg P4 [170 mg]

250

KENSPA † (हÂÒ¡Ø) chlordiazepoxide hydrochloride 5 mg P4 [246 mg]

251

TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 50 mg XP3

252

LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 2 mg P4 [200 mg]

253

LEXOTAN (âê) bromazepam 3 mg P4 [200 mg]

254

PHENOCON (ÁÒ«Òáź) phenobarbital sodium 60 mg XP4

255

ANAX (ÁÔÅÅÔàÁ´) alprazolam 0.5 mg P2 [130 mg]

256

ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 0.5 mg P2 [132.5 mg]

257

ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 0.5 mg P2 [130 mg]

258

ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 0.5 mg P2 [130 mg]

259

ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 0.5 mg P2

260

ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 1 mg P2

261

DIZOLAM (á͵ᏵԤ) alprazolam 0.5 mg P2 [130 mg]

262

FARZOLAM (¿ÒÃ�ÁÕ¹‹Ò) alprazolam 0.5 mg P2

263

MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [130 mg]

264

MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 0.5 mg P2 [130 mg]

265

MOXINAX (âÁà´ÍÃ�¹áÁ¹Ù) alprazolam 0.5 mg P2 [130 mg]

266

PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [131.9 mg]

267

PRAZOL (हÂÒ¡Ø) alprazolam 0.5 mg P2 [216.36 mg]

268

SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 0.5 mg P2 [125.75 mg]

269

XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2

270

XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 0.5 mg P2 [110 mg]

271

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

18 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 18 8/6/2013 2:03:48 PM

7

Page 9: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

7 พสจนสญลกษณจาก แผนดวด PNdex

(powered by MIMS.com)

แผนดวดระบบการสบคน MIMS PNdex จะใชงานไดด กบอปกรณของเครองทมคณสมบตอยางตาดงน

• Windows XP SP3• Intel® Pentium® 4 CPU 2.80GHz• 1GB RAM• มพนทวางสาหรบขอมลไมนอยกวา 3GB • Screen display resolution ไมตากวา 1280 x 800 pixels

ขอควรระวง

MIMS PNdex เปนโปรแกรมการสบคนหรอพสจนเอกลกษณ ของวตถออกฤทธและยาเสพตดใหโทษในประเทศไทย อาจมความคลาดเคลอนในการแสดงสของภาพเภสชภณฑ โดยขนกบการตงคาสและความละเอยดของหนาจอคอมพวเตอรแตละเครอง จงควรอานคาสและดคณสมบตอนเชน ขนาด หรอสญลกษณ รวมในการยนยนการพสจนใหตรงกนดวยเสมอ และขอมลทงหมดปรบปรงลาสดถง 30 มถนายน 2556 เทานน

หากมขอแนะนา ต ชม หรอมคาถาม ทเกยวกบโปรแกรมการสบคน MIMS PNdexกรณาตดตอไดทอเมล [email protected]

9

PRODUCT IDENTIFICATION SEQUENCEÅíҴѺ¡ÒèѴÀÒ¾ÂÒàÁç´

9

หมายเหต:

สทปรากฏในหนงสออาจคลาดเคลอนกบสจรงของเมดยาแนะนาใหตรวจดวยคณลกษณะอนรวมดวยเชนขนาดสญลกษณ

AW_PNdex front 20100402.indd 9 2/4/2553 13:57:09

8

Page 10: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

9

PRODUCT IDENTIFICATION SEQUENCEÅíҴѺ¡ÒèѴÀÒ¾ÂÒàÁç´

9

หมายเหต:

สทปรากฏในหนงสออาจคลาดเคลอนกบสจรงของเมดยาแนะนาใหตรวจดวยคณลกษณะอนรวมดวยเชนขนาดสญลกษณ

AW_PNdex front 20100402.indd 9 2/4/2553 13:57:09

Page 11: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ATIVAN (äÇàÍ· (»ÃÐà·Èä·Â)) lorazepam 1 mg XP4

023

KEMORA (âÍÅѹ-à¤ÁàÁ´) lorazepam 1 mg P4 [100 mg]

024

LIZAVAN (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) lorazepam 1 mg XP4 [100.4 mg]

025

LORAMED (âÍÅѹ-à¤ÁàÁ´) lorazepam 1 mg XP4

026

LORAPAM (ÊÂÒÁàÀÊѪ) lorazepam 1 mg XP4

027

LORAVAN (Êؾ§É�àÀÊѪ) lorazepam 1 mg XP4 [100 mg]

028

ORA (ÁÒ«Òáź) lorazepam 1 mg P4 [100 mg]

029

PHENOBARBITAL ACDHON (áͤ´Í¹) phenobarbital sodium 60 mg XP4

030

RAZEPAM (ä·Â¹¤Ã¾Ñ²¹Ò) lorazepam 1 mg XP4

031

VALAX (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) diazepam 2 mg XP4

032

LORAPINE (ÂÙâ·à»‚œÂ¹) lorazepam 1 mg XP4

033

DIAZEPAM T P DRUG (·Õ ¾Õ ´ÃÑ¡) diazepam 2 mg XP4

012

LORA-P (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) lorazepam 1 mg XP4 [113.37 mg]

013

LORAZENE (àºÍÃ�ÅÔ¹¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) lorazepam 1 mg XP4

014

PHENOBARBITAL ATLANTIC (á͵ᏵԤ) phenobarbital sodium 65 mg P4 [95 mg]

015

ZEDA (Íѧ¡ÄɵÃÒ§Ù (áÍÅ ¾Õ)) lorazepam 0.5 mg P4 [90 mg]

016

ALPRAXOL (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) alprazolam 0.25 mg P2

017

ANTA (¿ÒÃ�ÁÒÊѹµ� áÅçº) lorazepam 1 mg P4 [100 mg]

018

CODEINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) codeine phosphate 30 mg N2 [113 mg]

019

LONZA (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) lorazepam 1 mg P4 [85 mg]

020

ANXIRA (ÂÙâ·à»‚œÂ¹) lorazepam 1 mg P4 [100 mg]

021

MEILAX (àÁ¨Ô) ethyl lofl azepate 1 mg XP4

022

WHITE Tablet

BUPRINE (ÊÂÒÁàÀÊѪ/ÍÂ.) buprenorphine hydrochloride 0.2 mg P2 [50 mg]

001

DILOMIL † (ÊÂÒÁàÀÊѪ) diphenoxylate hydrochloride 2.5 mg XN3

002

CODEINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) codeine phosphate 15 mg N2 [73 mg]

003

LOMOTIL † (âÍÅÔ¤) diphenoxylate hydrochloride 2.5 mg N3 [63 mg]

004

LORAZEP (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) lorazepam 1 mg P4 [65 mg]

005

PHENOBARBITONENEW LIFE PHARMA (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) phenobarbital sodium 30 mg XP4

006

TEMGESIC (àá¤Ô··� ູ¤Õà«ÍÃ�/ÍÂ.) buprenorphine hydrochloride 0.2 mg P2 [59.98 mg]

007

DITROPINE † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) diphenoxylate hydrochloride 2.5 mg XN3

008

SPASIL † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) diphenoxylate hydrochloride 2.5 mg N3 [79.97 mg]

009

DIANO (ÁÔÅÒâ¹) diazepam 2 mg P4 [80 mg]

010

DIAPINE TABLET (á͵ᏵԤ) diazepam 2 mg P4 [100 mg]

011

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

10 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 10 8/13/2013 5:30:53 PM

Page 12: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

LORAZEPAM ACDHON (áͤ´Í¹) lorazepam 1 mg XP4

034

TRANAVAN (â»ÅÔ¿ÒÃ�Á) lorazepam 1 mg P4 [100 mg]

035

ALPRALAN (âÍÅѹ-à¤ÁàÁ´) alprazolam 0.25 mg P2 [154.7 mg]

036

DIPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) diazepam 2 mg XP4

037

FRISIUM («Ò⹿‚›-ÍàǹµÕÊ) clobazam 5 mg P4 [120 mg]

038

FRISIUM (ÍàǹµÕÊ) clobazam 10 mg XP4

039

LORA (á͵ᏵԤ) lorazepam 1 mg P4 [130 mg]

040

MED-ZEPAM (àǪºÃÔ¡ÒÃ) diazepam 2 mg XP4

041

RITALIN (â¹ÇÒÃ�µÕÊ/ÍÂ.) methylphenidate hydrochloride 10 mg P2 [140 mg]

042

RUBIFEN (áÅçº ÃÙºÔâÍ/ÍÂ.) methylphenidate hydrochloride 10 mg P2 [190 mg]

043

LORAZE (हÂÒ¡Ø) lorazepam 1 mg P4

044

LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 1 mg P4 [103.02 mg]

045

PSEUDOEPHEDRINEMILANO (ÁÔÅÒâ¹/ÍÂ.) pseudoephedrine hydrochloride 60 mg P2 [130 mg]

046

PHENOBARB (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) phenobarbital sodium 60 mg XP4 [130 mg]

047

PSEUDOEPHEDRINEASIAN PHARM (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ/ÍÂ.) pseudoephedrine hydrochloride 60 mg P2 [155 mg]

048

PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY (âç§Ò¹àÀÊѪ¡ÃÃÁ·ËÒÃ) pseudoephedrine hydrochloride 30 mg P2

049

PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY (âç§Ò¹àÀÊѪ¡ÃÃÁ·ËÒÃ) pseudoephedrine hydrochloride 60 mg P2

050

ZOPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 2 mg P4 [160 mg]

051

ALPRAX (·ÍÃ�àù·�) alprazolam 1 mg P2 [190 mg]

052

DACTIVE 10 (¤ÒÅÔÅÒ àÎÅ·�á¤Ã�/ÍÂ.) zolpidem tartrate 10 mg P2

053

DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 2 mg XP4 [158.25 mg]

054

DIAZEPAM GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) diazepam 2 mg P4 [182 mg]

055

DIVOPAN (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) diazepam 2 mg P4 [180 mg]

056

DONNATAL † (äÇ·�ÎÍÅÅ�) phenobarbital 16.2 mg XP4

057

GRANDAXIN (ÍÕ¨ÕÊ) tofi sopam 50 mg P4 [180 mg]

058

MED-ZEPOXIDE (àǪºÃÔ¡ÒÃ) chlordiazepoxide hydrochloride 10 mg XP4 [198.8 mg]

059

METHYLPHENIDATE HEXAL («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) methylphenidate hydrochloride 10 mg P2 [174.98 mg]

060

PRENARPIL (ÊËá¾·Â�àÀÊѪ) clonazepam 2 mg P4 [148.76 mg]

061

PSEUDOEPHEDRINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) pseudoephedrine hydrochloride 30 mg P2

062

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 11 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 11 8/13/2013 5:30:55 PM

Page 13: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

PSEUDOEPHEDRINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) pseudoephedrine hydrochloride 60 mg P2

063

RIVOTRIL (âê) clonazepam 2 mg P4 [170 mg]

064

SIPAM (ÊÂÒÁàÀÊѪ) diazepam 2 mg P4 [164 mg]

065

TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 25 mg XP3 [149 mg]

066

VOMED (ÂÙâ·à»‚œÂ¹) diazepam 2 mg XP4

067

ZAM (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) diazepam 2 mg P4

068

CLONARIL (ÂÙâ·à»‚œÂ¹) clonazepam 2 mg P4

069

CONVULSIL (2 àÍçÁ (àÁ´-àÁà¡ÍÃ�)) clonazepam 2 mg P4

070

DIAZ (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) diazepam 2 mg XP4 [180 mg]

071

NITRADOS (´Ñ¡ÅÒÊ/ÍÂ.) nitrazepam 5 mg P2

072

VORAPAM (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) diazepam 2 mg P4 [180 mg]

073

WINOPAM (ÅÔÇÔ¹à¹ÍÃ�¿ÒÃ�ÁÒ) diazepam 2 mg XP4

074

DIAZEPAM LERD SINGH (àÅÔÈÊÔ§Ë�) diazepam 2 mg P4 [180 mg]

075

POVANIL (¿ÒÃ�ÁÒÊѹµ� áÅçº) clonazepam 2 mg P4 [150 mg]

076

VALENIUM (हÂÒ¡Ø) diazepam 2 mg XP4

077

DIMED (ÊËá¾·Â�àÀÊѪ) diazepam 2 mg XP4

078

XANAX XR (ä¿à«ÍÃ�) alprazolam 1 mg P2 [347.19 mg]

079

LEXOTAN (âê) bromazepam 1.5 mg P4 [200 mg]

080

CEMOL CODEINE † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 15 mg XN3

081

COCET † (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) codeine phosphate 15 mg XN3

082

PARA WITH CODEINE † (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) codeine phosphate 15 mg N3

083

PARA WITH CODEINE † (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) codeine phosphate 30 mg N3

084

COTENOL † (·Õ ¾Õ ´ÃÑ¡) codeine phosphate 15 mg XN3

085

PARADEINE † (à¨ÃÔÞàÀÊѪ) codeine phosphate 15 mg N3 [470 mg]

086

TYLENOL WITH CODEINE † (âÍÅÔ¤) codeine phosphate 15 mg N3 [432.5 mg]

087

TYLENOL WITH CODEINE † (âÍÅÔ¤) codeine phosphate 30 mg XN3 [478.72 mg]

088

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

12 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 12 8/13/2013 5:30:56 PM

Page 14: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

PARCOD † (·Õ áÁ¹ ¿ÒÃ�ÁÒ) codeine phosphate 15 mg XN3 [600 mg]

089

ALODORM (ÍÑÅ¿Ò¿ÒÃ�Á/ÍÂ.) nitrazepam 5 mg P2 [556 mg]

nitrazepam 5 mg

090

MOGADON (âê/ÍÂ.) nitrazepam 5 mg P2

nitrazepam 5 mg

091

NASA W/ CODEINE † (ÁÔÅÅÔàÁ´) codeine phosphate 15 mg N3 [600 mg]

092

PARCONO † (ÁÔÅÒâ¹) codeine phosphate 8 mg XN3 [600 mg]

093

REINBAMATE (¨ÔǺÃÒà´ÍÃ�Ê) meprobamate 400 mg XP3 [525 mg]

094

PARADYL (ÁÒ«Òáź) codeine phosphate 8 mg XN3

095

DIETIL RETARD (à·Ã¹à¡ÍÃ�/ÍÂ.) diethylpropion hydrochloride 75 mg P2 [755 mg]

096

ANAX (ÁÔÅÅÔàÁ´) alprazolam 0.25 mg P2 [130 mg]

097

ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 0.25 mg P2 [132.25 mg]

098

ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 0.25 mg P2 [130 mg]

099

ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 0.25 mg P2 [130 mg]

100

ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 0.25 mg P2

101

ANPRESS (2 àÍçÁ (àÁ´-àÁà¡ÍÃ�)) alprazolam 0.25 mg P2 [131.2 mg]

102

DIZOLAM (á͵ᏵԤ) alprazolam 0.25 mg P2 [130 mg]

103

FARZOLAM (ÊËá¾·Â�àÀÊѪ) alprazolam 0.25 mg P2

104

LORAMET (äÇàÍ·-àÍàÂÔÃ�Ê·�/ÍÂ.) lormetazepam 1 mg P2

lormetazepam 1 mg

105

MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 0.25 mg P2 [130 mg]

106

MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 0.25 mg P2 [129.75 mg]

107

MOXINAX (âÁà´ÍÃ�¹áÁ¹Ù) alprazolam 0.25 mg P2 [130 mg]

108

PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 0.25 mg P2 [131.65 mg]

109

PRAZOL (हÂÒ¡Ø) alprazolam 0.25 mg P2

110

SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 0.25 mg P2 [125 mg]

111

XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 0.25 mg P2

112

XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 0.25 mg P2 [110 mg]

113

XANAX (ä¿à«ÍÃ�) alprazolam 0.25 mg P2 [128.25 mg]

114

ZOLAM (ÊËá¾·Â�àÀÊѪ) alprazolam 0.25 mg P2 [131.55 mg]

115

ALLAM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) alprazolam 0.25 mg P2 [130 mg]

116

ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 0.5 mg P2 [130 mg]

117

INZOLAM (ÍԹᾤ¿ÒÃ�ÁÒ) alprazolam 0.25 mg P2 [132 mg]

118

MITRANAX (â»ÅÔ¿ÒÃ�Á) alprazolam 0.25 mg P2 [130 mg]

119

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 13 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 13 8/16/2013 3:21:59 PM

Page 15: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

SUNAX (Êؾ§É�àÀÊѪ) alprazolam 0.25 mg P2 [130.03 mg]

120

XIEMED (ÂÙâ·à»‚œÂ¹) alprazolam 0.25 mg P2 [130.01 mg]

121

ALPRAZOLAM FRX (âÍÅÔ¤) alprazolam 0.25 mg P2 [130 mg]

122

STILNOX («Ò⹿‚›-ÇÔ¹·ÃÍ»/ÍÂ.) zolpidem hemitartrate 10 mg P2 [126 mg]

123

ZOLPIDEM TARTRATERIVOPHARM (ÃÔâÇ¿ÒÃ�Á/ÍÂ.) zolpidem tartrate 10 mg P2

124

ZOPIM (䵌ËÇѹ äºâÍà·¤/ÍÂ.) zolpidem tartrate 10 mg P2

125

POPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 2 mg XP4

126

CODIGESIC † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 15 mg N3 [550 mg]

127

PARAGEN CO † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 15 mg XN3 [478.77 mg]

128

CONCERTA (ᨹો¹-«ÕáÅ¡/ÍÂ.) methylphenidate hydrochloride 36 mg P2 [515 mg]

129

REGENON RETARD (à·ÁàÅÍÃ�/ÍÂ.) diethylpropion hydrochloride 75 mg P2 [755 mg]

130

PARDEX (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) dextropropoxyphene napsylate 32.5 mg X N3

131

WHITE Capsule

ZEPOXIN (¨ÔǺÃÒà´ÍÃ�Ê) chlordiazepoxide hydrochloride 10 mg XP4 [100 mg]

132

KAPANOL (á¡Åç¡â«ÊÁÔ·ä¤Å�¹/ÍÂ.) morphine sulfate 20 mg N2 [142.8 mg]

133

KAPANOL (á¡Åç¡â«ÊÁÔ·ä¤Å�¹/ÍÂ.) morphine sulfate 50 mg N2 [323.3 mg]

134

KAPANOL (á¡Åç¡â«ÊÁÔ·ä¤Å�¹/ÍÂ.) morphine sulfate 100 mg N2 [620.5 mg]

135

YELLOW Tablet

PHENOBARBITAL ACDHON (áͤ´Í¹) phenobarbital sodium 30 mg XP4

136

LORA-P (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) lorazepam 2 mg XP4 [113.43 mg]

137

ANTA (¿ÒÃ�ÁÒÊѹµ� áÅçº) lorazepam 2 mg P4 [100 mg]

138

BELLOID † (¡Õà´Õ¹ ÃÔªàµÍÃ�) butobarbital 30 mg XP4

139

METHADONE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) methadone hydrochloride 5 mg N2 [110 mg]

140

ATIVAN (äÇàÍ· (»ÃÐà·Èä·Â)) lorazepam 2 mg XP4

141

LORAPAM (ÊÂÒÁàÀÊѪ) lorazepam 2 mg XP4

142

LORAZENE (àºÍÃ�ÅÔ¹¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) lorazepam 2 mg XP4

143

RAZEPAM (ä·Â¹¤Ã¾Ñ²¹Ò) lorazepam 2 mg XP4

144

TRANOLAN (âÍÅѹ-à¤ÁàÁ´) diazepam 2 mg P4 [150.62 mg]

145

VALAX (ÂÙâ·à»‚œÂ¹) diazepam 5 mg XP4

146

DIAZEPAM VESCO (àÇÊâ¡¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 5 mg P4 [109 mg]

147

DOPAM (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) clorazepate dipotassium 5 mg XP4 [153 mg]

148

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

14 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 14 8/13/2013 5:30:59 PM

Page 16: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

COZEP (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 10 mg P4 [179.55 mg]

149

DIPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) diazepam 5 mg XP4

150

PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 1 mg XP4

151

PSEUDOEPHEDRINEBJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)/ÍÂ.) pseudoephedrine hydrochloride 60 mg P2 [158.22 mg]

152

PSEUDOEPHEDRINEMILANO (ÁÔÅÒâ¹/ÍÂ.) pseudoephedrine hydrochloride 30 mg P2 [110 mg]

153

DIANO (ÁÔÅÒâ¹) diazepam 5 mg P4 [110.2 mg]

154

DIAZEPAM SAMAKEEPHAESAJ (ÊÒÁѤ¤ÕàÀÊѪ) diazepam 5 mg XP4

155

MORPHINE SULFATE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) morphine sulfate 10 mg N2

morphine sulfate 10 mg

156

PHENYLPROPANOLAMINEPHARMASANT (¿ÒÃ�ÁÒÊѹµ� áÅçº/ÍÂ.) phenylpropanolamine hydrochloride 25 mg P2

157

PSEUDOEPHEDRINEASIAN PHARM (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ/ÍÂ.) pseudoephedrine hydrochloride 30 mg P2 [145 mg]

158

AMA † (á͵ᏵԤ) amobarbital 50 mg P3 [208.7 mg]

159

ZOPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 5 mg P4 [160 mg]

160

ALPRAX (·ÍÃ�àù·�) alprazolam 0.25 mg P2 [189.74 mg]

161

DIAZA (áʧä·Â) diazepam 5 mg XP4 [172 mg]

162

DIAZEPAM GENERAL DRUGS HOUSE (à¹à¹ÍÃ�ÃÒÅ´ÃÑê¡Ê�àÎŒÒÊ�) diazepam 5 mg P4 [160 mg]

163

DIAZEPAM GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) diazepam 5 mg P4 [182 mg]

164

DIAZEPAM T P DRUG (·Õ ¾Õ ´ÃÑ¡) diazepam 5 mg XP4

165

DIVOPAN (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) diazepam 5 mg P4 [209 mg]

166

DIZEPAM (ÁÒ«Òáź) diazepam 5 mg P4 [170 mg]

167

SIPAM (ÊÂÒÁàÀÊѪ) diazepam 5 mg P4 [164 mg]

168

VALENIUM (हÂÒ¡Ø) diazepam 5 mg XP4

169

VALIUM (âÍÅÔ¤) diazepam 5 mg XP4

170

VOMED («ÕàÁ´ â»Ã´Ñ¡Ê�) diazepam 5 mg XP4

171

ZAM (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) diazepam 5 mg P4

172

DIAZ (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) diazepam 5 mg XP4 [180 mg]

173

ROPAM (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) diazepam 5 mg XP4 [170 mg]

174

VORAPAM (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) diazepam 5 mg P4 [183 mg]

175

DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 5 mg P4 [160 mg]

176

DIAZEPAM LERD SINGH (àÅÔÈÊÔ§Ë�) diazepam 5 mg P4 [175 mg]

177

DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 5 mg XP4

178

POVANIL (¿ÒÃ�ÁÒÊѹµ� áÅçº) clonazepam 1 mg P4

179

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 15 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 15 8/13/2013 5:31:02 PM

Page 17: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

DIAZEPAM T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) diazepam 5 mg P4

180

DIMED (¸¹¾Ñ²¹�àÀÊѪ) diazepam 5 mg XP4

181

CO-COF † (ÁÔÅÅÔàÁ´) codeine phosphate 10 mg N3 [294.9 mg]

182

DIAPINE TABLET (á͵ᏵԤ) diazepam 5 mg P4 [280 mg]

183

MILA-TERCON † (ÁÔÅÒâ¹) codeine phosphate 8 mg XN3 [410.05 mg]

184

TRIALAM (ÍÑÅ¿Ò¿ÒÃ�Á/ÍÂ.) triazolam 0.25 mg P2 [100 mg]

185

CONCERTA (ᨹો¹-«ÕáÅ¡/ÍÂ.) methylphenidate hydrochloride 18 mg P2 [268 mg]

186

POPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 5 mg XP4

187

DIZEP (Êؾ§É�àÀÊѪ) diazepam 2 mg P4 [115.05 mg]

188

YELLOW Capsule

POSENE (ÊÂÒÁàÁ´Ôá¤Ã�) clorazepate dipotassium 5 mg XP4 [140 mg]

189

TRANCAP (·Õ ¾Õ ´ÃÑ¡) clorazepate dipotassium 10 mg XP4

190

PREFAMONE (à´¤â«/ÍÂ.) diethylpropion hydrochloride 75 mg P2

191

POZAPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) prazepam 10 mg P4 [336.5 mg]

192

CREAM Tablet

LOZEPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) lorazepam 1 mg XP4

193

MST CONTINUS (ºÒÃ�´/ÍÂ.) morphine sulfate 10 mg N2 [154 mg]

194

ALPRAX (·ÍÃ�àù·�) alprazolam 0.5 mg P2 [189.98 mg]

195

PRENARPIL (ÊËá¾·Â�àÀÊѪ) clonazepam 0.5 mg P4 [147.22 mg]

196

RIVOTRIL (âê) clonazepam 0.5 mg P4 [150 mg]

197

MASAPARA W/ CODEINE † (ÁÒ«Òáź) codeine phosphate 15 mg N3 [500 mg]

[500 mg]

198

ORANGE Tablet

MEILAX (àÁ¨Ô) ethyl lofl azepate 2 mg XP4

199

DILIUM (ˌҧ¢ÒÂÂÒµÃÒà¨ç´´ÒÇ) diazepam 2 mg XP4

200

TRANOLAN (âÍÅѹ-à¤ÁàÁ´) diazepam 5 mg P4 [150.85 mg]

201

COZEP (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 25 mg P4 [206.23 mg]

202

PHENOBARBITONENEW LIFE PHARMA (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) phenobarbital sodium 60 mg XP4

203

VICTAN («Ò⹿‚›-«Ô¹àµÅÒâº) ethyl lofl azepate 2 mg XP4

204

ZORA (à¹à¹ÍÃ�ÃÒÅ´ÃÑê¡Ê�àÎŒÒÊ�) lorazepam 2 mg P4 [130 mg]

205

MST CONTINUS (ºÒÃ�´/ÍÂ.) morphine sulfate 60 mg N2 [154 mg]

206

PSEUDOEPHEDRINEMEDICINE PRODUCTS (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�/ÍÂ.) pseudoephedrine hydrochloride 60 mg P2 [144.7 mg]

207

MENOBARB (ÁÔÅÒâ¹) phenobarbital 60 mg XP4 [120 mg]

208

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

16 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 16 8/13/2013 5:31:03 PM

Page 18: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ANCORIL (ÂÙâ·à»‚œÂ¹) clonazepam 0.5 mg P4

209

POVANIL (¿ÒÃ�ÁÒÊѹµ� áÅçº) clonazepam 0.5 mg P4 [150 mg]

210

EPOXIDE (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) chlordiazepoxide hydrochloride 10 mg XP4 [284.17 mg]

211

NEOCOF † (ÁÒ«Òáź) codeine phosphate 10 mg XN3

212

PACOGESIC † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 8 mg XN3 [580 mg]

213

DIZEP (Êؾ§É�àÀÊѪ) diazepam 5 mg P4 [115.05 mg]

214

ORANGE Capsule

DIAZEPION (¨ÔǺÃÒà´ÍÃ�Ê) diazepam 10 mg XP4 [100 mg]

215

RED Tablet

PONDNEBIUM (¾Í¹´�à¤ÁÕ¤ÍÅ) chlordiazepoxide hydrochloride 10 mg XP4 [74.82 mg]

216

EPOXIDE (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) chlordiazepoxide hydrochloride 25 mg XP4 [205.49 mg]

217

BENPINE (á͵ᏵԤ) chlordiazepoxide hydrochloride 25 mg P4 [165.2 mg]

218

AZEPAM (áÁ¤â¤Ã¿ÒÃ�) diazepam 2 mg XP4 [100 mg]

219

CHLORDIXIDE (àÅÔÈÊÔ§Ë�) chlordiazepoxide hydrochloride 10 mg XP4 [237 mg]

220

CLINOPECT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg XN3 [217 mg]

221

NEO-COPHEN (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 10 mg XN3

222

ZORITUSS (â¡Å´� á͹´� «ÔÅàÇÍÃ�àºÅÅ�) codeine phosphate 10 mg XN3

223

NEOPECT † (ÁÒ«Òáź) codeine phosphate 10 mg N3 [399.73 mg]

224

RED Capsule

CORYNIL † (àÁ´Ô᤻) codeine phosphate 10 mg XN3 [430 mg]

225

ROPECT † (¤ÒÃ�´Ô¹ÑÅ àÎÅ·� ÍÍÊàµÃàÅÕÂ) codeine phosphate 10 mg N3 [558.5 mg]

226

CODEPECT † (àÁ¡ŒÒ äÅ¿Šä«áÍ繫�) codeine phosphate 10 mg N3 [430 mg]

227

ROLAR † (àÁ¡ŒÒ äÅ¿Šä«áÍ繫�) codeine phosphate 10 mg N3 [430 mg]

228

ROTUSS † (¤ÒÃ�´Ô¹ÑÅ àÎÅ·� ÍÍÊàµÃàÅÕÂ) codeine phosphate 10 mg N3 [456.5 mg]

229

ZEPOXIN (¨ÔǺÃÒà´ÍÃ�Ê) chlordiazepoxide hydrochloride 5 mg XP4 [100 mg]

230

PINK Tablet

PAM (·Õ ÇÕ ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 5 mg XP4

231

BELLERGAL † (â¹ÇÒÃ�µÕÊ) phenobarbital sodium 20 mg XP4

phenobarbital sodium 20 mg

232

PHENOBARB (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) phenobarbital sodium 30 mg XP4 [90 mg]

233

PHENOBARBITAL ATLANTIC (á͵ᏵԤ) phenobarbital sodium 16.25 mg XP4 [84.99 mg]

234

ALPRAXOL (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) alprazolam 0.5 mg P2

235

DIAZEPAM T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) diazepam 5 mg P4 [62.46 mg]

236

LORAMED (âÍÅѹ-à¤ÁàÁ´) lorazepam 2 mg P4 [100 mg]

237

ORA (ÁÒ«Òáź) lorazepam 2 mg XP4

238

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 17 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 17 8/13/2013 5:31:06 PM

Page 19: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 5 mg XP4 [70.02 mg]

239

ALPRALAN (âÍÅѹ-à¤ÁàÁ´) alprazolam 0.5 mg P2 [157.28 mg]

240

PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 2 mg XP4

241

DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 5 mg P4 [145.6 mg]

242

DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 2 mg P4 [130 mg]

243

LORA (á͵ᏵԤ) lorazepam 2 mg P4 [200 mg]

244

MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 60 mg N2

245

S.CO ZEPAM (àÍÊ â¤ ¿ÒÃ�ÁÒ) diazepam 5 mg XP4

246

BELLADONNA ALKALOIDS W/ PHENOBARBITAL † (ÊÒÁѤ¤ÕàÀÊѪ) phenobarbital sodium 16.2 mg XP4 [160 mg]

247

CENTRODINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 10 mg N3 [205.2 mg]

248

DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 10 mg XP4 [233 mg]

249

DIZEPAM (ÁÒ«Òáź) diazepam 2 mg P4 [170 mg]

250

KENSPA † (हÂÒ¡Ø) chlordiazepoxide hydrochloride 5 mg P4 [246 mg]

251

TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 50 mg XP3

252

LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 2 mg P4 [200 mg]

253

LEXOTAN (âê) bromazepam 3 mg P4 [200 mg]

254

PHENOCON (ÁÒ«Òáź) phenobarbital sodium 60 mg XP4

255

ANAX (ÁÔÅÅÔàÁ´) alprazolam 0.5 mg P2 [130 mg]

256

ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 0.5 mg P2 [132.5 mg]

257

ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 0.5 mg P2 [130 mg]

258

ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 0.5 mg P2 [130 mg]

259

ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 0.5 mg P2

260

ALPAZAM (ä·Â¹¤Ã¾Ñ²¹Ò) alprazolam 1 mg P2

261

DIZOLAM (á͵ᏵԤ) alprazolam 0.5 mg P2 [130 mg]

262

FARZOLAM (¿ÒÃ�ÁÕ¹‹Ò) alprazolam 0.5 mg P2

263

MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [130 mg]

264

MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 0.5 mg P2 [130 mg]

265

MOXINAX (âÁà´ÍÃ�¹áÁ¹Ù) alprazolam 0.5 mg P2 [130 mg]

266

PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [131.9 mg]

267

PRAZOL (हÂÒ¡Ø) alprazolam 0.5 mg P2 [216.36 mg]

268

SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 0.5 mg P2 [125.75 mg]

269

XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2

270

XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 0.5 mg P2 [110 mg]

271

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

18 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 18 8/13/2013 5:31:07 PM

Page 20: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

XANAX (ä¿à«ÍÃ�) alprazolam 0.5 mg P2 [128.56 mg]

272

ZOLAM (ÊËá¾·Â�àÀÊѪ) alprazolam 0.5 mg P2 [133.8 mg]

273

ANPRESS (ÂÙâ·à»‚œÂ¹) alprazolam 0.5 mg P2 [130 mg]

274

ALLAM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) alprazolam 0.5 mg P2 [130 mg]

275

ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 0.25 mg P2 [130 mg]

276

INZOLAM (ÍԹᾤ¿ÒÃ�ÁÒ) alprazolam 0.5 mg P2 [132.81 mg]

277

MITRANAX (â»ÅÔ¿ÒÃ�Á) alprazolam 0.5 mg P2 [130 mg]

278

SUNAX (Êؾ§É�àÀÊѪ) alprazolam 0.5 mg P2 [129.95 mg]

279

XIEMED (2 àÍçÁ (àÁ´-àÁà¡ÍÃ�)) alprazolam 0.5 mg P2 [130.25 mg]

280

CODICET PINK † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 15 mg N3

281

ALPRAZOLAM FRX (âÍÅÔ¤) alprazolam 0.5 mg P2 [130 mg]

282

TRANSPON FORTE (àÅÔÈÊÔ§Ë�) clorazepate dipotassium 10 mg XP4 [190 mg]

283

PINK Capsule

DIPOSEF (Âٹիѹ) clorazepate dipotassium 10 mg XP4 [140 mg]

284

SANOR (äºâÍáÅ») clorazepate dipotassium 10 mg XP4

285

SERENE MASA LAB (ÁÒ«Òáź) clorazepate dipotassium 10 mg XP4 [173.5 mg]

[173.5 mg]

286

TRANMED (ÊËá¾·Â�àÀÊѪ) clorazepate dipotassium 10 mg XP4 [163.13 mg]

[163.13 mg]

287

ANXENE (ÂÙâ·à»‚œÂ¹) clorazepate dipotassium 10 mg XP4

288

MANOTRAN (áËÅÁ·Í§¡ÒÃá¾·Â�) clorazepate dipotassium 10 mg XP4 [150 mg]

289

CLORAMED (àÁ´Ôä¿Ç�) clorazepate dipotassium 10 mg XP4

290

DEDA (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) clorazepate dipotassium 10 mg XP4 [130 mg]

[130 mg]

291

CLORAZE (âÁà´ÍÃ�¹áÁ¹Ù) clorazepate dipotassium 10 mg XP4 [120 mg]

[120 mg]

292

UPTRAN (ÍѾ«Ñ¹) clorazepate dipotassium 10 mg XP4

293

POLIZEP (â»ÅÔ¿ÒÃ�Á) clorazepate dipotassium 10 mg XP4 [234 mg]

294

POLYDINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 10 mg XN3

295

TENMED (ÍԹᾤ¿ÒÃ�ÁÒ) clorazepate dipotassium 10 mg XP4 [234 mg]

296

TRANCLOR (ÊÂÒÁàÀÊѪ) clorazepate dipotassium 10 mg XP4

297

TRANXENE («Ò⹿‚›-«Ô¹àµÅÒâº) clorazepate dipotassium 10 mg XP4

298

CEXENE (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) clorazepate dipotassium 10 mg XP4

299

FLULIUM (¿ÒÃ�ÁÒÊѹµ� áÅçº) clorazepate dipotassium 10 mg XP4

300

DAVOL † (ºÕਠ(àºÞ¨âÍʶ)) dextropropoxyphene hydrochloride 32.5 mg XN3 [377.5 mg]

301

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 19 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 19 8/13/2013 5:31:09 PM

Page 21: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

PURPLE Tablet

CALMIPAM (à©ÅÔÁªÑÂàÀÊѪ) diazepam 5 mg XP4

302

PHENOBARBITAL ATLANTIC (á͵ᏵԤ) phenobarbital sodium 100 mg P4 [128.97 mg]

303

MST CONTINUS (ºÒÃ�´/ÍÂ.) morphine sulfate 30 mg N2 [154 mg]

304

ZEPOXIDE (·Õ ¾Õ ´ÃÑ¡) chlordiazepoxide hydrochloride 10 mg P4 [91.2 mg]

305

ANZION (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) alprazolam 1 mg P2 [133.12 mg]

306

ALNAX (¾Í¹´�à¤ÁÕ¤ÍÅ) alprazolam 1 mg P2 [100 mg]

307

ALCELAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) alprazolam 1 mg P2 [130.2 mg]

308

ANPRESS (2 àÍçÁ (àÁ´-àÁà¡ÍÃ�)) alprazolam 1 mg P2 [131.2 mg]

309

FARZOLAM (¿ÒÃ�ÁÕ¹‹Ò) alprazolam 1 mg P2

310

MANEX (·Õ áÁ¹ ¿ÒÃ�ÁÒ) alprazolam 1 mg P2 [130 mg]

311

MARZOLAM (áËÅÁ·Í§¡ÒÃá¾·Â�) alprazolam 1 mg P2 [130 mg]

312

PHARNAX (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) alprazolam 1 mg P2 [132.41 mg]

313

PRAZOL (हÂÒ¡Ø) alprazolam 1 mg P2

314

SIAMPRAXOL (ÊÂÒÁàÀÊѪ) alprazolam 1 mg P2

315

XALAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) alprazolam 1 mg P2

316

XANACINE (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) alprazolam 1 mg P2 [110 mg]

317

XANAX (ä¿à«ÍÃ�) alprazolam 1 mg P2 [129.12 mg]

318

ZOLAM (ÊËá¾·Â�àÀÊѪ) alprazolam 1 mg P2 [136.67 mg]

319

ALLAM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) alprazolam 1 mg P2 [130 mg]

320

INZOLAM (ÍԹᾤ¿ÒÃ�ÁÒ) alprazolam 1 mg P2 [134.39 mg]

321

MITRANAX (â»ÅÔ¿ÒÃ�Á) alprazolam 1 mg P2 [130 mg]

322

XIEMED (ÂÙâ·à»‚œÂ¹) alprazolam 1 mg P2 [130 mg]

323

DIZOLAM (á͵ᏵԤ) alprazolam 1 mg P2 [130 mg]

324

BRONPECT † (हÂÒ¡Ø) codeine phosphate 10 mg XN3 [573.5 mg]

325

AZEPAM (áÁ¤â¤Ã¿ÒÃ�) diazepam 5 mg XP4

326

BLUE Tablet

ANXIRA (ÂÙâ·à»‚œÂ¹) lorazepam 0.5 mg P4 [50 mg]

327

LORAZENE (àºÍÃ�ÅÔ¹¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) lorazepam 0.5 mg XP4

328

LORAVAN (Êؾ§É�àÀÊѪ) lorazepam 0.5 mg P4 [50 mg]

329

ANTA (¿ÒÃ�ÁÒÊѹµ� áÅçº) lorazepam 0.5 mg P4 [49.6 mg]

330

LOZEPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) lorazepam 0.5 mg XP4

331

ATIVAN (äÇàÍ· (»ÃÐà·Èä·Â)) lorazepam 0.5 mg XP4

332

LIZAVAN (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) lorazepam 0.5 mg XP4 [50.22 mg]

333

LORAMED (àÁ´Ôä¿Ç�) lorazepam 0.5 mg XP4

334

TRANAVAN (â»ÅÔ¿ÒÃ�Á) lorazepam 0.5 mg P4 [50 mg]

335

LORAPAM (ÊÂÒÁàÀÊѪ) lorazepam 0.5 mg XP4 [43.67 mg]

336

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

20 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 20 8/13/2013 5:31:11 PM

Page 22: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

LORAZEP (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) lorazepam 0.5 mg P4 [50 mg]

337

ORA (ÁÒ«Òáź) lorazepam 0.5 mg P4 [50.02 mg]

338

LONZA (àÁ´Ô«Õ¹â»Ã´Ñ¡Ê�) lorazepam 0.5 mg P4 [50 mg]

339

LORAPINE (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) lorazepam 0.5 mg XP4

340

PHENOBARBITALCHEW BROTHERS (¨ÔǺÃÒà´ÍÃ�Ê) phenobarbital sodium 30 mg XP4 [70 mg]

341

RAZEPAM (ä·Â¹¤Ã¾Ñ²¹Ò) lorazepam 0.5 mg XP4

342

VEMED (ÂÙâ·à»‚œÂ¹) lorazepam 0.5 mg XP4

343

LORAZEPAM ACDHON (áͤ´Í¹) lorazepam 0.5 mg XP4 [50 mg]

344

DIAZEPAM GENERALDRUGS HOUSE (à¹à¹ÍÃ�ÃÒÅ´ÃÑê¡Ê�àÎŒÒÊ�) diazepam 2 mg P4 [139.83 mg]

345

DIAZEPAM SOMMAI BHAESAJ (ÊÁËÁÒÂàÀÊѪ) diazepam 5 mg XP4

346

LORA-P (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) lorazepam 0.5 mg XP4 [105.2 mg]

347

HAWKCOPAX (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) lorazepam 0.5 mg P4 [100 mg]

348

VALAX (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) diazepam 10 mg XP4

349

VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 10 mg XP4 [102.26 mg]

350

DIAZEPAM VESCO (àÇÊâ¡¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 2 mg P4 [110 mg]

351

LORAZIN (ÍԹᾤ¿ÒÃ�ÁÒ) lorazepam 0.5 mg P4 [103.03 mg]

352

DIAZEPAM T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) diazepam 10 mg XP4

353

DILIUM (ˌҧ¢ÒÂÂÒµÃÒà¨ç´´ÒÇ) diazepam 5 mg XP4

354

DIAPAM (à¡Ãç·àµÍÃ�¿ÒÃ�ÁÒ) diazepam 5 mg P4 [152 mg]

355

ZORA (à¹à¹ÍÃ�ÃÒÅ´ÃÑê¡Ê�àÎŒÒÊ�) lorazepam 0.5 mg P4 [130 mg]

356

DIPAM (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) diazepam 10 mg XP4

357

MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 30 mg N2

358

ZOPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 10 mg P4 [180 mg]

359

BLUCON † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 10 mg +pseudoephedrine hydrochloride 30 mg XN3 [175.2 mg]

360

DIAZA (áʧä·Â) diazepam 2 mg XP4 [172 mg]

361

DIAZEPAM CHAROEN BHAESAJ (à¨ÃÔÞàÀÊѪ) diazepam 2 mg XP4

362

DIAZEPAM GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) diazepam 10 mg P4 [182 mg]

363

DIAZEPAM T P DRUG (·Õ ¾Õ ´ÃÑ¡) diazepam 10 mg P4

364

MANODIAZO (áËÅÁ·Í§¡ÒÃá¾·Â�) diazepam 10 mg P4 [160 mg]

365

MED-ZEPAM (àǪºÃÔ¡ÒÃ) diazepam 5 mg XP4

366

PRENARPIL (ÊËá¾·Â�àÀÊѪ) clonazepam 1 mg P4 [147.79 mg]

367

SIPAM (ÊÂÒÁàÀÊѪ) diazepam 10 mg XP4 [160 mg]

368

DIAZ (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) diazepam 10 mg XP4 [180 mg]

369

CLONARIL (ÂÙâ·à»‚œÂ¹) clonazepam 1 mg P4 [150 mg]

370

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 21 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 21 8/13/2013 5:31:13 PM

Page 23: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

DIAZEPAM H K PHARM (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 10 mg P4 [166.62 mg]

371

XANAX XR (ä¿à«ÍÃ�) alprazolam 0.5 mg P2 [346.11 mg]

372

NEOCOD † (ÁÒ«Òáź) codeine phosphate 10 mg XN3 [497.3 mg]

373

NEO-CODEIN † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 10 mg XN3 [503 mg]

374

PARA-CO (ÊËá¾·Â�àÀÊѪ) codeine phosphate 15 mg N3 [390.09 mg]

375

TRYCAM (´Ñ¡ÅÒÊ/ÍÂ.) triazolam 0.25 mg P2

376

DIADON (áͤ´Í¹) diazepam 5 mg XP4

377

HALCION (¿ÒÃ�ÁÒà«ÕÂ/ÍÂ.) triazolam 0.25 mg P2 [97.41 mg]

378

DORMICUM (âê/ÍÂ.) midazolam 15 mg P2 [208 mg]

379

CODICET BLUE 300 † (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§) codeine phosphate 15 mg N3 [365 mg]

380

XANAX XR (ä¿à«ÍÃ�) alprazolam 2 mg P2 [345.69 mg]

381

BLUE Capsule

ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 5 mg XP4

382

BLUCO † (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§) codeine phosphate 10 mg +pseudoephedrine hydrochloride 30 mg XN3 [249.7 mg]

383

GREEN Tablet

PHENOBARBITAL ACDHON (áͤ´Í¹) phenobarbital sodium 15 mg XP4

phenobarbital sodium 15 mg

384

LORAZEP (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) lorazepam 2 mg P4 [65 mg]

385

CHLORDIXIDE (àÅÔÈÊÔ§Ë�) chlordiazepoxide hydrochloride 5 mg XP4 [232 mg]

386

CHLORZEP (ºÕàÁ´¿ÒÃ�ÁÒ) chlordiazepoxide hydrochloride 5 mg XP4

chlordiazepoxide hydrochloride 5 mg

387

CALMIPAM (à©ÅÔÁªÑÂàÀÊѪ) diazepam 2 mg XP4

388

ZEDA (Íѧ¡ÄɵÃÒ§Ù (áÍÅ ¾Õ)) lorazepam 1 mg P4 [90 mg]

389

COMOBEN (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) chlordiazepoxide hydrochloride 5 mg P4 [125.82 mg]

390

DIAZEPAM SAMAKEEPHAESAJ (ÊÒÁѤ¤ÕàÀÊѪ) diazepam 2 mg XP4

391

DIAZEPAM T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) diazepam 2 mg P4 [115 mg]

392

HAWKCOPAX (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) lorazepam 1 mg XP4

393

VISPAM (ÂÙâ·à»‚œÂ¹) diazepam 2 mg XP4 [140 mg]

394

DIAZEPAM POND'S CHEMICAL (¾Í¹´�à¤ÁÕ¤ÍÅ) diazepam 2 mg P4 [122 mg]

395

DIAPAM (à¡Ãç·àµÍÃ�¿ÒÃ�ÁÒ) diazepam 2 mg P4 [142 mg]

396

LORA (á͵ᏵԤ) lorazepam 0.5 mg P4 [100 mg]

397

PORA (¾Í¹´�à¤ÁÕ¤ÍÅ) lorazepam 0.5 mg XP4

398

PONDNEBIUM (¾Í¹´�à¤ÁÕ¤ÍÅ) chlordiazepoxide hydrochloride 5 mg XP4 [200 mg]

399

LORAZEPAM MACROPHAR (áÁ¤â¤Ã¿ÒÃ�) lorazepam 1 mg XP4 [120 mg]

400

CHLORDIAZEPOXIDE T MAN (·Õ áÁ¹ ¿ÒÃ�ÁÒ) chlordiazepoxide hydrochloride 10 mg P4 [168.8 mg]

401

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

22 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 22 8/13/2013 5:31:15 PM

Page 24: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

DIAZEPAM BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)) diazepam 5 mg P4 [190.2 mg]

402

POBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4

403

WINOPAM (ÅÔÇÔ¹à¹ÍÃ�¿ÒÃ�ÁÒ) diazepam 5 mg XP4

404

MODURAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]

chlordiazepoxide hydrochloride 5 mg

405

CEBARAX † (ÁÒ«Òáź) chlordiazepoxide hydrochloride 5 mg P4 [250 mg]

406

CHLORDIBRAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4

407

CLINOPRONT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg N3 [283.31 mg]

408

LIBRAX † (âÍÅÔ¤) chlordiazepoxide 5 mg P4 [299 mg]

chlordiazepoxide 5 mg

409

LICON † (äÅ¿Š ¤Í¹à«Ô¹) chlordiazepoxide hydrochloride 5 mg XP4

410

UTORAX † (ÂÙâ·à»‚œÂ¹) chlordiazepoxide hydrochloride 5 mg XP4

411

ZEPOBRAX † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) chlordiazepoxide hydrochloride 5 mg XP4

412

DIRAX † (ÊËá¾·Â�àÀÊѪ) chlordiazepoxide 5 mg P4 [200 mg]

413

DIAPINE TABLET (á͵ᏵԤ) diazepam 10 mg P4 [320 mg]

414

TERCO-C † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 10 mg N3 [591.1 mg]

415

CODEE-C † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 10 mg N3 [345.02 mg]

416

SECO † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) codeine phosphate 10 mg N3 [331.56 mg]

417

TOCODYL † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) codeine phosphate 10 mg XN3 [325.82 mg]

418

CODESIA † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 10 mg N3 [350 mg]

419

RADIBRAX † (¿ÒÃ�ÁÒÊѹµ� áÅçº) chlordiazepoxide hydrochloride 5 mg XP4

420

ALPRAMED (àÅÔÈÊÔ§Ë�) alprazolam 1 mg P2 [259 mg]

421

CODENOL † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 15 mg N3

422

ROHYPNOL (âê/ÍÂ.) fl unitrazepam 1 mg P2 [175 mg]

423

PARAMED-CO † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 15 mg XN3 [601.1 mg]

424

VASON (ÁÔÅÅÔàÁ´) diazepam 2 mg P4 [110 mg]

425

CELIUM (ÂÙâ·à»‚œÂ¹) medazepam 5 mg P4 [110 mg]

426

GREEN Capsule

EUHYPNOS 20 (ÍÒÃ� ¾Õ àªÍàÃÍÃ�/ÍÂ.) temazepam 20 mg P2 [868.96 mg]

[868.96 mg]

427

TUMAX † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) chlordiazepoxide hydrochloride 5 mg P4 [180 mg]

428

ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 2 mg XP4

429

POSENE (ÊÂÒÁàÁ´Ôá¤Ã�) clorazepate dipotassium 10 mg XP4

430

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 23 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 23 8/13/2013 5:31:17 PM

Page 25: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

STESOLID (´ÙàÁç¡«�) diazepam 2 mg XP4

431

BROWN Tablet

NEURAMIZONE † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) phenobarbital 20 mg P4 [30.3 mg]

432

BENERA † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) phenobarbital 20 mg XP4 [135.5 mg]

433

GREY Tablet

KEMORA (âÍÅѹ-à¤ÁàÁ´) lorazepam 0.5 mg P4 [50 mg]

434

BENPINE (á͵ᏵԤ) chlordiazepoxide hydrochloride 5 mg P4 [136.82 mg]

435

PHENOBARBITAL ATLANTIC (á͵ᏵԤ) phenobarbital sodium 32.5 mg P4 [86 mg]

436

ZEPOXIDE (·Õ ¾Õ ´ÃÑ¡) chlordiazepoxide hydrochloride 5 mg XP4

437

MORPHINE SALUTAS PHARMA («ÒÅÙ·ÑÊ ¿ÒÃ�ÁÒ/ÍÂ.) morphine sulfate 10 mg N2

438

CONCERTA (ᨹો¹-«ÕáÅ¡/ÍÂ.) methylphenidate hydrochloride 27 mg P2

439

MULTICOLOURED Tablet

CODICET † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 15 mg XN3 [565 mg]

440

MULTICOLOURED Capsule

FREXENE (äÅ¿Š ¤Í¹à«Ô¹) clorazepate dipotassium 5 mg XP4

441

TRANPATE (·Õ áÁ¹ ¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg XP4 [146 mg]

442

DIZAN (áŪáÁ¹) diazepam 5 mg XP4 [175 mg]

443

DITRAN (ˌҧÂÒä·Â 1942) diazepam 2 mg P4 [163 mg]

444

FREXENE (äÅ¿Š ¤Í¹à«Ô¹) clorazepate dipotassium 10 mg XP4

445

CLOZENE (ÂÙàÁ´ŒÒ) clorazepate dipotassium 5 mg XP4 [165 mg]

446

CONZEP (ÁÒ«Òáź) clorazepate dipotassium 10 mg XP4

447

TRANCON (ÂÙâ·à»‚œÂ¹) clorazepate dipotassium 10 mg XP4 [140 mg]

448

POMADOM (¿ÒÃ�ÁÒÊѹµ� áÅçº) clorazepate dipotassium 10 mg XP4 [140 mg]

449

PANBESY (ÍÍÊâÁ¿ÒÃ�Á/ÍÂ.) phentermine hydrochloride 15 mg P2 [310 mg]

450

PHENTERMINE TRENKER (à·Ã¹à¡ÍÃ�/ÍÂ.) phentermine resinate 30 mg P2 [180 mg]

451

TRANMED (ÊËá¾·Â�àÀÊѪ) clorazepate dipotassium 5 mg P4 [163.1 mg]

452

DIPOSEF (Âٹիѹ) clorazepate dipotassium 5 mg XP4 [140 mg]

453

SANOR (äºâÍáÅ») clorazepate dipotassium 5 mg XP4 [149.55 mg]

[149.55 mg]

454

ANXENE (ÂÙâ·à»‚œÂ¹) clorazepate dipotassium 5 mg XP4

455

CLORAMED (àÁ´Ôä¿Ç�) clorazepate dipotassium 5 mg XP4

456

SERENE V S PHARMA (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg XP4 [163.1 mg]

[163.1 mg]

457

CLORAZE (âÁà´ÍÃ�¹áÁ¹Ù) clorazepate dipotassium 5 mg P4 [120 mg]

458

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

24 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 24 8/13/2013 5:31:18 PM

Page 26: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

DIPOT (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) clorazepate dipotassium 5 mg P4 [145 mg]

459

TRANZEP (á¾¹´ÃÑ¡Ê�) clorazepate dipotassium 5 mg XP4

460

MANOTRAN (áËÅÁ·Í§¡ÒÃá¾·Â�) clorazepate dipotassium 5 mg XP4 [150 mg]

461

CLORAXENE (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) clorazepate dipotassium 5 mg P4 [121.8 mg]

462

DEDA (àͪ ठ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) clorazepate dipotassium 5 mg XP4 [160 mg]

463

TRANCLOR (ÊÂÒÁàÀÊѪ) clorazepate dipotassium 5 mg XP4

464

TRANXENE (ÍÔ¹àµÍÃ�ä·Â) clorazepate dipotassium 5 mg P4 [145 mg]

465

CLOZEPATE (¹ÔÇäÅ¿Š¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg XP4

466

FLULIUM (¿ÒÃ�ÁÒÊѹµ� áÅçº) clorazepate dipotassium 5 mg P4 [160 mg]

467

POLIZEP (â»ÅÔ¿ÒÃ�Á) clorazepate dipotassium 5 mg P4 [234 mg]

468

TAMYLAB-S (¾Í¹´�à¤ÁÕ¤ÍÅ) clorazepate dipotassium 5 mg XP4 [220 mg]

469

TENMED (ÍԹᾤ¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg P4 [234 mg]

470

T-FIVE (·Õ àÍÊ ¿ÒÃ�ÁÒ) clorazepate dipotassium 5 mg XP4

471

TRANPON (àÅÔÈÊÔ§Ë�) clorazepate dipotassium 5 mg XP4 [173 mg]

472

CEXENE (·Õ àÍçÁ àÍç¹ ÍÔÁᾡ«�) clorazepate dipotassium 5 mg XP4

473

GAXENE (¡ÒÃ�à´Õé¹ ´ÃÑ¡àÎÒÊ�) clorazepate dipotassium 5 mg XP4

474

TRANADON-S (áͤ´Í¹) clorazepate dipotassium 5 mg XP4 [220 mg]

475

ZETRAN (ÁÒ«Òáź) clorazepate dipotassium 5 mg XP4 [166 mg]

476

PHENTERMINE OSMOPHARM (ÍÍÊâÁ¿ÒÃ�Á/ÍÂ.) phentermine hydrochloride 15 mg P2 [130.01 mg]

477

CLOZENE (ÂÙàÁ´ŒÒ) clorazepate dipotassium 10 mg XP4 [165 mg]

478

A-ZERAX (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) diazepam 2 mg P4 [145 mg]

479

CONZEP (ÁÒ«Òáź) clorazepate dipotassium 5 mg XP4

480

POMADOM (¿ÒÃ�ÁÒÊѹµ� áÅçº) clorazepate dipotassium 5 mg XP4

481

TRANCON (ÂÙâ·à»‚œÂ¹) clorazepate dipotassium 5 mg P4 [140 mg]

482

DIZAN (áŪáÁ¹) diazepam 2 mg XP4 [175 mg]

483

PRASEPINE (âÍÅÔ¤) prazepam 5 mg XP4

484

POZAPAM (¿ÒÃ�ÁÒÊѹµ� áÅçº) prazepam 5 mg P4 [170 mg]

485

†Indicates brands that contain more than one ingredientÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 25 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 25 8/13/2013 5:31:19 PM

Page 27: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ANXIELAX (áÁ¤â¤Ã¿ÒÃ�) clorazepate dipotassium 5 mg XP4 [248 mg]

486

PANBESY (ÍÍÊâÁ¿ÒÃ�Á/ÍÂ.) phentermine hydrochloride 30 mg P2 [320 mg]

487

ZEPAXID (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) diazepam 5 mg P4

488

A-ZERAX (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) diazepam 5 mg P4 [145 mg]

489

DOMAR (â»ÅÔ¿ÒÃ�Á) pinazepam 5 mg P4 [101 mg]

490

V DAY ZEPAM (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) diazepam 5 mg XP4 [200 mg]

491

PHENTERMINE TRENKER (à·Ã¹à¡ÍÃ�/ÍÂ.) phentermine resinate 15 mg P2 [160 mg]

492

MINOXIDE (ºÕਠ(àºÞ¨âÍʶ)) chlordiazepoxide hydrochloride 10 mg P4 [149.5 mg]

493

MED-ZEPOXIDE (àǪºÃÔ¡ÒÃ) chlordiazepoxide hydrochloride 5 mg XP4

494

MANODIAZO (áËÅÁ·Í§¡ÒÃá¾·Â�) diazepam 2 mg P4 [165 mg]

495

TRANCAP (·Õ ¾Õ ´ÃÑ¡) clorazepate dipotassium 5 mg XP4 [160 mg]

496

DZP2 (¿ÒÃ�ÁÒÊѹµ� áÅçº) diazepam 2 mg XP4

497

DIAZEPAM ACDHON (áͤ´Í¹) diazepam 2 mg XP4

498

DIAPINE CAPSULE (á͵ᏵԤ) diazepam 2 mg P4 [146 mg]

499

DIAZEPION (¨ÔǺÃÒà´ÍÃ�Ê) diazepam 5 mg XP4 [100 mg]

500

DITRAN (ˌҧÂÒä·Â 1942) diazepam 5 mg XP4 [165 mg]

501

V DAY ZEPAM (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) diazepam 2 mg XP4 [200 mg]

502

CHLORDIAZEPOXIDE MARCH PHARMA (áËÅÁ·Í§¡ÒÃá¾·Â�) chlordiazepoxide hydrochloride 25 mg XP4 [346 mg]

503

REGENON RETARD (à·ÁàÅÍÃ�/ÍÂ.) diethylpropion hydrochloride 75 mg P2 [480 mg]

504

ATRACTIL (à·Ã¹à¡ÍÃ�/ÍÂ.) diethylpropion resinate 75 mg P2 [402.64 mg]

505

DIAPINE CAPSULE (á͵ᏵԤ) diazepam 5 mg P4 [147 mg]

506

STESOLID (äºâÍáÅ») diazepam 5 mg XP4

507

EXAN (Âٹիѹ) clorazepate dipotassium 5 mg XP4

508

UPZENE (ÊËá¾·Â�àÀÊѪ) clorazepate dipotassium 5 mg XP4

509

COMOBEN (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) chlordiazepoxide hydrochloride 10 mg P4 [211.36 mg]

[211.36 mg]

510

EXAN (Âٹիѹ) clorazepate dipotassium 10 mg XP4

511

DALMADORM (âê/ÍÂ.) fl urazepam hydrochloride 15 mg P2

512

STESOLID (äºâÍáÅ») diazepam 10 mg XP4

513

DIAZEPION (¨ÔǺÃÒà´ÍÃ�Ê) diazepam 2 mg XP4 [100 mg]

514

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

26 PRODUCT IDENTIFICATION CHART PN DEX 2013

†Indicates brands that contain more than one ingredient

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 26 8/13/2013 5:31:20 PM

Page 28: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

METAXIDE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) chlordiazepoxide hydrochloride 10 mg XP4 [120 mg]

515

MIRAPRONT N (áÁç¤/ÍÂ.) cathine 20 mg P2

516

D-NORPSEUDOEPHEDRINE SR OSMOPHARM (ÍÍÊâÁ¿ÒÃ�Á/ÍÂ.) cathine 20 mg P2 [173.28 mg]

517

DIAMED (ÊËá¾·Â�àÀÊѪ) diazepam 5 mg P4 [168.5 mg]

518

MEDAZINE (ÊËá¾·Â�àÀÊѪ) medazepam 10 mg P4 [165 mg]

519

MEDAZINE (ÊËá¾·Â�àÀÊѪ) medazepam 5 mg P4 [165 mg]

520

DUROMINE (´Ñ¡ÅÒÊ/ÍÂ.) phentermine resinate 30 mg P2 [291 mg]

521

CODIPRONT † (ÍÔ¹àµÍÃ�ä·Â) codeine 30 mg XN3 [234 mg]

522

CODIPRONT † (âÍÅÔ¤) codeine 30 mg N3 [298.6 mg]

523

CLINEPECT † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 10 mg + phenylpropanolamine hydrochloride 12.5 mg XN3 [270 mg]

524

MONOZIDE (ä·Â ¾Õ ´Õ à¤ÁÕ¤ÍÅÊ�) diazepam 2 mg XP4

525

BENPINE (á͵ᏵԤ) chlordiazepoxide hydrochloride 10 mg P4 [130 mg]

526

DUROMINE (´Ñ¡ÅÒÊ/ÍÂ.) phentermine resinate 15 mg P2 [291.03 mg]

527

CHLORDIAZEPOXIDE CHAROEN BHAESAJ (à¨ÃÔÞàÀÊѪ) chlordiazepoxide hydrochloride 10 mg XP4

528

CHLORDIAZEPOXIDE ACDHON (áͤ´Í¹) chlordiazepoxide hydrochloride 10 mg XP4

529

MANODIAZO (áËÅÁ·Í§¡ÒÃá¾·Â�) diazepam 5 mg P4 [165 mg]

530

DIAMED (ÊËá¾·Â�àÀÊѪ) diazepam 2 mg P4 [165.53 mg]

531

ZEPAXID (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) diazepam 2 mg XP4

532

OTHERS

*BENADRYL CD † (âÍÅÔ¤) codeine phosphate 60 mL XN3

533

*BENADRYL CD † (âÍÅÔ¤) codeine phosphate 1000 mL XN3

534

*BENYLIN CD † (âÍÅÔ¤) codeine phosphate 60 mL XN3

535

*BONADINE CD † (¿ÒÃ�ÁÒÊѹµ� áÅçº) codeine phosphate 60 mL XN3

536

*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 27 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 27 8/13/2013 5:31:21 PM

Page 29: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*BROMTUSSIA DC † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 60 mL XN3

537

*BROWN MIXTURE GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 180 mL N3

538

*BROWN MIXTURE GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 450 mL N3

539

*BROWN MIXTURE OSOTH INTERLAB † (âÍʶÍÔ¹àµÍÃ�) camphorated opium tincture 180 mL N3

540

*CAMPHORATED OPIUM TINCTURE GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 1000 mL N3

541

*CODESIA † (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) codeine phosphate 60 mL N3

542

*CODIPRONT SYRUP † (áÁç¤) codeine 60 mL XN3

codeine 60 mL

543

*CODYL COUGH LINCTUS † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 60 mL N3

codeine phosphate 60 mL

544

*CODYL COUGH LINCTUS † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 100 mL N3

545

*CODYL COUGH LINCTUS † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 1000 mL XN3

546

*CODYL COUGH LINCTUS † (ÊËá¾·Â�àÀÊѪ) codeine phosphate 4500 mL XN3

547

*COFCODYL † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 60 mL N3

548

†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

28 PRODUCT IDENTIFICATION CHART PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 28 8/13/2013 5:31:22 PM

Page 30: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*COFCODYL † (ºÒ§¡Í¡áÅç»á͹´�¤ÍÊàÁµÔ¤) codeine phosphate 100 mL N3

549

*COMODINE COUGH † (àÍ àÍç¹ àͪ â»Ã´Ñ¤Ê�) codeine phosphate 60 mL XN3

550

*CONADYL † (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) codeine phosphate 60 mL XN3

551

*COSEDYL † (·Õ ¾Õ ´ÃÑ¡) codeine phosphate 60 mL XN3

552

*COUGH SYRUP GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 60 mL XN3

553

*DECOS † (àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì) codeine phosphate 100 mL N3

554

*DIMETANE EXPECTORANT DC † (äÇ·�ÎÍÅÅ�) codeine phosphate, phenylpropanolamine hydrochloride 2.5 L XN3

hydrochloride 2.5 L

555

*ELIXIR PHENOBARB (Êؾ§É�àÀÊѪ) phenobarbital sodium 60 mL XP4

phenobarbital sodium 60 mL

556

*HISEDYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 60 mL XN3

557

*HISEDYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 120 mL XN3

558

*MANTADYL COUGH † (·Õ áÁ¹ ¿ÒÃ�ÁÒ) codeine phosphate 60 mL XN3

559

*MASADYL COUGH † (ÁÒ«Òáź) codeine phosphate 60 mL XN3

560

*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 29 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 29 8/13/2013 5:31:22 PM

Page 31: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*MASADYL COUGH † (ÁÒ«Òáź) codeine phosphate 100 mL XN3

561

*MASADYL COUGH † (ÁÒ«Òáź) codeine phosphate 240 mL XN3

562

*MENOBARB (ÁÔÅÒâ¹) phenobarbital sodium 15 mg/5 mL x 60 mL XP4

563

*MENOBARB (ÁÔÅÒâ¹) phenobarbital sodium 20 mg/5 mL x 60 mL XP4

564

*METHADONE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) methadone hydrochloride 10 mg/mL x 1000 mL N2

10 mg/mL x 1000 mL

565

*MILA-CONO † (ÁÔÅÒâ¹) codeine phosphate 60 mL XN3

566

*MIST TUSSIS † (ÇÔ·ÂÒÈÃÁ) camphorated opium tincture 450 mL XN3

camphorated opium tincture 450 mL

567

*MIST. SCILL AMMON. GPO † (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) camphorated opium tincture 180 mL XN3

568

*MIXTURE SCILLAE AMMON † (âÍʶÍÔ¹àµÍÃ�) camphorated opium tincture 180 mL XN3

569

*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 30 mL N3

570

*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 60 mL N3

571

*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 120 mL N3

572

†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

30 PRODUCT IDENTIFICATION CHART PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 30 8/13/2013 5:31:23 PM

Page 32: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 240 mL N3

573

*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 450 mL N3

574

*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 1800 mL XN3

575

*MIXTURE TUSSIS † (Êؾ§É�àÀÊѪ) camphorated opium tincture 3600 mL XN3

576

*MORPHINE SULFATE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) morphine sulfate 10 mg/5 mL N2

577

*NEO COUGH † (ÁÒ«Òáź) codeine phosphate 60 mL XN3

578

*NEO COUGH † (ÁÒ«Òáź) codeine phosphate 100 mL XN3

579

*NEO COUGH † (ÁÒ«Òáź) codeine phosphate 240 mL XN3

5 80

*NORDYL LINCTUS † (âÃÊÁ͹·� ¿ÒÃ�Á«ÙµÔ¤ÍÅ) codeine phosphate 100 mL XN3

581

*NORDYL LINCTUS † (âÃÊÁ͹·� ¿ÒÃ�Á«ÙµÔ¤ÍÅ) codeine phosphate 500 mL XN3

582

*NORTUSS LINCTUS † (âÃÊÁ͹·� ¿ÒÃ�Á«ÙµÔ¤ÍÅ) codeine phosphate 100 mL XN3

583

*NORTUSS LINCTUS † (âÃÊÁ͹·� ¿ÒÃ�Á«ÙµÔ¤ÍÅ) codeine phosphate 500 mL XN3

584

*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 31 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 31 8/13/2013 5:31:24 PM

Page 33: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*OPIUM TINCTURE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) morphine 1% x 450 mL N2

585

*ORAMORPH (àºÍÃÔ§à¡ÍÃ� ÍÔ¹à¡ÅäÎÁ�/ÍÂ.) morphine sulfate 10 mg/5 mL x 250 mL N2

586

*ORAMORPH (àºÍÃÔ§à¡ÍÃ� ÍÔ¹à¡ÅäÎÁ�/ÍÂ.) morphine sulfate 20 mg/mL x 30 mL N2

587

*P-CODYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 60 mL XN3

588

*P-CODYL † (âÍʶÍÔ¹àµÍÃ�) codeine phosphate 120 mL XN3

589

*PERCIDYL COUGH † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 100 mL XN3

590

*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 60 mL XN3

591

*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 500 mL XN3

592

*PHENCODIN † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 1000 mL XN3

593

*PHENOBARB ELIXIR (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) phenobarbital sodium 20 mg/5 mL x 60 mL XP4

phenobarbital sodium 20 mg/5 mL x 60 mL

594

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 30 mL XP4

phenobarbital sodium 20 mg/5 mL x 30 mL

595

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 60 mL XP4

596

†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

32 PRODUCT IDENTIFICATION CHART PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 32 8/13/2013 5:31:24 PM

Page 34: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 120 mL XP4

phenobarbital sodium 20 mg/5 mL x 120 mL

597

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 240 mL XP4

598

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 450 mL XP4

phenobarbital sodium 20 mg/5 mL x 450 mL

599

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 500 mL XP4

600

*PHENOBARBITAL ELIXIR ACDHON (áͤ´Í¹) phenobarbital sodium 20 mg/5 mL x 1000 mL XP4

601

*PHENOCO ELIXIR (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) phenobarbital sodium 20 mg/5 mL x 450 mL XP4

602

*PHENOCO ELIXIR (·Õ âÍ à¤ÁÕ¤ÍÅÊ�) phenobarbital sodium 20 mg/5 mL x 3800 mL XP4

603

*PHENOSIL ELIXIR (ÊÕÅÁ¡ÒÃá¾·Â�) phenobarbital sodium 20 mg/5 mL x 60 mL XP4

604

*PHENOSIL ELIXIR (ÊÕÅÁ¡ÒÃá¾·Â�) phenobarbital sodium 20 mg/5 mL x 450 mL XP4

605

*PHENOTAL ELIXIR (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ) phenobarbital sodium 20 mg/5 mL x 60 mL P4

606

*PHENSEDYL OLIC † (âÍÅÔ¤) codeine phosphate 100 mL XN3

607

*PHENSODI † (à¨ÃÔÞàÀÊѪ) codeine phosphate 60 mL XN3

608

*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 33 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 33 8/13/2013 5:31:25 PM

Page 35: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*PHENSODI † (à¨ÃÔÞàÀÊѪ) codeine phosphate 120 mL XN3

codeine phosphate 120 mL

609

*PHENSODI † (à¨ÃÔÞàÀÊѪ) codeine phosphate 1000 mL XN3

610

*POLY-COF † (ÁÔÅÅÔàÁ´) codeine phosphate 60 mL N3

codeine phosphate 60 mL

611

*POLY-COF † (ÁÔÅÅÔàÁ´) codeine phosphate 100 mL N3

612

*PONDNADYL † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 60 mL XN3

613

*PONDNADYL † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 100 mL XN3

614

*PONDNADYL † (¾Í¹´�à¤ÁÕ¤ÍÅ) codeine phosphate 1000 mL XN3

615

*PSEUDOEPHEDRINE ASIAN PHARM (àÍàªÕ蹿ÒÃ�ÁÒ«ÙµÔ¤ÑÅ/ÍÂ.) pseudoephedrine hydrochloride 30 mg/5 mL x 60 mL P2

30 mg/5 mL x 60 mL

616

*PSEUDOEPHEDRINE BJ BENJAOSOTH (ºÕਠ(àºÞ¨âÍʶ)/ÍÂ.) pseudoephedrine hydrochloride 30 mg/5 mL x 60 mL P2

617

*PSEUDOEPHEDRINE MILANO (ÁÔÅÒâ¹/ÍÂ.) pseudoephedrine hydrochloride 30 mg/5 mL x 60 mL P2

30 mg/5 mL x 60 mL

618

*SQUILL AND AMMONIA VIDHYASOM † (ÇÔ·ÂÒÈÃÁ) camphorated opium tincture 450 mL XN3

camphorated opium tincture 450 mL

619

*TENADRIN-C † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate 60 mL XN3

620

†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

34 PRODUCT IDENTIFICATION CHART PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 34 8/13/2013 5:31:26 PM

Page 36: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*TERADENE † (ºÕ àÍçÅ ÎÑéÇ) codeine phosphate, pseudoephedrine hydrochloride 60 mL XN3

621

*TERADYL † (àÍçÁ á͹ � àÍçª áÁ¹Ùῤà¨ÍÃÔè§) codeine phosphate 60 mL XN3

622

*TERADYL † (àÍçÁ á͹ � àÍçª áÁ¹Ùῤà¨ÍÃÔè§) codeine phosphate 1000 mL XN3

623

*TUSSIDYL † (ÇÕ àÍÊ ¿ÒÃ�ÁÒ) codeine phosphate 60 mL XN3

624

*DIAPINE (á͵ᏵԤ) diazepam 5 mg/mL x 1 mL P4

625

*DIAPINE (á͵ᏵԤ) diazepam 10 mg/2 mL x 2 mL P4

626

*DIAZA (áʧä·Â) diazepam 10 mg/2 mL x 2 mL XP4

627

*DIAZEPAM GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ) diazepam 10 mg/2 mL x 2 mL XP4

628

*DIAZEPAM T P DRUG (·Õ ¾Õ ´ÃÑ¡) diazepam 10 mg/2 mL x 2 mL P4

diazepam 10 mg/2 mL x 2 mL

629

*DORMICUM («Ô¹ÔÊÕ/ÍÂ.) midazolam 5 mg/mL x 1 mL P2

midazolam 5 mg/mL x 1 mL

630

*DORMICUM (âê/ÍÂ.) midazolam 15 mg/3 mL x 3 mL P2

631

*EPHEDRINE GPO (ͧ¤�¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.) ephedrine hydrochloride 30 mg/mL x 1 mL P2

632

*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 35 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 35 8/13/2013 5:31:26 PM

Page 37: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*FENTANYL ANTIGEN (á͹µÔਹ/ÍÂ.) fentanyl 0.05 mg/mL x 2 mL N2

fentanyl 0.05 mg/mL x 2 mL

633

*FENTANYL ANTIGEN (á͹µÔਹ/ÍÂ.) fentanyl 0.05 mg/mL x 10 mL N2

fentanyl 0.05 mg/mL x 10 mL

634

*FENTANYL JANSSEN-CILAG (ᨹો¹-«ÕáÅ¡/ÍÂ.) fentanyl citrate 0.05 mg/mL x 2 mL N2

fentanyl citrate 0.05 mg/mL x 2 mL

635

*FENTANYL JANSSEN-CILAG (ᨹો¹-«ÕáÅ¡/ÍÂ.) fentanyl citrate 0.05 mg/mL x 10 mL N2

636

*FENTANYL SANDOZ (᫹´ÍÊ á¤¹Ò´Ò/ÍÂ.) fentanyl citrate 0.05 mg/mL x 2 mL N2

637

*FENTANYL-HAMELN (ÎÒàÁŹ/ÍÂ.) fentanyl citrate 50 mcg/mL x 2 mL N2

638

*FENTANYL-HAMELN (ÎÒàÁŹ/ÍÂ.) fentanyl citrate 50 mcg/mL x 10 mL N2

639

*FENTANYL-SNS (àÍÊàÍç¹àÍÊ/ÍÂ.) fentanyl citrate 50 mcg/mL x 2 mL N2

640

*FORTWIN (áùáºç¡«Õè) pentazocine lactate 30 mg/mL x 1 mL XP3

641

*LAYLIUM-10 (ÂÙàÁ´ŒÒ) diazepam 10 mg/2 mL x 2 mL XP4

642

*MANOLIUM (áËÅÁ·Í§¡ÒÃá¾·Â�) diazepam 10 mg/2 mL x 2 mL P4

643

*MIDAZ (ÍÔ¹·ÑÊ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ/ÍÂ.) midazolam 5 mg/mL x 1 mL P2

644

†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

36 PRODUCT IDENTIFICATION CHART PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 36 8/13/2013 5:31:27 PM

Page 38: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*MIDAZ (ÍÔ¹·ÑÊ¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ/ÍÂ.) midazolam 5 mg/mL x 3 mL P2

645

*MIDAZOLAM HEXAL (¨Õ¹ÒàΡ«ÒÅ/ÍÂ.) midazolam 5 mg/mL x 1 mL P2

midazolam 5 mg/mL x 1 mL

646

*MIDAZOLAM HEXAL (¨Õ¹ÒàΡ«ÒÅ/ÍÂ.) midazolam 5 mg/mL x 3 mL P2

midazolam 5 mg/mL x 3 mL

647

*MONOZIDE-10 (ä·Â ¾Õ ´Õ à¤ÁÕ¤ÍÅÊ�) diazepam 10 mg/2 mL x 2 mL XP4

648

*MORPHINE SULFATE INJ BLUE (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2

649

*MORPHINE SULFATE INJ PURPLE (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2

650

*MORPHINE T P DRUG (·Õ ¾Õ ´ÃÑ¡/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2

651

*MORPHINE T P DRUG (·Õ ¾Õ ´ÃÑ¡/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2

652

*MORPHINE T P DRUG (·Õ ¾Õ ´ÃÑ¡/ÍÂ.) morphine sulfate 10 mg/mL x 1 mL N2

653

*PANGON (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) pentazocine lactate 30 mg/mL x 1 mL P3

654

*PENTAZOCINE ALL PLANTS (ÍÍÅá¾ÅŒ¹·�Ê) pentazocine 30 mg/mL x 1 mL XP3

655

*PETHIDINE BIOLAB (äºâÍáÅ»/ÍÂ.) pethidine hydrochloride 100 mg/2 mL x 2 mL N2

656

*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 37 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 37 8/13/2013 5:31:28 PM

Page 39: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*PETHIDINE HAMELN (ÎÒàÁŹ/ÍÂ.) pethidine hydrochloride 50 mg/mL N2

657

*PETHIDINE M & H MANUFACTURING (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.) pethidine hydrochloride 50 mg/mL x 1 mL N2

658

*PETHIDINE M & H MANUFACTURING (àÍçÁ á͹´� àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ.) pethidine hydrochloride 100 mg/2 mL x 2 mL N2

pethidine hydrochloride 100 mg/2 mL x 2 mL

659

*PETHIDINE T P DRUG (·Õ ¾Õ ´ÃÑ¡/ÍÂ.) pethidine hydrochloride 50 mg/mL x 1 mL N2

pethidine hydrochloride 50 mg/mL x 1 mL

660

*RIVOTRIL (âê) clonazepam 1 mg/mL x 1 mL XP4

661

*ROPAM (áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè) diazepam 10 mg/2 mL x 2 mL P4

662

*SIPAM (ÊÂÒÁàÀÊѪ) diazepam 10 mg/2 mL x 2 mL P4

663

*SOSEGON («Ò⹿‚›-«Ô¹àµÅÒâº) pentazocine lactate 30 mg/mL x 1 mL XP3

664

*TAZCINE (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) pentazocine 30 mg/mL x 1 mL XP3

665

*TEMGESIC (àá¤Ô··� ູ¤Õà«ÍÃ�/ÍÂ.) buprenorphine hydrochloride 0.3 mg/mL x 1 mL P2

0.3 mg/mL x 1 mL

666

*TRANOLAN (âÍÅѹ-à¤ÁàÁ´) diazepam 10 mg/2 mL x 2 mL P4

diazepam 10 mg/2 mL x 2 mL

667

*V DAY ZEPAM (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) diazepam 10 mg/2 mL x 2 mL XP4

668

†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

38 PRODUCT IDENTIFICATION CHART PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 38 8/13/2013 5:31:28 PM

Page 40: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*V DAY ZEPAM NL (¾Õ ¾Õ áźÍÃÒµÍÃÕèÊ�) diazepam 10 mg/2 mL x 2 mL XP4

669

*VALIUM (âê) diazepam 10 mg/2 mL x 2 mL XP4

diazepam 10 mg/2 mL x 2 mL

670

*VESCOPAM (àÇÊâ¡¿ÒÃ�ÁÒ«ÙµÔ¤ÍÅ) diazepam 10 mg/2 mL x 2 mL P4

671

*ZEPAM (âÁà´ÍÃ�¹áÁ¹Ù) diazepam 10 mg/2 mL x 2 mL XP4

672

*ZEPAXID (ÍØ´Á¾Ã (¿‚ÎÒáÅçº)) diazepam 10 mg/2 mL x 2 mL XP4

673

*AMYTAL (ÍÕäÅ ÅÔÅÅÕè) amobarbital 0.5 g XP3

674

*CALYPSOL (¡Õà´Õ¹ ÃÔªàµÍÃ�/ÍÂ.) ketamine hydrochloride 50 mg/mL x 10 mL P2

675

*FENTANYL SANDOZ (᫹´ÍÊ á¤¹Ò´Ò/ÍÂ.) fentanyl citrate 500 mcg/10 mL N2

676

*GARDENAL («Ò⹿‚›-ÍàǹµÕÊ) phenobarbital sodium 200 mg/4 mL P4

phenobarbital sodium 200 mg/4 mL

677

*KETA-HAMELN (ÎÒàÁŹ/ÍÂ.) ketamine hydrochloride 50 mg/mL x 10 mL P2

678

*KETALAR (¾ÒÃ�¤à´ÇÔÊ/ÍÂ.) ketamine hydrochloride 50 mg/mL x 10 mL P2

679

*NEMBUTAL («ÕÇÒ á͹ÔÁÍÅ àÎÅ·�) pentobarbital sodium 54.7 mg/mL x 100 mL P3

680

*Shown smaller than the actual sizeÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

PRODUCT IDENTIFICATION CHART 39 PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 39 8/13/2013 5:31:28 PM

Page 41: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

*DUROGESIC PATCH (ᨹો¹ ¿ÒÃ�ÁÒ/ÍÂ.) fentanyl 12 mcg/hr N2

681

*DUROGESIC PATCH (ᨹો¹ ¿ÒÃ�ÁÒ/ÍÂ.) fentanyl 25 mcg/hr N2

682

*DUROGESIC PATCH (ᨹો¹ ¿ÒÃ�ÁÒ/ÍÂ.) fentanyl 50 mcg/hr N2

683

*DUROGESIC PATCH (ᨹો¹ ¿ÒÃ�ÁÒ/ÍÂ.) fentanyl 100 mcg/hr N2

684

*FENTADUR (ÅÒÇÔ¿ÒÃ�Á/ÍÂ.) fentanyl 25 mcg/hr N2

685

*FENTANYL GPO (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 12 mcg/hr N2

686

*FENTANYL GPO (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 25 mcg/hr N2

687

*FENTANYL GPO (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 50 mcg/hr N2

688

*FENTANYL HEXAL (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 12 mcg/hr N2

689

*FENTANYL HEXAL (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 25 mcg/hr N2

690

*FENTANYL HEXAL (àΡ«ÒÅ àͨÕ/ÍÂ.) fentanyl 50 mcg/hr N2

691

†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

40 PRODUCT IDENTIFICATION CHART PN DEX 2013

TH PNDEX PIC CHART 2013 - FINAL - July31.indd 40 8/13/2013 5:31:29 PM

Page 42: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ตารางบนทกขอหาและบทกำาหนดโทษ ทมา : บนทก ป.ป.ส. 2556 สำานกงาน ป.ป.ส. กระทรวงยตธรรม

ขอหา ยาเสพตดใหโทษประเภท 1

ผลตนำาเขาสงออก(ม.15, 65)

•จำ�คกตลอดชวตและปรบ1ล�น-5ล�นบ�ท•ถ�กระทำ�เพอจำ�หน�ยประห�รชวตถ�ปรม�ณตอไปนขนไปใหถอว�ผลตนำ�เข�สงออกครอบครองเพอจำ�หน�ยแอลเอสดส�รบรสทธ0.75มลลกรมหรอ15หนวยก�รใชหรอนำ�หนกสทธ300มลลกรม(หนวยก�รใช=เมด,ซอง,ขวดหรอหนวยอย�งอนททำ�ขนโดยปกตสำ�หรบก�รใชเสพหนงครง)ยาบาส�รบรสทธ375มลลกรมหรอ15หนวยก�รใชหรอนำ�หนกสทธ1.5กรมยาเสพตดใหโทษประเภท 1 อนๆส�รบรสทธ3กรม•ถ�เปนก�รผลตโดยก�รแบงบรรจหรอรวมบรรจจำ�คก4-15ปหรอปรบ80,000-300,000บ�ทหรอทงจำ�ทงปรบถ�กระทำ�เพอจำ�หน�ยจำ�คก4ป-ตลอดชวตและปรบ400,000-5ล�นบ�ท

จำาหนายครอบครองเพอจำ�หน�ย(ม.15, 66)

•จำ�คก4-15ปหรอปรบ80,000-300,000บ�ทหรอทงจำ�ทงปรบ•ถ�มส�รบรสทธปรม�ณตอไปนแอลเอสด0.75มลลกรม-20กรมหรอย�บ�375มลลกรม-20กรมหรอย�เสพตดใหโทษประเภท1อนๆ3-20กรมจำ�คก40ป-ตลอดชวตและปรบ400,000-5ล�นบ�ท•ถ�มส�รบรสทธเกน20กรมจำ�คกตลอดชวตและปรบ1ล�นบ�ท-5ล�นบ�ทหรอประห�รชวต

ครอบครอง(ม.15, 67)

•จำ�คก1-10ปหรอปรบ20,000-200,000บ�ทหรอทงจำ�ทงปรบ

เสพ(ม.57, 91)

•จำ�คก6เดอน-3ปหรอปรบ10,000-60,000บ�ทหรอทงจำ�ทงปรบ

หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)

•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป–ตลอดชวตและปรบ300,000-5,000,000บ�ทถ�เปนเฮโรอนตองระว�งโทษเปนสองเท�และถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะประห�รชวต

ขอหา ยาเสพตดใหโทษประเภท 2

ผลตนำาเขาสงออก(ม.16, 68)

•จำ�คก1-10ปและปรบ100,000-1ล�นบ�ท•ถ�เปนมอรฟนฝนหรอโคค�อนจำ�คก20ป-ตลอดชวตและปรบ2ล�น-5ล�นบ�ท

จำาหนายครอบครองเพอจำาหนาย(ม.17, 69)

•จำ�คก1-10ปหรอปรบ20,000บ�ท-200,000บ�ทหรอทงจำ�ทงปรบ•ถ�เปนมอรฟนฝนหรอโคค�อนปรม�ณส�รบรสทธไมถง100กรมจำ�คก3-20ปหรอปรบ60,000-400,000บ�ทหรอทงจำ�ทงปรบถ�มส�รบรสทธ100กรมขนไปจำ�คก5ป-ตลอดชวตและปรบ500,000-5ล�นบ�ท

ครอบครอง(ม.17, 69)

•จำ�คกไมเกน5ปหรอปรบไมเกน100,000บ�ทหรอทงจำ�ทงปรบ

เสพ(ม.58, 91)

•จำ�คก6เดอน-3ปหรอปรบ10,000-60,000บ�ทหรอทงจำ�ทงปรบเวนแตเปนก�รเสพเพอรกษ�โรคต�มคำ�สงของแพทยทไดรบใบอนญ�ต

หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)

•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ300,000–5,000,000บ�ทถ�เปนมอรฟนหรอโคค�อนตองระว�งโทษเพมขนอกกงหนงและถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะจำ�คกตลอดชวตและปรบ1,000,000–5,000,000บ�ท

Thai Narcotics Act B.E. 2522 (1979)พระร�ชบญญตย�เสพตดใหโทษพ.ศ.2522

PINK PAGES 2013-FINAL-July31.indd 41 8/15/2013 3:09:49 PM

Page 43: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ขอหา ยาเสพตดใหโทษประเภท 3

ผลตนำาเขา(ม.20, 70)

•จำ�คก1-3ปและปรบ100,000-300,000บ�ท

สงออกจำาหนายครอบครองเพอจำาหนาย(ม.20, 71)

•จำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ•ถ�เกนจำ�นวนต�มประก�ศกระทรวงส�ธ�รณสขจำ�คกไมเกน2ปและปรบไมเกน200,000บ�ท(ประก�ศกระทรวงส�ธ�รณสขฉบบท181พ.ศ.2545กำ�หนดว�ย�เสพตดใหโทษประเภท3ตำ�รบทมโคเดอนเปนสวนผสมเกนจำ�นวน250มลลลตรหรอ30เมดหรอ30แคปซล)

ครอบครองเสพ

•ไมมคว�มผดเพร�ะเปนตำ�รบย�

ขอหา ยาเสพตดใหโทษประเภท 4

ผลตนำาเขาสงออกจำาหนายครอบครองเพอจำาหนาย(ม.26, 73)

•จำ�คก1-10ปและปรบ20,000-200,000บ�ท•ถ�นำ�หนก10กโลกรมขนไปจำ�คก1-15ปและปรบ100,000-1,500,000บ�ท

ครอบครอง(ม.26, 74)

•จำ�คกไมเกน5ปหรอปรบไมเกน100,000บ�ทหรอทงจำ�ทงปรบ

ขอหา ยาเสพตดใหโทษประเภท 5

ผลตนำาเขาสงออก(ม.26, 75)

•จำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�เปนพชกระทอมจำ�คกไมเกน2ปและปรบไมเกน200,000บ�ท

จำาหนายครอบครองเพอจำาหนาย(ม.26,76/1)

•จำ�คก2-10ปหรอปรบ40,000-200,000บ�ทหรอทงจำ�ทงปรบ•ถ�นำ�หนก10กโลกรมขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�เปนพชกระทอมจำ�คกไมเกน2ปหรอปรบไมเกน40,000บ�ทหรอทงจำ�ทงปรบถ�นำ�หนก10กโลกรมขนไปจำ�คกไมเกน2ปและปรบไมเกน200,000บ�ท

ครอบครอง(ม.26,76)

•จำ�คกไมเกน5ปหรอปรบไมเกน100,000บ�ทหรอทงจำ�ทงปรบ•ถ�เปนพชกระทอมจำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ

เสพ(ม.57,92)

•จำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ•ถ�เปนพชกระทอมจำ�คกไมเกน1เดอนหรอปรบไมเกน2,000บ�ท

หลอกลวง หรอขมขนใจใหผอนเสพ(ม.93)

•จำ�คก1-10ปและปรบ100,000-1,000,000บ�ท•ถ�กระทำ�โดยมอ�วธหรอรวมกระทำ�ตงแต2คนขนไปจำ�คก2-15ปและปรบ200,000-1,500,000บ�ท•ถ�กระทำ�ตอหญงหรอตอบคคลซงยงไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�ผดท�งอ�ญ�หรอเพอประโยชนในก�รกระทำ�ผดท�งอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ300,000-5,000,000บ�ท

42 PN DEX 2013

PINK PAGES 2013-FINAL-July31.indd 42 8/15/2013 3:09:50 PM

Page 44: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ตารางบนทกขอหาและบทกำาหนดโทษ ทมา : บนทก ป.ป.ส. 2556 สำานกงาน ป.ป.ส. กระทรวงยตธรรม

ขอหา ประเภท 1 (P1) ประเภท2(P2) ประเภท 3 (P3) ประเภท 4 (P4)

ผลตนำ�เข�สงออกข�ย

•จำ�คก5-20ปและปรบตงแต100,000-400,000บ�ท(ม.13,13ทว,89)

•จำ�คกไมเกน5ปและปรบไมเกน100,000บ�ท(ม.16,90)

นำ�ผ�น •จำ�คกไมเกน5ปและปรบไมเกน100,000บ�ท(ม.16,90)

ครอบครองใชประโยชน •จำ�คก1-5ปและปรบ20,000-100,000บ�ท(ม.62,106)•ถ�ปรม�ณเกนทกำ�หนดในประก�ศกระทรวงส�ธ�รณสข(ปจจบนคอฉบบพ.ศ.2555)จำ�คก5-20ปและปรบ100,000-400,000บ�ท(ม.62,106ทว)

•จำ�คกไมเกน1ปหรอปรบไมเกน20,000บ�ทหรอทงจำ�ทงปรบ(ม.62,106)

เสพ •จำ�คก1-5ปและปรบ20,000-100,000บ�ท(ม.62ทว,106ตร)

•จำ�คก1-5ปและปรบ20,000-100,000บ�ทเวนแตเสพต�มคำ�สงแพทย(ม.62ตร,106ตร)

•ไมมคว�มผด

จงใจชกนำ�ยยงสงเสรมใชอบ�ยหลอกลวงขเขญใหผอนเสพ

•จำ�คก2-10ปและปรบ40,000-200,000บ�ท(ม.62จตว�,106จตว�)•ถ�กระทำ�ตอหญงหรอบคคลไมบรรลนตภ�วะหรอเพอจงใจใหผอนกระทำ�คว�มผดท�งอ�ญ�หรอเพอประโยชนแกตนเองหรอผอนในก�รกระทำ�คว�มผดอ�ญ�จำ�คก3ป-ตลอดชวตและปรบ60,000-500,000บ�ท(ม.62จตว�,106จตว�)

Thai Psychotropic Substances Act B.E. 2518 (1975)พระร�ชบญญตวตถทออกฤทธตอจตและประส�ทพ.ศ.2518

PINK PAGES 2013-FINAL-July31.indd 43 8/16/2013 3:28:00 PM

Page 45: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ส�ระสำ�คญในก�รควบคมต�มกฎหม�ยวตถออกฤทธในประเภท 1 (P1)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท1ยกเวนกระทรวงส�ธ�รณสขหรอผซงไดรบมอบหม�ยจ�กกระทรวงส�ธ�รณสข

วตถออกฤทธในประเภท 2 (P2)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท2ยกเวนกระทรวงส�ธ�รณสขหรอผซงไดรบมอบหม�ยจ�กกระทรวงส�ธ�รณสขทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมทข�ยใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงทข�ยเฉพ�ะสำ�หรบใชกบสตวทตนบำ�บดหรอปองกนโรคหรอข�ยโดยกระทรวงทบวงกรมสภ�ก�ช�ดไทย

วตถออกฤทธในประเภท 3 และ 4 (P3, P4)ห�มมใหผใดผลตข�ยนำ�เข�หรอสงออกซงวตถออกฤทธในประเภท3หรอ4หรอนำ�ผ�นวตถออกฤทธทกประเภทเวนแตไดรบอนญ�ตทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมทข�ยใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงทข�ยเฉพ�ะสำ�หรบใชกบสตวทตนบำ�บดหรอปองกนโรคและไมใชบงคบในก�รผลตข�ยนำ�เข�หรอสงออกโดยกระทรวงทบวงกรมสภ�ก�ช�ดไทยองคก�รเภสชกรรม

ยาเสพตดใหโทษในประเภท 1 (N1)ห�มมใหผใดผลตนำ�เข�สงออกจำ�หน�ยหรอมไวในครอบครองซงย�เสพตดใหโทษในประเภท1เวนแตรฐมนตรไดอนญ�ตเฉพ�ะในกรณจำ�เปนเพอประโยชนของท�งร�ชก�ร

ยาเสพตดใหโทษในประเภท 2 (N2)ห�มมใหผใดผลตนำ�เข�หรอสงออกย�เสพตดใหโทษในประเภท2เวนแตไดรบอนญ�ตในกรณจำ�เปนเพอประโยชนของท�งร�ชก�รในกรณจำ�หน�ยหรอมไวในครอบครองตองไดรบอนญ�ต

ยาเสพตดใหโทษในประเภท 3 (N3)ห�มมใหผใดผลตนำ�เข�สงออกจำ�หน�ยหรอมไวในครอบครองเพอจำ�หน�ยซงย�เสพตดใหโทษในประเภท3เวนแตไดรบอนญ�ตทงนไมใชบงคบกบผประกอบวช�ชพเวชกรรมหรอผประกอบโรคศลปะแผนปจจบนชนหนงส�ข�ทนตกรรมจำ�หน�ย/ครอบครองใหแกคนไขของตนหรอผประกอบก�รบำ�บดโรคสตวชนหนงจำ�หน�ย/ครอบครองสำ�หรบใชกบสตวทตนบำ�บด

ยาเสพตดใหโทษในประเภท 4 และ 5 (N4 & N5)ห�มมใหผใดผลตจำ�หน�ยนำ�เข�สงออกหรอมไวในครอบครองซงย�เสพตดใหโทษในประเภท4หรอในประเภท5เวนแตรฐมนตรจะไดอนญ�ตโดยคว�มเหนชอบของคณะกรรมก�รควบคมย�เสพตดใหโทษเปนร�ยๆไป

1. ชอส�มญของวตถออกฤทธในประเทศไทย (ชอทเปนตวหน�หม�ยถงเปนวตถออกฤทธทยงคงมตำ�รบย�ในประเทศไทยถงเดอนพฤษภ�คม2556)

วตถออกฤทธในประเภท 1 (P1)

วตถออกฤทธในประเภท 2 (P2)

วตถออกฤทธในประเภท 3 (P3)

วตถออกฤทธในประเภท 4 (P4)

Cathinone Alprazolam Pemoline Amobarbital Allobarbital MedazepamDET Amfepramone

(Diethylpropion)Phencyclidine Butalbital Barbital Mefenorex

DMHP Phendimetrazine Cyclobarbital Benzphetamine MethyphenobarbitalDMT Amineptine Phenmetrazine Glutethimide Bromazepam MethyprylonEtryptamine Aminorex Phentermine Meprobamate Butobarbital Nordazepam

(Nordiazepam)GHB Brotizolam Phenylpropanolamine Pentazocine CamazepamMethcathinone Buprenorphine Pipradrol Pentobarbital Chloral hydrate and

its adductsOxazepam

Mescaline Butorphanol Pseudoephedrine OxazolamMescaline derivatives Cathine (D-Norpseu-

doephedrine)Quazepam Chlodiazepoxide Perlapine

Mescaline analog e.g. Escaline

Secobarbital Chlophentermine PhenobarbitalEphedrine Temazepam Clobazam Pinazepam

Isoproscaline Estazolam Triazolam Clonazepam PrazepamProscaline Fencamfamin Zalepron Clorazepate Propylhexedrine4-Thiomescaline or 4-TM Fenethylline Zipeprol Clortermine Pyrovalerone4-Thioescaline or 4-TE Flunitrazepam Zopiclone Clotiazepam Secbutabarbital4-Thiooproscaline or 4-TP Flurazepam Zolpidem Cloxazolam SPA (Lefetamine)3- Thiomescaline or 3-TM Haloxazolam Diazepam Tetrazepam3-Thioescaline or 3-TE Ketamine Delorazepam Tofisopam3-Thiometaescaline or 3-TME Loprazolam Ethchlorvynol Vinylbital4-Methylaminorex Lormetazepam EthinamateParahexyl Mazindol Ethyl loflazepatePCE Methylphenidate FenproporexPHP(PCPY) Mesocarb FludiazepamPsilocine Midazolam HalazepamPsilocybine N-Ethylamphetamine Inorganic bromideTCP Nimetazepam KetazolamTetrahydrocannabinol Nitrazepam Lorazepam

CLASSIFICATION OF PSYCHOTROPICS & NARCOTICSประเภทของวตถออกฤทธและย�เสพตดใหโทษในประเทศไทย

PINK PAGES 2013-FINAL-July31.indd 44 8/15/2013 3:09:51 PM

Page 46: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

2. ชอส�มญของย�เสพตดในประเทศไทย (ชอทเปนตวหน�หม�ยถงเปนย�เสพตดทยงคงมตำ�รบย�ในประเทศไทยถงเดอนพฤษภ�คม2556)

ยาเสพตดใหโทษในประเภท 1 (N1)

ยาเสพตดใหโทษในประเภท 2 (N2)

Acetorphine MMDA Acetyldihydrocodeine Dipipanone NoracymethadolAcetyl-alpha-Methylfentanyl 3-Methylfentanyl Acetylmethadol Drotebanol NorcodeineAlpha-Methylfentanyl 3-Methylthiofentanyl Alfentanil Ecgonine NorlevorphanolAlpha-Methylthiofentanyl Methylone Allylprodine Ethylmethylthiambutene NormethadoneAmphetamine MMDA Alphacetylmethadol Ethylmorphine NormorphineBeta-Hydroxy-3-methylfentanyl MPPP Alphameprodine Etonitazene NorpipanoneBeta-Hydroxyfentanyl N - ethyl MDA or MDE Alphamethadol Etoxeridine OpiumBZP (Benzylpiperazine) N - hydroxy MDA or

N-OH MDAAlphaprodine Fentanyl Oripavine

2CB Anileridine Furethidine Oxycodone2CD MDA Benzethidine Hydrocodone OxymorphoneDesomorphine Para-Fluorofentanyl Benzylmorphine Hydromorphinol PethidineDexamphetamine PEPAP Betacetylmethadol Hydromorphone Pethidine-Intermediate-ADihydroetophine PMA Betameprodine Hydroxypethidine Pethidine-Intermediate-BDMA (Dimehoxyamphetamine) STP or DOM Betamethadol Isomethadone Pethidine-Intermediate-CDimethylamphetamine TFMPP Betaprodine Levomethorphan PhenadoxoneDOB Thiofentanyl Bezitramide Levomoramide PhenampromideDOET TMA Clonitazene Levophenacylmorphan PhenazocineEtorphine Coca bush Levorphanol PhenomorphanHeroin Cocaine Medicinal Opium PhenoperidineKetobemidone Codeine Metazocine PholcodineLevamphetamine Codoxime Methadone PiminodineLevomethamphetamine Concentrate of Poppy Straw Methadone lntermediate PiritramideLSD Dextromoramide Methyldesorphine ProheptazineMDA Diampromide Methyldihydromorphine ProperidineMDMA Diethylthiambutene Metopon PropiramMecloqualone Difenoxin Moramide-Intermediate RacemethorphanMephedrone Dihydrocodeine Morphine RacemoramideMethamphetamine Dihydromorphine Morphine Methobromide RacemorphanMethaqualone Dimenoxadol Morphine N-Oxide RemifentanilMethylenedioxypyrovalerone

(MDPV)Dimepheptanol Morpheridine SufentanilDimethylthiambutene Myrophine Thebacon

3-Methylfentanyl Dioxaphetylbutyrate Nicocodine Thebaine3-Methylthiofentanyl Diphenoxylate Nicodicodine TilidineMethylone Nicomorphine Trimepridine

ยาเสพตดใหโทษในประเภท 3 (N3)

ยาเสพตดใหโทษในประเภท 4 (N4)

ยาเสพตดใหโทษในประเภท 5 (N5)

ตำ�รบทมย�เสพตดใหโทษประเภท2อยดวย Acetic Anhydride Ergosterol CannabisCamphorated opium tincture Acetyl Chloride Ergotamine Mitragyna speciosaCodeine (antitussive/analgesic) Alpha – Ergocryptine Ergotaminine Papaver somiferumDextropropoxyphene Alpha – Ergocryptinine Ergothioneine Psilocybe cubensisDiphenoxylate Anthranilic Acid Ethylidine Diacetate

Beta – Ergocryptine IsosafroleBeta – Ergocryptinine Lysergic AcidChlorpseudoephedrine LysergamideElymoclavine 3,4-Methylenedioxyphenyl-2-

propanononeErgocornineErgocristine N-acetylanthranilic AcidErgocristinine 1-Phenyl-2-propanoneErgometrine Phenylacetic AcidErgometrinine PiperonalErgosine SafroleErgosinine

45 PN DEX 2013

PINK PAGES 2013-FINAL-July31.indd 45 8/15/2013 3:09:52 PM

Page 47: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

บญช ก ร�ยก�รย�ม�ตรฐ�นทใชในก�รปองกนและแกไขปญห�สขภ�พทพบบอยมหลกฐ�นชดเจนทสนบสนนก�รใชมประสบก�รณก�รใชในประเทศไทยอย�งพอเพยงและเปนย�ทควรไดรบก�รเลอกใชเปนอนดบแรกต�มขอบงใชของย�นน

บญช ข ร�ยก�รย�ทใชสำ�หรบขอบงใชหรอโรคบ�งชนดทใชย�ในบญชกไมไดหรอไมไดผลหรอใชเปนย�แทนย�ในบญชกต�มคว�มจำ�เปน

บญช ค ร�ยก�รย�ทตองใชในโรคเฉพ�ะท�งโดยผชำ�น�ญหรอผทไดรบมอบหม�ยจ�กผอำ�นวยก�รของสถ�นพย�บ�ลนนๆโดยมม�ตรก�รกำ�กบก�รใชซงสถ�นพย�บ�ลทใชจะตองมคว�มพรอมตงแตก�รวนจฉยจนถงก�รตดต�มผลก�รรกษ�เนองจ�กย�กลมนเปนย�ทถ�ใชไมถกตองอ�จเกดพษหรอเปนอนตร�ยตอผปวยหรอเปนส�เหตใหเกดเชอดอย�ไดง�ยหรอเปนย�ทมแนวโนมในก�รใชไมตรงต�มขอบงชหรอไมคมค�หรอมก�รนำ�ไปใชในท�งทผดหรอมหลกฐ�นสนบสนนก�รใชทจำ�กดหรอมประสบก�รณก�รใชในประเทศไทยอย�งจำ�กดหรอมร�ค�แพงกว�ย�อนในกลมเดยวกน

บญช ง ร�ยก�รย�ทมหล�ยขอบงใชแตมคว�มเหม�ะสมทจะใชเพยงบ�งขอบงใชหรอมแนวโนมจะมก�รสงใชย�ไมถกตองหรอเปนร�ยก�รย�ทมร�ค�แพงจงเปนกลมย�ทมคว�มจำ�เปนตองมก�รระบขอบงใชและเงอนไขก�รสงใชย�ก�รใชบญชย�หลกแหงช�ตไปอ�งองในก�รเบกจ�ยควรนำ�ขอบงใชและเงอนไขก�รสงใชไปประกอบในก�รพจ�รณ�อนมตก�รเบกจ�ยจงจะกอประโยชนสงสดทงนย�ในบญชงจำ�เปนตองใชสำ�หรบผปวยบ�งร�ยแตอ�จทำ�ใหเกดอนตร�ยตอผปวยหรอกอปญห�เชอดอย�ทร�ยแรงก�รสงใชย�ซงตองใหสมเหตผลเกดคว�มคมค�สมประโยชนจะตองอ�ศยก�รตรวจวนจฉยและพจ�รณ�โดยผชำ�น�ญเฉพ�ะโรคทไดรบก�รฝกอบรมในส�ข�วช�ทเกยวของจ�กสถ�นฝกอบรมหรอไดรบวฒบตรหรอหนงสออนมตจ�กแพทยสภ�หรอทนตแพทยสภ�เท�นนและโรงพย�บ�ลจะตองมระบบก�รกำ�กบประเมนและตรวจสอบก�รใชย�(DrugUtilizationEvaluation,DUE)โดยตองมก�รเกบขอมลก�รใชย�เหล�นนเพอตรวจสอบในอน�คตได

บญช จ(1) ร�ยก�รย�สำ�หรบโครงก�รพเศษของกระทรวงทบวงกรมหรอหนวยง�นของรฐทมก�รกำ�หนดวธก�รใชและก�รตดต�มประเมนก�รใชย�ต�มโครงก�รโดยมหนวยง�นนนรบผดชอบและมก�รร�ยง�นผลก�รดำ�เนนง�นตอคณะอนกรรมก�รพฒน�บญชย�หลกแหงช�ตเปนระยะต�มคว�มเหม�ะสมเพอพจ�รณ�จดเข�ประเภทของบญชยอยอนในบญชย�หลกตอไปเมอมขอมลเพยงพอ

บญช จ(2) ร�ยก�รย�สำ�หรบผปวยทมคว�มจำ�เปนเฉพ�ะใหเข�ถงย�ไดอย�งสมเหตผลและคมค�ซงมก�รจดกลไกกล�งเปนพเศษในกำ�กบก�รใชย�ภ�ยใตคว�มรบผดชอบรวมกนของระบบประกนสขภ�พซงดแลโดยกรมบญชกล�งกระทรวงก�รคลงสำ�นกง�นประกนสงคมกระทรวงแรงง�นสำ�นกง�นหลกประกนสขภ�พแหงช�ตและหนวยง�นอนๆทเกยวของโดยมแนวท�งกำ�กบก�รใชย�ต�มภ�คผนวก3

“ร�ยก�รย�สำ�หรบผปวยทมคว�มจำ�เปนเฉพ�ะ”ต�มบญชจ(2)หม�ยคว�มว�ย�ทจำ�เปนตองใชสำ�หรบผปวยเฉพ�ะร�ยโดยย�มคว�มเหม�ะสมทจะใชเพยงบ�งขอบงใชหรอมแนวโนมจะมก�รสงใชย�ไมถกตองหรอเปนย�ทตองอ�ศยคว�มรคว�มชำ�น�ญเฉพ�ะโรคหรอใชเทคโนโลยขนสงและเปนย�ทมร�ค�แพงม�กหรอสงผลอย�งม�กตอคว�มส�ม�รถในก�รจ�ยทงของสงคมและผปวยจงตองมระบบกำ�กบและอนมตก�รสงใชย�(authorizedsystem)ทเหม�ะสมโดยหนวยง�นสทธประโยชนหรอหนวยง�นกล�งทไดรบมอบหม�ยทงนเพอใหเปนไปต�มขอบงใชและเงอนไขก�รสงใชย�จงจะกอประโยชนสงสดโรงพย�บ�ลจะตองมระบบก�รกำ�กบประเมนและตรวจสอบก�รใชย�และมเกบขอมลก�รใชย�เหล�นนเพอใหตรวจสอบโดยกลไกกล�งในอน�คตได

NATIONAL LIST OF ESSENTIAL MEDICINES (NLEM)วตถออกฤทธและย�เสพตดใหโทษในบญชย�หลกแหงช�ต

บญชย�หลกแหงช�ต พ.ศ.2555 มจดประสงคเพอสร�งเสรมระบบก�รใชย�อย�งสมเหตผล

ย�ทอยในบญชย�หลกแหงช�ตนจะแสดงร�ยก�รย�โดยใชชอส�มญของย�ทงในรปเบสเกลอหรอเอสเทอรของย�โดยจะระบคณสมบตเฉพ�ะต�งๆไดแกรปแบบผลตภณฑคว�มแรงขน�ดบรรจ(บ�งร�ยก�ร)ย�ทมคณสมบตครบต�มขอกำ�หนดดงกล�วเท�นนจงจดเปนย�ในบญชย�หลกแหงช�ตทงนสำ�หรบย�ทมเงอนไขหรอมหม�ยเหตจะตองใชต�มเงอนไขและหม�ยเหตทแสดงไวในร�ยละเอยดของย�แตละชนดกอนเสมอ

ก�รจดแบงกลมย�เปนสวนหนงในก�รสงเสรมใหย�ในบญชย�หลกแหงช�ตใชอย�งเหม�ะสมและคมค�โดยมหลกก�รแบงต�มระดบคว�มรคว�มส�ม�รถและคว�มเชยวช�ญของแพทยและผประกอบวช�ชพด�นสขภ�พทจะใชย�แบงเปน5บญชยอยคอบญชก.ข.ค.ง.และจ.โดยแบงยอยอกเปนจ(1)และจ(2)

ย�แตละชนดจะส�ม�รถจดอยในบญชยอยไดม�กกว�1บญชโดยขนกบขอบงชรปแบบและร�ยละเอยดต�งๆทกำ�หนดไว

PINK PAGES 2013-FINAL-July31.indd 46 8/15/2013 3:09:52 PM

Page 48: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ชอส�มญ(Generic Name)

กลม รปแบบ(Form, Strength)

บญช ลำ�ดบและชอกลมของย�ในบญชย�หลกแหงช�ต

เงอนไข

Alprazolam P2 tab ง 4.1. Hypnotics and anxiolytics

ใหตดต�มก�รสงใช

Buprenorphine hydrochloride

P2 sublingual tab, sterile sol

ค 4.7.1. Opioid analgesics

Chloral hydrate P4 oral sol (hosp) ก 4.1. Hypnotics and anxiolytics

Chlordiazepoxide P4 cap, tab ก 4.1. Hypnotics and anxiolytics

Clonazepam P4 tab ข 4.1. Hypnotics and anxiolytics

4.8.1. Drugs used in the control of epilepsy

4.9. Drugs used in movement disorders

Codeine phosphate N2 tab ค 4.7.1. Opioid analgesics

Diazepam P4 cap, tab

cap, tab, sterile sol

sterile sol

4.9. Drugs used in movement disorders

15.1.4. Sedative and analgesic peri-operative drugs

4.1. Hypnotics and anxiolytics

16. Antidotes

4.8.2. Drugs used in status epilepticus

ใชบำ�บดอ�ก�รชกทเกดจ�กย�หรอส�รพษ

Dipotassium clorazepate

P4 cap, tab ข 4.1. Hypnotics and anxiolytics

Ephedrine hydrochloride

P2 nasal drop (hosp) (เฉพ�ะ 0.5-3%) sterile sol

12.2.2. Topical nasal decongestants

2.7.2. Vasoconstrictor sympathomimetics

Fentanyl N2 sterile sol (as citrate), transdermal therapeutic system (as base)

ค 4.7.1. Opioid analgesics ใชกบผปวยโรคมะเรงทมคว�มเจบปวดรนแรง

Fentanyl citrate N2 sterile sol ค 15.1.4. Sedative and analgesic peri-operative drugs

วตถออกฤทธและย�เสพตดใหโทษ ในบญชย�หลกแหงช�ต พ.ศ.2555 (ฉบบท 2)จ�กประก�ศคณะกรรมก�รพฒน�ระบบย�แหงช�ตในร�ชกจจ�นเบกษ�วนท23มกร�คม2556http://www.nlem.in.th/sites/default/files/ratchakitcha_2-55.pdf

47 PN DEX 2013

PINK PAGES 2013-FINAL-July31.indd 47 8/15/2013 3:09:52 PM

Page 49: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ชอส�มญ(Generic Name)

กลม รปแบบ(Form, Strength)

บญช ลำ�ดบและชอกลมของย�ในบญชย�หลกแหงช�ต

เงอนไข

Ketaminehydrochloride

P2 sterile sol ง 15.1.1. Intravenous anaesthetics

1.ใชฉดเข�กล�มเนอกบผปวยทห�เสนเลอดสำ�หรบใหนำ�เกลอไมไดและใชในกรณทผปวยมคว�มดนเลอดตำ�

2.ใชในก�รระงบคว�มรสกสำ�หรบก�รทำ�หตถก�รทใชระยะเวล�สนๆ

3.ใชเปนย�เสรม(adjuncttherapy)เพอระงบอ�ก�รปวดรนแรง(intractablepain)

Lorazepam P4 tab ก 4.1. Hypnotics and anxiolytics

Methadone hydrochloride

N2 oral sol

tab, oral sol

4.10.3. Drugs used in opioid dependence

4.7.1. Opioid analgesics

ใชสำ�หรบผปวยตดเฮโรอน

Methylphenidate P2 tab (เฉพ�ะ10 mg) ค 4.4. Central nervous system stimulants

ใชสำ�หรบAttentionDeficitHyperactivityDisorder(ADHD)

Midazolam hydrochloride

P2 sterile sol ง 15.1.4. Sedative and analgesic peri-operative drugs

4.8.2. Drugs used in status epilepticus

เงอนไข:ใชเสรมย�ระงบคว�มรสกทวตวและใชรกษ�ผปวยทมอ�ก�รกระวนกระว�ยหรอชกหลงใหย�ระงบคว�มรสก

ใชสำ�หรบrefractorystatusepilepticus

Midazolam maleate

P2 tab ง 15.1.4. Sedative and analgesic peri-operative drugs

ใชเตรยมผปวยกอนใหย�ระงบคว�มรสก(premedication)เท�นนโดยเบกไดวนละไมเกน2เมดตอผปวยหนงร�ย

Morphine sulfate N2 cap, tab, SR cap, SR tab, oral sol, sterile sol

sterile sol

4.7.1. Opioid analgesics

15.1.4. Sedative and analgesic peri-operative drugs

Pethidine hydrochloride

N2 sterile sol ค 15.1.4. Sedative and analgesic peri-operative drugs

4.7.1. Opioid analgesics

Phenobarbital sodium P4 sterile pwdr, sterile sol ก

4.8.2. Drugs used in status epilepticus

16. Antidotes ใชบำ�บดอ�ก�รชกทเกดจ�กย�

Pseudoephedrine hydrochloride

P2 tab, syr ก 3.7. Systemic nasal decongestants

48 PN DEX 2013

PINK PAGES 2013-FINAL-July31.indd 48 8/15/2013 3:09:53 PM

Page 50: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

IMPORTANT DRUG NOTESขอมลสำ�คญของตวย�วตถออกฤทธและย�เสพตดใหโทษ

Provides Useful Information On Significant Contraindications, Precautions, Adverse Reactions And Interactions Of Drugs, Presented According To The Psychotropic & Narcotic Drugs List Of Thailand Note: I: Indications; CI: Contraindications; SP: Precautions; AR: Adverse Reactions; DI: Drug Interactions.

P2 - Psychotropic Substance Schedule 2

• Alprazolam •

ลดอ�ก�รวตกกงวลและอ�ก�รตนตระหนก

I: Management of anxiety and panic attacks.

CI: Acute narrow-angle glaucoma, pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; pregnancy, lactation.

SP: Dosage reduction or gradual withdrawal. Dependence. Geriatric or debilitated patients. Muscle weakness, impaired hepatic or renal func-tion; arteriosclerosis; obesity; depression particu-larly suicidal tendency; chronic pulmonary insuf-ficiency. May impair ability to drive or operate machinery. Children <18 yr.

AR: Psychological & physical dependence, with-drawal syndrome; drowsiness, sedation, vertigo, headache, visual disturbances, photosensitivity, GI disturbances, jaundice; fatigue, muscle weakness, ataxia, seizures, delirium, dizziness, confusion & depression. Blood dyscrasias. Mania & hypomania.

DI: Potentiates action of alcohol & CNS depressants. Reduced conc w/ cigarette smoking by 50%. Cimeti-dine & fluoxetine reduce the clearance of alprazolam. Alprazolam enhances activity of imipramine & desip-ramine. Decreased metabolism w/ CYP3A4 inhibitors.

• Amfepramone • (diethylpropion)

ลดคว�มอย�กอ�ห�รในก�รรกษ�ผทมนำ�หนกเกนกว�ปกต

I: Obesity.

CI: Advanced arteriosclerosis. Hyperthyroid-ism. Hypersensitivity. Glaucoma. Agitated states. History of drug abuse. Pulmonary HTN or severe hypertension. Heart murmur or valvular disorders. Emotional instability. History of psychiatric illness. Concomitant use w/ other anorectic agents. MAOI

therapy or w/in 2 wk of discontinuation. Pregnancy & lactation. Childn & elderly.

SP: Increased risk of developing primary pulmonary HTN (PPH). HTN & severe CV disease. Prolonged use may induce dependence w/ withdrawal symp-toms on cessation of therapy; do not use for more than 3 months. May increase convulsions in some epileptic patients. Toxic psychosis. Peptic ulceration. Prostatic hyperplasia. Diabetes mellitus. May impair ability to perform hazardous activities w/c requires mental alertness or physical coordination.

AR: CV & CNS disturbances; GI effects; allergic reactions; impotence; changes in libido, gyneco-mastia, menstrual upset; hematopoietic effects; dyspnea, hair loss, muscle pain, dysuria, increased sweating, polyuria.

DI: Hypertensive risk w/ MAOIs. b-blockers, guanethidine, TCAs, urinary alkalinisers or acidifiers, sibutramine. Alters antidiabetic drug requirements.

• ÄBuprenorphine •

บรรเท�ปวดระดบป�นกล�งถงปวดรนแรงสำ�หรบใชในก�รผ�ตด

I: As a perioperative analgesic supplement. Moder-ate to severe pain. Premedication before anaesthe-sia. Management of opiate dependence. Reversal of fentanyl-induced anesthesia.

CI: Acute alcoholism; convulsive disorders; head injuries; increased intracranial pressure; comatose patients; resp depression & obstructive airway disease; patients on established opioid agonists.

SP: Hepatic or renal disease; pregnancy, lactation; hypothyroidism; adrenocortical insufficiency; asthma; prostatic hyperplasia; shock; hypotension; inflam-matory or obstructive bowel disorders; myasthae-nia gravis; infants/neonates. Reduce dose in elderly & debilitated patients. May precipitate withdrawal symptoms in narcotic addicts. Pulmonary impair-ment. Patients w/ delirium tremens, toxic psycho-ses, kyphoscoliosis, prostatic hypertrophy, urethral stricture, increased intracranial pressure, seizure disorder, dysfunction of biliary tract, hypokalemia. May impair ability to perform hazardous activities w/c requires mental alertness or physical coordination.

PINK PAGES 2013-FINAL-July31.indd 49 8/15/2013 3:09:53 PM

Page 51: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

50 IMPORTANT DRUG NOTES PN DEX 2013AR: Sedation, nausea, dizziness, vertigo, hypoten-sion, miosis, headache, hypoventilation, resp or CNS depression; tachycardia, bradycardia, urinary reten-tion, coma, vomiting, drowsiness, sweating, confu-sion, dry mouth, diaphoresis, withdrawal syndrome.

DI: Plasma-buprenorphine concentrations may be affected when co-administered w/ drugs that induce or inhibit cytochrome P450 isoenzyme CYP3A4. Enhanced depressant effects w/ other CNS depressants e.g. alcohol, anaesthetics, anxi-olytics, hypnotics, opiate agonists, TCAs & anti-psychotics. Diazepam may produce resp & cardiac collapse. Increased risk of QT interval prolongation w/ anti-arrhythmic agents.

• ÄCathine • (d-norpseudoephedrine)

ลดคว�มอย�กอ�ห�รในก�รรกษ�ผทมนำ�หนกเกนกว�ปกตI: Obesity.

CI: Patients treated w/ MAOI or stopped MAOI w/in the last 2 wk; moderate or severe hyper-tension; pulmonary hypertension; structural cardiac abnormalities or advanced arteriosclerosis; adrenal tumour; hyperthyroidism or hyperexcitabil-ity; coronary thrombosis; closed-angle glaucoma; pregnancy.

SP: Heart disease, mild hypertension, CHF or angina of effort; prostate hyperplasia; patients w/ history of drug or alcohol abuse; DM; psychotic patients; renal disease. Growth retardation may occur in children.

AR: Headache, tachycardia, precordial pain, giddi-ness, restlessness or insomnia; dry mouth & thirst, nausea, vomiting, sweating; difficulty in micturi-tion; muscular weakness & tremors; tolerance &/or dependence may occur.

DI: Reduced effect of guanethidine. Increased risk of arrhythmia in patients treated w/ digitalis due to its sympathomimetic effects. Increased risk of arrhythmia w/ choroform, cyclopropane, halo-thane or other halogenated anesthetics. The effect of cathine may be reduced/enhanced by tricyclic antidepressants. Cathine should not be used in patients treated w/ a MAOI or w/in 14 days of stop-ping MAOI as hypertensive crisis may occur if used.

• Ephedrine •

บรรเท�ภ�วะหลอดลมหดเกรงเพมคว�มดนเลอดในภ�วะชอค

I: Relief of moderate to severe acute asthma, relief of bronchoconstriction.

CI: Hypersensitivity. Hypertension, thyrotoxicosis, cardiovascular disease. BPH. Lactation.

SP: Ischaemic heart disease, hyperthyroidism, diabetes mellitus, hypertension, angle-closure glaucoma, renal impairment; prostatic enlarge-ment; children, pregnancy, elderly.

AR: Anxiety, tachycardia, tremor, dry mouth, hyper-tension, cardiac arrhythmias, impaired circulation to the extremities, nervousness, insomnia, palpitations. Difficulty in micturition in patients w/ prostatic enlarge-ment. Nasal drops: Local irritation, rebound nasal congestion & drug-induced rhinitis on prolonged use. Delusions, hallucinations. Seen w/ hypersensitivity & overdosage. Acute CNS & CVS stimulation present-ing as vomiting, fever, hypertension, psychosis. Cardi-ac arrhythmias. Urinary retention. Restlessness.

DI: Reduces antihypertensive effect of bethanidine & guanethidine. May increase clearance of dexa-methasone. Increased incidence of adverse effects when used w/ theophylline. Severe HTN when combined w/ MAOIs or within 2 wk of discontinu-ance of MAOI treatment. Increased risk of arrhyth-mias w/ cardiac glycosides, quinidine or tricyclic antidepressants. Increased vasoconstriction or pressor effects w/ ergot alkaloids or oxytocin. Additive effects & increased toxicity w/ sympatho-mimetic agents. Reduced/blocked effects w/ a- & b-blocking agents.

• Flunitrazepam •

รกษ�อ�ก�รนอนไมหลบอย�งรนแรงและใชในระยะสน

I: Short-term management of severe insomnia.

CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psycho-sis, phobic or obsessional states; may precipitate suicide or aggressive behavior; not to be used alone to treat depression or anxiety associated w/ depres-sion; glaucoma. Pregnancy, lactation. Neonates.

SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory function when used for deep sedation; personality disorders or organic brain changes; history of alcohol or drug addic-tion. Resp depression & hypotension w/ parenteral admin; this route should only be used when facilities for reversing resp depression are available.

AR: Drowsiness & lightheadedness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in sali-vation & amnesia.

DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antide-pressants, antihistamines, antipsychotics, general

PINK PAGES 2013-FINAL-July31.indd 50 8/15/2013 3:09:53 PM

Page 52: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

IMPORTANT DRUG NOTES 51 PN DEX 2013anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Alcohol. Calcium-channel blockers; clonidine; diaxozide; disulfiram; clozap-ine; diuretics; moxonidine; nabitone; nitrates; cimetidine, esomeprazole & omeprazole; muscle relaxants; dopaminergics; lofexidine; hydralazine, minoxidil & nitroprusside; antifungals; angiotensin II receptor antagonist; antiepileptics; b-blockers; antibacterials. Drugs which alter the hepatic microsomal enzymes.

• ÄFlurazepam •

ชวยก�รนอนไมหลบระยะสน

I: Short-term management of insomnia.

CI: Hypersensitivity; porphyria. Pregnancy (3rd trimester); neonates.

SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory function when used for deep sedation; personality disorders or organic brain changes; history of alcohol or drug addiction. Respiratory depression & hypotension w/ parenteral admin. Dependence; lactation. Safety & efficacy are not proven in child <15 yr.

AR: Drowsiness & lightheadedness, sedation, palpitations, chest pain, muscle weakness & atax-ia, staggering; less frequently vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary reten-tion, GI disturbances, heartburn, changes in saliva-tion & amnesia. heartburn, staggering.

DI: Antidepressants, antihistamines, antipsychot-ics, general anesthetics, other hypnotics or seda-tives, opioid analgesics & cisapride. Increased toxicity by amprenavir, cimetidine, ciprofloxacin, clarithromycin, clozapine, CNS depressants, diltiazem, disulfiram, digoxin, erythromycin, ethanol, levodopa, loxapine, metoprolol, metro-nidazole, miconazole, nefazodone, nelfinavir, omeprazole, phenytoin, rifabutin, rifampicin, rito-navir, troleandromycin, valproic acid & verapamil. Effect is decreased by carbamazepine, rifampicin & rifabutin. Alcohol.

• Ketamine •

เหนยวนำ�ทำ�ใหเกดก�รสลบ รกษ�สภ�วะก�รสลบ ใชรวมกบย�ระงบคว�มรสกอนเพอเหนยวนำ�และรกษ�สภ�วะก�รสลบใชรวมกบย�แกปวดกลมopioidsเพอเสรมฤทธระงบปวด

I: Induction of anaesthesia. Adjunct to opioids in management of pain.

CI: Hypertension, cardiac disease, history of cerebro-vascular accident. Eye injury, raised ocular & intracra-nial pressure. Psychotic disorders. Porphyria. Preec-lampsia, eclampsia.

SP: Minimise verbal & tactile stimulation during recovery period. Chronic alcoholic & alcohol-intoxi-cated patients. Preanaesthetic elevated CSF pres-sure. Dependence & tolerance may develop. May impair ability to drive or operate machinery. Moni-tor cardiac function in patients w/ HTN or cardiac decompensation. Pregnancy & lactation.

AR: Emergence reactions e.g. vivid dreams, hallu-cinations, confusion, irrational behaviour. Increased muscle tone sometimes resembling seizures. Tempo-rary HTN & tachycardia. Hypotension, bradycardia, arrhythmias. Respiratory depression, apnoea, laryn-gospasm, diplopia, nystagmus, nausea, vomiting, lachrymation, hypersalivation, raised intraocular & CSF pressure, skin rash & pain at inj site.

DI: May increase effects of nondepolarising muscle relaxants. May reduce hypnotic effect of thiopental. Prolonged recovery time w/ barbiturates/narcot-ics. Reduced cardiac output, BP & pulse rate w/ halothane. Increased risk of HTN & tachycardia w/ thyroid hormones. Seizures & tachycardia may occur when used w/ theophyllines.

• ÄLormetazepam •

ชวยก�รนอนไมหลบระยะสน

I: Short-term management of insomnia.

CI: CNS depression; resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psychosis, phobic or obsessional states; not to be used alone to treat depression or associated anxiety; unstable myas-thenia gravis; glaucoma. Pregnancy & lactation, childn.

SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; personality disorders or organic brain changes; history of alcohol or drug addiction.

AR: Drowsiness & lightheadedness, muscle weak-ness & ataxia, vertigo, headache, confusion, depression, slurred speech, changes in libido, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia.

DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antide-pressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & alcohol.

PINK PAGES 2013-FINAL-July31.indd 51 8/15/2013 3:09:53 PM

Page 53: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

52 IMPORTANT DRUG NOTES PN DEX 2013

• Methylphenidate •

รกษ�โรคสม�ธสนและรกษ�โรคสม�ธสนอยไมนงรกษ�narcolepsy

I: Attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD) and treatment of narcolepsy.

CI: Marked anxiety, tension, agitation; glaucoma; Tourette’s syndrome or tics. Known severe structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac disor-ders that could increase the risk of sudden death, anorexia nervosa, hyperthyroidism, phaeochromocy-toma, vasculitis, cerebrovascular disorders. Extend-ed-release form: Severe hypertension, heart failure, arrhythmia, hyperthyroidism, recent MI or angina.

SP: Pregnancy & lactation. History of alcohol or drug abuse. Hypertension & other CV disorders that might be exacerbated by increases in BP or heart rate. Pre-existing psychosis or bipolar disor-der; monitor for symptoms of aggression or hostility. History of seizure disorder. Phenylketonuria. Fruc-tose intolerance, glucose-galactose malabsorption, sucrose-isomaltase insufficiency. Children <6 yr (growth suppression); monitor growth during thera-py. May impair ability to drive or operate machinery. Transdermal: Avoid exposure of application site to any direct external heat source.

AR: Angina, arrhythmia, cerebral arteritis, cerebral occlusion, changes in BP, MI, necrotising vasculitis, palpitation, pulse changes, stroke, tachycardia; anxi-ety, abnormal behavior, depression, irritability, dizzi-ness, drowsiness, fever, headache, insomnia, nerv-ousness, neuroleptic malignant syndrome (NMS), suicidal behavior, Tourette’s syndrome, toxic psycho-sis; erythema multiforme, exfoliative dermatitis, hair loss, rash, urticaria; growth retardation; abdominal pain, anorexia, diarrhoea, dysmenorrhea, nausea, vomiting, wt loss; anaemia, leukopenia, thrombocy-topenic purpura, thrombocytopenia; abnormal LFTs, hepatic coma, increased transaminases; arthralgia, dyskinesia; blurred vision, visual accommodation disturbance; cough, pharyngitis, sinusitis, upper resp tract infection; accidental injury, hypersensi-tivity. Transdermal: Insomnia, decreased appetite; nausea; tic, emotional instability; vomiting, anorexia; nasal congestion, nasopharyngitis; wt loss.

DI: May reduce effects of antihypertensive agents. Reduced serum level w/ carbamazepine. Increased serum levels or effects w/ CYP2D6 inhibitors e.g. chlorpromazine, delavirdine, fluoxetine, miconazole, paroxetine, pergolide, quinidine, quinine, ritonavir, ropinirole. May increase serum levels of anticoagu-lants, phenylbutazone, phenytoin, TCAs. Possible severe HTN & tachycardia w/ sibutramine. CNS depression w/ alcohol. Severe toxic reactions w/ cloni-dine. Increased risk of hypertensive crisis w/ MAOIs.

• Midazolam •

ทำ�ใหสงบระงบกอนก�รผ�ตด ทำ�ใหสงบระงบกอนหรอระหว�งก�รทำ�หตถก�ร ทำ�ใหสงบสำ�หรบผปวยในภ�วะวกฤต ใชรวมกบย�ระงบคว�มรสกเพอก�รผ�ตดหรอก�รทำ�หตถก�รทกอใหเกดคว�มปวด ชวยเหนยวนำ�ใหสลบและใชเตรยมผปวยกอนใหย�ระงบคว�มรสก

I: Induction of anaesthesia. Premedication in surgery. Sedation for minor surgical procedures.

CI: Acute narrow-angle glaucoma; coma or patients in shock; acute alcohol intoxication; intrathecal & epidural admin. Acute pulmonary insufficiency or marked neuromuscular resp weakness including unstable myasthenia gravis; severe resp depres-sion. Neonates.

SP: Paediatric patients w/ CV instability; chronic renal failure; open-angle glaucoma; cardiac disease; resp disease; myasthenia gravis; neonates; histo-ry of drug or alcohol abuse; elderly & debilitated (reduce dose); avoid prolonged use or abrupt with-drawal; hepatic impairment; severe fluid or elec-trolyte disturbances. May impair ability to drive or operate machinery; titrate dose carefully; monitor for early signs of hypoventilation, airway obstruction, or apnea. Pregnancy, lactation.

AR: Physical & psychological dependence w/ with-drawal symptoms; decreased tidal vol & respira-tory rate; apnoea; headache; hiccup; nausea, increased appetite, vomiting; cough; oversedation; seizure-like activity (paediatrics); paradoxical reac-tions; kernicterus; nystagmus; skin rash, pruritus; reduced alertness, confusion, euphoria, hallucina-tions, fatigue, dizziness, ataxia, post-op sedation, anterograde amnesia; jaundice; cardiac arrest, heart rate changes, thrombosis; anaphylaxis; laryn-gospasm, bronchospasm. Respiratory depression, resp arrest; hypotension.

DI: Increased CNS depression w/ alcohol, opioids, barbiturates, other sedatives & anaesthetics. Increased resp depression w/ opiates, phenobarbi-tal, other benzodiazepines. Plasma concentrations increased by CYP3A4 inhibitors such as cimeti-dine, erythromycin, clarithromycin, diltiazem, vera-pamil, ketoconazole & itraconazole, antiretroviral agents, quinupristin w/ dalfopristin. Midazolam conc decreased by phenytoin, carbamazepine, pheno-barbital, rifampicin. Halothane, thiopental require-ments may be reduced during concurrent use.

• Nitrazepam •

ชวยทำ�ใหหลบและรกษ�โรคลมชกในเดก

I: Management of insomnia, infantile spasms.

CI: Myasthenia gravis, narrow-angle glaucoma, severe resp insufficiency, sleep apnoea syndrome,

PINK PAGES 2013-FINAL-July31.indd 52 8/15/2013 3:09:53 PM

Page 54: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

IMPORTANT DRUG NOTES 53 PN DEX 2013severe hepatic impairment, porphyria, chronic psychosis.

SP: May induce anterograde amnesia; caution patients to have uninterrupted sleep of 7-8 hr after ingestion of dose. May impair ability to drive or oper-ate machinery. Depression, esp if suicidal risk may be present. History of drug abuse or acute alco-holism. Hepatic & renal impairment. Respiratory disease. Debilitated patients. Patients who are at risk of falls. Children, elderly. Pregnancy & lactation.

AR: Hypotension, palpitation; agitation, aggressive-ness, amnesia, ataxia, confusion, delusions, disori-entation, dizziness, drowsiness, fatigue, hallucina-tion, hangover, headache, irritability, nightmares, psychoses, rage, restlessness, sedation; rash; changes in libido; constipation, diarrhoea, exces-sive salivation, heartburn, nausea, vomiting; granu-locytopenia, leukopenia; falling, muscle weakness; blurred or double vision; tinnitus (associated w/ withdrawal); aspiration, increased bronchial secre-tion, dyspnoea. Acute porphyria.

DI: CNS depressant effect increased w/ alcohol, barbiturates, TCAs, phenothiazines, morphine derivatives. Effects may be antagonised by theo-phylline. Increased levels/effects w/ probenecid. Reduced levels/effects w/ rifampicin. May reduce effects of levodopa.

• Phentermine •

ลดคว�มอย�กอ�ห�รในก�รรกษ�ผทมนำ�หนกเกนกว�ปกต

I: Anorectic in short-term treatment of moderate to severe obesity.

CI: Pulmonary hypertension, advanced arterioscle-rosis, moderate to severe hypertension, hyperthy-roidism, CV disease, glaucoma, history of alcohol/drug abuse, agitated states, use during or w/in 14 days following MAOI therapy. Lactation.

SP: Hypertension, DM, seizure disorder, Tourette’s syndrome, patients who have used other anorexi-gens w/in the past year; children. May impair abil-ity to drive & operate machinery. Potential for drug dependency. Discontinue if results are not satisfac-tory w/in 4 wk or if tolerance develops. History of epilepsy. Renal or hepatic disease. Pregnancy.

AR: Urticaria, GI upsets, palpitations, tachycardia, elevated blood pressure, overstimulation, restless-ness, insomnia, tremor, headache, dry mouth, dizziness, dysphoria, euphoria, psychosis, chang-es in libido & impotence. Primary pulmonary HTN & valvular heart disease.

DI: Decreased excretion by antacids, carbonic anhy-drase inhibitors (e.g. acetazolamide, dichlorphena-mide, methazolamide). Excretion is increased by urinary acidifiers. Increased risk of adverse effects

w/ other sympathomimetic agents. There is a risk of arrhythmias when used w/ TCA. May reduce serum concentrations of phenytoin, phenobarb & etho-suximide. Severe hypertensive episodes w/ MAOIs. Primary pulmonary HTN or valvular heart disease may occur when phentermine is used concur-rently w/ fenfluramine or dexfenfluramine. Avoid concurrent use w/ sibutramine. May decrease insu-lin requirements in patients w/ diabetes. Severe adverse reactions w/ SSRIs.

• ÄPhenylpropanolamine •

บรรเท�อ�ก�รคดจมก

I: Nasal congestion.

CI: Concurrent use or w/in 14 days after stopping MAOI.

P: Hyperthyroidism, DM, ischaemic heart disease, HTN, renal impairment, closed-angle glaucoma. Patients who are overweight, or w/ eating disor-ders. May precipitate anginal pain in patients w/ angina pectoris. Pregnancy, lactation, elderly. May impair ability to drive or operate machinery.

AR: Hypertensive crisis, haemorrhagic stroke, HTN, headache, confusions, anxiety, dizziness, restlessness, insomnia, agitations, palpitations, tremors, blurred vision.

DI: Increased risk of potentially fatal hyperten-sive crisis w/ or w/in 14 days after stopping MAOI. Increased risk of severe HTN and complications w/ bromocriptine. Increased risk of psychosis w/ amantadine. Increased risk of HTN w/ indometacin.

• Pseudoephedrine •

บรรเท�อ�ก�รคดจมกอนเนองจ�กโรคหวดภมแพและโพรงอ�ก�ศอกเสบทำ�ใหก�รขบส�รคดหลงสะดวกขน

I: Nasal congestion from colds, allergy and sinusitis.

CI: Severe hypertension, phaeochromocytoma, hyperthyroidism, ischaemic heart disease, HTN or aneurysms, DM & closed-angle glaucoma.

SP: Arrhythmia or tachycardia; occlusive vascular disorders e.g. arteriosclerosis, renal impairment, prostatic enlargement. Pregnancy; lactation.

AR: Anginal pain; rebound congestion & rhinor-rhoea; fear, anxiety, restlessness, tremor, insom-nia, confusion, irritability & psychotic states; reduced appetite, nausea, vomiting; gangrene; cerebral haemorrhage & pulmonary oedema; reflex bradycardia, tachycardia & cardiac arrhythmias, palpitations & cardiac arrest, hypotension & dizzi-ness, fainting & flushing. Tissue necrosis & slough-ing; myocardial & arterial necrosis. Hallucinations,

PINK PAGES 2013-FINAL-July31.indd 53 8/15/2013 3:09:53 PM

Page 55: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

54 IMPORTANT DRUG NOTES PN DEX 2013phenylketonuria, seizures, pallor.

DI: Increased risk of HTN & arrhythmias if given w/ cardiac glycosides, quinidine or TCAs. Increased risk of vasoconstrictor effects if given w/ ergot alka-loids or oxytocin. Co-admin w/ MAOIs may cause hypertensive crisis. Anaesthetics e.g. cyclopro-pane, halothane & other halogenated anaesthes-tics; antihypertensive agents. Possible additive effects & increased toxicity w/ sympathomimetic agents. Increased absorption w/ antacids.

• ÄTemazepam •

ชวยก�รนอนไมหลบระยะสน

I: Short-term management of insomnia.

CI: Severe hepatic impairment. Pregnancy.

SP: Chronic pulmonary insufficiency, elderly or debilitated patients, impaired liver or kidney func-tion, personality disorders or organic brain chang-es, history of alcohol or drug addiction, lactation.

AR: Confusion, dizziness, drowsiness, fatigue, headache, lethargy, hangover, euphoria, difficulty w/ coordination, ataxia, anorexia, tremor, vomiting & backache, behavioral changes, vertigo, weak-ness, syncope, somnolence, anterograde amnesia.

DI: Enhanced sedation, resp & CV depression w/ drugs w/ CNS depressant properties.

• ÄTriazolam •

ชวยก�รนอนไมหลบระยะสน

I: Short-term management of insomnia.

CI: Pre-existing CNS depression or coma; resp depression; acute pulmonary insufficiency or sleep apnoea; myasthenia gravis; chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behaviour so it should not be used alone to treat depression or anxiety associated w/ depression. Porphyria. Pregnancy & lactation. Childn.

SP: Chronic pulmonary insufficiency; elderly or debilitated patients; sleep apnoea; muscle weakness; impaired liver or kidney function; drowsiness may affect skilled tasks; personality disorders or organic brain changes; history of alcohol or drug addiction.

AR: Drowsiness, lightheadedness, dizziness, sedation, agitation, hallucinations, abnormal behaviour, muscle weakness, ataxia confusion, slurred speech, changes in libido, urinary retention, anterograde amnesia.

DI: Increased plasma triazolam concentrations w/ oral contraceptives, ergotamine, ciclosporin, isoniazid, ranitidine & CYP3A inhibitors such as

some macrolide antibiotics, cimetidine, isoniazid, fluvoxamine, sertraline, paroxetine, diltiazem, vera-pamil, amiodarone. Additive CNS depression w/ other CNS depressants eg, antipsychotics, other hypnotics or sedatives, opioid analgesics & alco-hol. Increased risk of prolonged sedation w/ potent CYP3A inhibitors such as azole antifungal agents, nefazodone, HIV protease inhibitors, nonnucleo-side reverse transcriptase inhibitors. Increased exposure w/ grapefruit juice & diltiazem.

• Zolpidem •

รกษ�อ�ก�รนอนไมหลบโดยเฉพ�ะอย�งยงผทนอนหลบย�กชนดinitialinsomnia

I: Management of insomnia especially initial insom-nia.

CI: Severe hepatic insufficiency.

SP: Obstructive sleep apnoea, myasthenia gravis, compromised resp function, hepatic impairment. Caution in patients exhibiting symptoms of depres-sion. Patients should be warned from doing any work involving mental alertness or motor coordination after ingestion of the drug. Pregnancy & lactation. Re-evaulate if insomnia fails to remit after 7-10 days. Max duration of treatment: 4 wk including tapering.

AR: Amnesia, drowsiness, dizziness, diarrhoea, nausea, vomiting, abnormal thinking & behav-iour, drugged feelings, back pain, ataxia, hiccups, confusion, euphoria, insomnia, vertigo, diplopia, abnormal vision. Hepatitis, anaphylactic reactions, sleep-driving (driving while not fully awake after drug ingestion, w/ no recollection of the event).

DI: Increased sedation & incoordination w/ TCA. Increased sedation w/ haloperidol & alcohol. Small increase in zolpidem conc w/ ketoconazole. Reduced effect of hypnotic effects w/ rifampic-in. Increased risk of prolonged sedation & resp depression w/ ritonavir.

P3 - Psychotropic Substance Schedule 3

• Amobarbital •

ชวยใหนอนหลบในผปวยจตเวชทมอ�ก�รนอนไมหลบอย�งรนแรง

I: Severe intractable insomnia.

CI: Depression; pulmonary insufficiency; sleep apnoea; preexisting CNS depression or coma; severe hepatic impairment. Porphyria. Renal impairment. Pregnancy & lactation. Elderly & debili-tated patients; young adults & childn.

SP: Renal insufficiency; given to patients in pain

PINK PAGES 2013-FINAL-July31.indd 54 8/15/2013 3:09:53 PM

Page 56: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

IMPORTANT DRUG NOTES 55 PN DEX 2013may provoke a paradoxical excitatory reaction, unless an analgesic is given concomitantly; may impair ability to drive or operate machinery.

AR: Dependence; drowsiness, sedation, ataxia; resp depression; headache; GI disturbances; skin reactions; confusion & memory defects; paradoxi-cal excitement, irritability; hypersensitivity reac-tions; haematologic disorders.

DI: Sedation or resp depression may be enhanced by drugs w/ CNS depressants; MAOIs may prolong the CNS depressant effects & also reduce the convulsive threshold, thereby antagonise the anti-convulsant action of barbiturates. Others: Feno-profen, methadone, pethidine & opioid analgesics; disopyramide, lidocaine & quinidine; chlorampheni-col, doxycycline; warfarin & coumarin; antidepres-sants eg, bupropion, fluoxetine, lithium & mianserin; valproate & progabide; vigabatrin, oxcarbazepine, carbamazepine, clonazepam, ethosuximide, lamo-trigine, tiagabine & zonisamide, griseofulvin; teniposide; metronidazole; chlorpromazine; HIV-protease inhibitors; b-blockers; calcium-channel blockers eg, nifedipine & verapamil; digitoxin; ciclo-sporin; corticosteroids; furosemide; montelukast; oral contraceptives; theophylline; levothyroxine; flu vaccination & vitamins. Alcohol. St. John’s wort.

• ÄMeprobamate •

บรรเท�อ�ก�รวตกกงวลนอนไมหลบระยะสนและก�รชก

I: Sedative. Short-term management of anxiety & insomnia. Seizures.

CI: Acute intermittent porphyria; pre-existing CNS depression; pregnancy & lactation.

SP: Hepatic or renal impairment; depression; muscle weakness; impaired resp function; elderly or debilitated patients; history of epilepsy; may impair ability to operate machinery.

AR: Drowsiness, dizziness, vertigo, ataxia, GI disturbances, paraesthesia, weakness; CNS effects; visual disturbances; CV disturbances; hypersensitivity reactions; blood disorders.

DI: CNS depressants, e.g. alcohol, opioids, barbi-turates & antihistamines. Increased breakthrough bleeding may occur w/ combined oral contracep-tives. Anticoagulants.

• Pentazocine •

ลดอ�ก�รปวดป�นกล�งถงปวดรนแรง

I: Moderate to severe pain.

CI: Head injury; narcotic dependence; resp depres-sion; raised intracranial pressure; acute MI; heart

failure; arterial or pulmonary hypertension; acute porphyria; pregnancy (prolonged use or high doses at term).

SP: May precipitate withdrawal in narcotic addicts. Impaired resp, renal & hepatic function; morbidly obese patients; thyroid dysfunction; prostatic hyper-plasia or urinary stricture; biliary tract impairment; adrenal insufficiency (including Addison’s disease); abdominal conditions. Patients w/ head injury, cyanosis, COPD, cardiac arrhythmias, phaeochro-mocytoma. Elderly or debilitated patients; seizure-prone patients; childn & infants (safety & efficacy not established in <1 yr); lactation. May impair abil-ity to drive or operate machinery. Administer IM rather than SC (when frequent inj are needed) & inj sites should be varied.

AR: Physical dependence, weakness or faintness; sedation, dizziness, euphoria, lightheadedness, headache, irritability, alterations of mood; disturbed dreams, insomnia; syncope; muscle tremors; resp depression; blurred vision, nystagmus, diplopia, miosis, visual hallucinations, disorientation, confu-sion; hypertension, tachycardia, circulatory depres-sion; shock; hypotension; laryngospasm, dry mouth, taste alteration, nausea, vomiting, constipa-tion; seizures, diaphoresis; rash; blood dyscrasias, agranulocytosis, granulocytopenia; local tissue damages (SC), muscle fibrosis (IM). Respiratory depression, hypotension, circulatory failure, deep-ening coma, convulsions.

DI: Depressant effects potentiated by alcohol, CNS depressants; concurrent use w/ fluoxetine may lead to diaphoresis, ataxia, flushing & tremor associated w/ serotonin syndrome. Increased metabolsim w/tobacco smoking.

• Pentobarbital •

1.ใชเปนย�สลบสำ�หรบสตวในกรณทก�รผ�ตดใชระยะเวล�สน2.ใชเปนย�ควบคมกนก�รชกในสนขทไดรบย�พษstrychnine

I: Short-term anaesthesia for animal surgery. Controls seizure of strychnine poisoning in dog.

CI: Bronchopneumonia, severe pulmonary impair-ment. History of porphyria and addiction to sedative and hypnotics. Concomitant use of sodium oxybate.

SP: Mental depression; acute and chronic pain; hepatic and renal impairment. Parenteral admin to patients w/ HTN, hypotension, cardiovascular or pulmonary disease. Too rapid IV admin may result in resp depression, apnea, laryngospasm, or vasodila-tion w/ fall in blood pressure. Pregnancy, lactation, elderly. May impair ability to perform activities requir-ing mental alertness or physical coordination (e.g. driving and operating machinery).

AR: Drowsiness, somnolence, dizziness, anxiety, insomnia; hypotension, apnea, resp depression,

PINK PAGES 2013-FINAL-July31.indd 55 8/15/2013 3:09:53 PM

Page 57: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

56 IMPORTANT DRUG NOTES PN DEX 2013bronchospasm, laryngospasm, bradycardia, CNS depression, physical and psychological depend-ence, psychiatric disturbance, confusion, halluci-nations, nightmares, thinking abnormality, synco-pe, hyperkinesias, ataxia, agitation, nervousness, nausea, vomiting, constipation.

DI: Increased sleep duration and CNS depression w/ sodium oxybate. Additive effects w/ other CNS depressants. Increased plasma levels w/ MAOI. May decrease serum levels of phenytoin, carba-mazepine, valproic acid. May increase metabolism of anticoagulants, corticosteroids, griseofulvin, doxycycline, and hormonal contraceptives.

P4 - Psychotropic Substance Schedule 4

• Bromazepam •

ลดอ�ก�รวตกกงวล

I: Anxiety.

CI: Pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnea; severe hepatic impairment; not indicated for chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behavior, not used alone to treat depression or anxiety associ-ated w/ depression; glaucoma.

SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory function when used for deep sedation; patients w/ personal-ity disorders or organic brain changes; pregnancy & lactation; history of alcohol or drug addiction due to risk of dependence. Resp depression & hypo-tension w/ parenteral administration; therefore this route should only be used when facilities for revers-ing resp depression are available.

AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confu-sion, depression, slurred speech, changes in libi-do, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitiv-ity reactions; pain & thrombophlebitis; raised liver enzyme values; paradoxical excitation.

DI: Enhanced sedation or resp & CV depression w/ drugs w/ CNS depressant properties eg, antide-pressants, antihistamines, antipsychotics, general anesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Alcohol. Drugs which alter the hepatic microsomal enzymes.

• ÄButobarbital •

ใชกบผปวยจตเวชทนอนไมหลบอย�งรนแรง

I: Severe intractable insomnia.

CI: Children, young adults, elderly & debilitated patients. Patients w/ depression or w/ a history of drug or alcohol abuse or addiction. Insomnia caused by pain. Acute porphyria. Severe hepatic impairment. History of CNS depression or coma, pulmonary insuf-ficiency & sleep apnoea. Pregnancy & lactation.

SP: Renal impairment. Drowsiness may persist until the next day. Tolerance & dependence likely. Must not be withdrawn abruptly as withdrawal syndrome (including mortality) may occur.

AR: Drowsiness, ataxia, paradoxical excitement, confusion, headache & CNS depression; resp depression; GI disorders; hepatitis; fever; megalo-blastic anaemia. Erythema multiforme; exfoliative dermatitis.

DI: Butobarbital is a potent liver enzyme inducer & may reduce the effect of coumarin for up to 6 wk. Additive CNS depression w/ alcohol. Reduced effect of TCAs (such as amitriptyline, clomipramine, desipramine, dosulepin, imipramine, melitracen etc), corticosteriods (such as hydrocortisone, dexameth-asone etc), coumarins, darifenacin, disopyramide, doxorubicin, metronidazole, theophylline & tolvap-tan. It is also likely that the drug level of lidocaine is reduced due to the increased liver enzyme activ-ity. May reduce drug level of memantine. Increased sedation w/ thalidomide. Concurrent long-term use w/ phenmetrazine may result in psychosis. Concur-rent use w/ Na oxybate is contraindicated due to the additive CNS depressant effect. Butobarbital is a potent inducer of CYP3A4 & is expected to reduce the AUC of gefitinib significantly.

• Chlordiazepoxide •

ลดอ�ก�รวตกกงวลและใชในผตดสร�ทมอ�ก�รข�ดสร�

I: Anxiety disorders. Acute symptoms of alcohol withdrawal.

CI: Chronic pulmonary insufficiency, resp depres-sion, patients w/ marked neuromuscular resp weakness; hypersensitivity to benzodiazepines; chronic psychosis; depressive neuroses; porphyria; pregnancy & lactation.

SP: Alcohol; sedation, dependence. Elderly & debilitated patients. Childn < 6 yr. Liver or kidney dysfunction. Avoid prolonged usage.

AR: Physical & psychological dependence; with-drawal syndrome; impairs psychomotor perfor-mance, aggression (in predisposed individuals esp

PINK PAGES 2013-FINAL-July31.indd 56 8/15/2013 3:09:53 PM

Page 58: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

IMPORTANT DRUG NOTES 57 PN DEX 2013in combination w/ alcohol); sedation; blood dyscra-sias, jaundice, hepatic dysfunction. May rarely cause hypoplastic or haemolytic anaemia.

DI: Cimetidine increases serum conc of chlordiaz-epoxide. Potentiates action of major neuroleptics. Alcohol potentiates CNS depressant effect of chlor-diazepoxide.

• Clobazam •

ใชเปนย�เสรมรวมกบย�กนชกชนดอนลดอ�ก�รวตกกงวล

I: Adjunct in epilepsy. Management of anxiety.

CI: Hypersensitivity; history of drug dependence; myasthaenia gravis; pregnancy (1st trimester), lactation; serious liver damage; sleep apnoea syndrome; impaired resp function.

SP: May impair ability to perform skilled tasks & hazardous activities; elderly; renal or hepatic impairment; alcoholism; obesity; withdrawal should be gradual.

AR: Constipation, anorexia, nausea; dizziness, somnolence, sedation, muscle weakness, fine tremors; worsening of resp symptoms in predis- posed individuals; ataxia, drowsiness, headache, vertigo, depression, dysarthria, amnesia, para-doxical excitation, confusion; lethargy; urinary tract infection; loss of libido, motor dysfunction; depend-ence; visual disturbances & wt gain. Hypotension. Elevated liver enzymes. Resp depression.

DI: Increased hepatic clearance of clobazam when administered w/ phenytoin, phenobarb or carbamazepine. Cimetidine may increase levels of clobazam. Concurrent alcohol, hypnotics & seda-tive antidepressants can potentiate CNS side effects of clobazam.

• Clonazepam •

กนชกลดอ�ก�รตนตระหนก

I: Seizure disorders. Panic disorders.

CI: Hypersensitivity to benzodiazepines, acute pulmo-nary insufficiency, acute narrow angle glaucoma.

SP: Avoid abrupt withdrawal. Neonates, chronic pulmonary insufficiency, hepatic/renal dysfunc-tion, porphyria, elderly; pregnancy & lactation. May impair ability to perform activities that require mental & physical alertness. May increase suicidal-ity. Childn w/ panic & seizure disorders.

AR: Drowsiness, fatigue, muscular hypotonia, coordination disturbances, dizziness, vertigo, headache, anorexia, visual disturbances, abnormal eye movements, glassy-eyed appearance, dysar-thria. Libido changes. Behavioural disturbances (in

childn) including irritability, agitation, hyperkinesis. Forgetfulness, hallucinations, hysteria, insomnia. Salivary or bronchial hypersecretion leading to resp problems (childn). May produce diminished reflexes or coma. Sexual dysfunction, Rarely, blood dyscrasias. Thromobophlebitis (IV).

DI: Carbamazepine, phenobarb or phenytoin may accelerate clonazepam metabolism. Increased sedative effect w/ alcohol, general anaesthet-ics & TCAs. Additive CNS depression with opiate agonists, barbiturates, anxiolytics, sedatives & hypnotics, antipsychotic agents & MAOIs.

• Clorazepate •

ลดอ�ก�รวตกกงวล ใชในผตดสร�ทมอ�ก�รข�ดสร� และบรรเท�หรอรกษ�โรคลมชก

I: Management of anxiety. Alcohol withdrawal syndrome. Epilepsy & seizure disorders.

CI: Hypersensitivity (cross-sensitivity w/ other benzodiazepines may occur); narrow-angle glauco-ma. Patients w/ depressive or psychotic disorders. childn <9 yr. Pregnancy; lactation.

SP: Elderly, debilitated patients; hepatic disease, alcoholics; renal impairment; resp disease; impaired gag reflex; patients experiencing apnoea during sleep; patients with limited pulmonary reserve, unstable CV status, palpitation, tachycardia, short-ness of breath; diaphoresis, flushing; operating machines or driving; patients on CNS depressant or psychoactive drug therapy; depression, esp those w/ suicidal tendencies; history of drug dependence.

AR: Jaundice, hepatic necrosis; extrapyramidal disorders; acute attacks of porphyria in porphyric patients, hypotension; prolonged CNS depression (neonates), drowsiness, fatigue, ataxia, lighthead-edness, memory impairment, reversible dementia (prolonged use in the elderly). insomnia, anxi-ety, headache, depression, slurred speech, confu-sion, nervousness, dizziness, irritability; pruritus & erythematous rash; decreased libido; xerostomia, constipation, diarrhoea, decreased salivation, nausea, vomiting, increased or decreased appetite; dysarthria, tremor; blurred vision, diplopia. Resp depression.

DI: Potentiates CNS effects of narcotic analge-sics, barbiturates, phenothiazines, ethanol, anti-histamines, MAOIs, sedative-hypnotics, cyclic antidepressants. CYP3A4 inhibitors eg, amprena-vir, cimetidine, ciprofloxacin, clarithromycin may increase serum conc & toxicity of clorazepate. Carbamazepine, rifampin & rifabutin may decrease clorazepate therapeutic effects by enhancement of clorazepate metabolism.

PINK PAGES 2013-FINAL-July31.indd 57 8/15/2013 3:09:54 PM

Page 59: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

58 IMPORTANT DRUG NOTES PN DEX 2013

• Diazepam •

แกอ�ก�รชกหรอเกรง ลดอ�ก�รวตกกงวลอย�งรนแรงและคล�ยกล�มเนอ

I: Anticonvulsant, severe anxiety, muscle spasms.

CI: Hypersensitivity; myasthenia gravis, acute angle-closure glaucoma. Chronic psychosis, phobic or obsessional states. Not used alone in the treatment of depression or anxiety associated with depression. Premature babies or neonates (parenteral).

SP: Impaired renal & hepatic function, resp disease, organic cerebral changes, arterioscle-rosis, elderly, patients with personality disorders, epileptics, history of alcohol or drug addiction, impaired gag reflex, obese patients. Pre-existing CNS depression, coma, resp depression, acute & chronic pulmonary insufficiency, debilitated patients, muscle weakness. Discontinue treatment if patient develops psychiatric & paradoxical reac-tions. Patients w/ depression or anxiety associated w/ depression esp if patient has suicidal risk. May increase risk of falls. Safety & efficacy of the inj have not been established in childn <1 mth of age. Safety & efficacy of oral use have not been estab-lished in childn <6 mth of age. Safety & efficacy of rectal gel have not been established in childn <2 yr of age. Not recommended for infants <6 months. Abrupt withdrawal or large dose reduction may cause rebound or withdrawal symptoms.

AR: Psychological & physical dependence w/ withdrawal syndrome, fatigue, drowsiness, sedation, ataxia, vertigo, confusion, depression, somnolence; GI disturbances, changes in saliva-tion, amnesia, jaundice, paradoxical excitation; focal hepatic necrosis with intracellular cholestasis, elevated liver enzyme values; muscle weakness, tremors, visual disturbances, headache, slurring of speech & dysarthria, mental changes, incon-tinence, constipation, hypotension, tachycardia, changes in libido, pain & thrombophlebitis at inj site (IV). Respiratory & CNS depression, coma. Blood disorders. Galactorrhea, gynecomastia.

DI: Decreased oral absorption with morphine or pethi-dine pretreatment. Increased half-life with isoniazid, decreased half-life with rifampicin. Reduced plasma binding of diazepam with IV heparin. Complex & unpre-dictable interactions with NNRTIs. Prolonged half-life & reduced clearance with disulfiram, cimetidine, omepra-zole & esomeprazole. Accelerated absorption of diaz-epam with metoclopramide and cisapride. Reduced clearance with fluvoxamine. Increased clearance of diazepam when used w/ phenytoin, carbamazepine & phenobarbital. Reversible deterioration of parkin-sonism may occur when given together w/ levodopa. Combination w/ lithium may produce hypothermia. May need to reduce dose of narcotics when used concurrently. Phenothiazines, barbiturates, MAOIs

potentiate action of diazepam. Additive CNS depres-sant effects w/ alcohol & CNS depressants or psycho-active medications. Mutual potentiation of action w/ analgesics, anaesthetics & some anticonvulsants, anti-depressants, sedating antihistamines & other hypnot-ics & sedatives. May reduce clearance of & increase the plasma half-life of digoxin.

• ÄEthyl loflazepate •

บรรเท�อ�ก�รวตกกงวลระยะสน

I: Short-term management of anxiety.

CI: Preexisting CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; not indicated for chronic psychosis, phobic or obsessional states; may precipitate suicide or aggressive behaviour, not used alone to treat depression or anxiety asso-ciated w/ depression; glaucoma.

SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory function when used for deep sedation; patients w/ personal-ity disorders or organic brain changes; pregnancy, lactation; history of alcohol or drug addiction due to risk of dependence. Respiratory depression & hypotension may occur w/ parenteral admin.

AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confu-sion, depression, slurred speech, changes in libi-do, tremor, visual disturbances, urinary retention or incontinence, GI disturbances, changes in saliva-tion & amnesia; rarely, jaundice, blood disorders & hypersensitivity reactions; pain & thrombophlebitis; raised liver enzyme values; paradoxical excitation.

DI: Enhanced sedation or resp & CV depression w/ drugs that have CNS depressant properties e.g. antidepressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Drugs which alter the hepatic microsomal enzymes.

• Lorazepam •

ลดอ�ก�รวตกกงวลและชวยใหนอนหลบ

I: Management of anxiety and insomnia.

CI: Severe hepatic impairment; resp depression; acute narrow-angle glaucoma; pregnancy & lacta- tion. Sleep apnoea syndrome; pulmonary insuffi-ciency.

SP: Hepatic & renal dysfunction; myasthenia gravis; may impair ability to drive or operate

PINK PAGES 2013-FINAL-July31.indd 58 8/15/2013 3:09:54 PM

Page 60: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

IMPORTANT DRUG NOTES 59 PN DEX 2013machinery; elderly or debilitated patients. Childn <18 yr, neonates.

AR: Drowsiness, headache, dizziness, confusion; blurred vision; nausea; weakness; unsteadiness. Respiratory depression. Changes in vital signs, e.g. respiratory rate, BP.

DI: Potentiation of CNS depression produced by alcohol; general anaesthetics; narcotic analge-sics; TCAs; MAOIs; phenothiazines; antipsychot-ics; barbiturates; scopolamine; opiate agonists or partial agonists.

• Medazepam •

ลดอ�ก�รวตกกงวล

I: Management of anxiety.

CI: Glaucoma.

SP: Severe hepatic impairment. Elderly or debilitat-ed patients; muscle weakness or myasthenia gravis; impaired liver or kidney function; predisposition to seizures; depression; severe resp dysfunction; sleep apnoea; movement disorders; drowsiness may affect skilled tasks; history of alcohol or drug addic-tion. Treatment withdrawal should be gradual. Avoid long-term use. Pregnancy & lactation.

AR: Fatigue, drowsiness, dizziness, prolonged reaction time, headache, coordination disorders (ataxia), confusion, anterograde amnesia. Rarely, GI symptoms, laryngeal spasm, chest pain, hypo-tension, bradycardia, depression, decreased libido, increased appetite, dry mouth, muscle weakness, resp failure.

DI: Additive CNS depression or sedative effects w/ drugs that have CNS depressant properties e.g. alcohol, antidepressants, sedating antihistamines, antipsychotics, general anaesthetics, other hypnot-ics or sedatives, opioid analgesics, cisapride. Increased risk of toxicity w/ hepatic microsomal enzyme inhibitors.

• Phenobarbital •

แกและกนชกสงบประส�ทกอนผ�ตด

I: Management and prevention of seizures. Pre-operative sedation.

CI: Severe renal & hepatic disorders. Severe resp depression, dyspnoea or airway obstruction; porphyria. Pregnancy.

SP: Elderly or debilitated patients, childn. Withdraw gradually. Nephritis/renal insufficiency. Impaired hepatic & resp function. Patients w/ acute pain & depressive disorders. Patients with depression, suicidal tendencies, history of drug abuse. Acute or

chronic pain. May impair ability to drive or operate machinery. Lactation.

AR: Bradycardia, hypotension, syncope; drowsi-ness, lethargy, CNS excitation or depression, sedation, subtle mood changes, impaired cogni-tion & memory, impaired judgment, hangover effect, confusion, somnolence, agitation, restless-ness, hyperkinesia, ataxia, nervousness, head-ache, insomnia, nightmares, hallucinations, anxi-ety, dizziness; rash, exfoliative dermatitis; nausea, vomiting, diarrhea, constipation; agranulocytosis, thrombocytopenic purpura, megaloblastic anaemia; pain at inj site, thrombophlebitis (IV); oliguria; laryn-gospasm, resp depression, apnoea, hypotension, shock, (especially w/ rapid IV admin), hypoven-tilation Stevens-Johnson syndrome; hyperthermia. Hepatitis, disturbances in liver function. Irritability & hyperactivity in childn.

DI: May enhance the hepatotoxic potential of parace-temol overdoses. May decrease levels/effects of various CYP isoenzyme substrates e.g. teniposide, methotrexate, antipsychotics, b-blockers, calcium- channel blockers, other anti-convulsants, chloram- phenicol, cimetidine, corti-costeroids, ciclosporin, doxycycline, oestrogens, felbamate, griseofulvin, tacrolimus, furosemide, methadone, oral contra- ceptives, theophylline, TCAs, warfarin. May reduce effects of guanfa-cine. Reduced metabolism & or increased toxic-ity w/ chloramphenicol, felbamate, MAOIs, valp-roic acid. May enhance the nephrotox- ic effects of methoxyflurane. Additive sedation &/ or resp depression w/ alcohol, sedatives, antide- pres-sants, opioid analgesics, benzodiazepines & other CNS depressants. May decrease levels/ effects of antiarrhythmic drugs e.g. disopyramide, propafenone, quinidine. Decreased antiepileptic effect with antidepressants, antiretroviral agents (tipranavir/ritonavir). Increased concentration with phenytoin, progabide, influenza vaccination.

• Pinazepam •

ลดอ�ก�รวตกกงวล

I: Management of anxiety.

CI: Pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency, myas-thenia gravis, sleep apnoea, severe hepatic impair-ment; chronic psychosis, phobic or obsessional states; glaucoma.

SP: Chronic pulmonary insufficiency; elderly or debilitated patients; childn; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory func-tion when used for deep sedation; patients w/ personality disorders or organic brain changes;

PINK PAGES 2013-FINAL-July31.indd 59 8/15/2013 3:09:54 PM

Page 61: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

60 IMPORTANT DRUG NOTES PN DEX 2013pregnancy, lactation; history of alcohol or drug addiction, hypotension & apnoea w/ IV admin; therefore this route should only be used when facil-ities for reversing resp depression are available. Monitor for signs of suicidal tendency or aggressive behavior; not to be used alone to treat depression or anxiety associated w/ depression. Porphyria.

AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confu-sion, depression, slurred speech, changes in libi-do, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitiv-ity reactions; pain & thrombophloebitis; raised liver enzyme values; paradoxical excitation. Hypoten-sion & resp depression (rapid IV).

DI: Enhanced sedation or resp & CV depres-sion w/ drugs w/ CNS depressant properties e.g. alcohol, antidepressants, antihistamines, antipsy-chotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics. Accelerated absorp-tion w/ cisapride.

• Prazepam •

บรรเท�อ�ก�รวตกกงวลระยะสน

I: Short-term management of anxiety.

CI: Pre-existing CNS depression or coma, resp depression, acute pulmonary insufficiency or sleep apnoea; severe hepatic impairment; chronic psychosis, phobic or obsessional states; glaucoma; porphyria. Myasthenia gravis.

SP: Chronic pulmonary insufficiency; elderly or debilitated patients; muscle weakness, impaired liver or kidney function; drowsiness may affect skilled tasks; monitor cardiorespiratory func-tion when used for deep sedation; patients w/ personality disorders or organic brain changes; pregnancy & lactation; history of alcohol or drug addiction due to risk of depression. Resp depres-sion & hypotension w/ parenteral admin; there-fore this route should only be used when facilities for reversing resp depression are available. May precipitate suicide or aggressive behavior, not used alone to treat depression or anxiety associ-ated w/ depression.

AR: Drowsiness, sedation, muscle weakness & ataxia; less frequently vertigo, headache, confu-sion, depression, slurred speech, changes in libi-do, tremor, visual disturbances, urinary retention, GI disturbances, changes in salivation & amnesia; rarely, jaundice, blood disorders & hypersensitiv-ity reactions; pain & thrombophloebitis; raised liver enzyme values; paradoxical excitation. Hypoten-sion & resp depression (rapid IV).

DI: Enhanced sedation or resp & CV depression w/ alcohol, drugs w/ CNS depressant properties eg, antidepressants, antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics & cisapride. Decreased serum levels when used w/ phenytoin. May increase the plasma levels of bupivacaine. Serum levels may be increased by valproate & modafinil.

• Tofisopam •

บรรเท�อ�ก�รหยดเหล� และอ�ก�รวตกกงวลระยะสน

I: Alcohol withdrawal syndrome. Short-term management of anxiety.

CI: Aggressive-impulsive psychopathy. Pregnancy.

SP: Discontinue if sleep disturbances occur. Avoid sleep disturbances by taking last dose earlier (e.g. before 5 pm).

AR: Nausea, rash, epigastric pain, itching, extreme liveliness, hyperactivity, aggressiveness.

N2 - Narcotic Drug Schedule 2

• Codeine •

บรรเท�อ�ก�รปวดเลกนอยถงปวดป�นกล�ง

I: Mild to moderate pain.

CI: Respiratory depression, obstructive airway disease, asthma. Severe CNS depression, acute alcoholism, convulsive disorders, head injuries, brain tumours, comatose patients, raised intracra-nial pressure. Pregnancy (prolonged use or high doses at term).

SP: Hypothyroidism, adrenocortical insufficiency; asthma, impaired hepatic or renal function, pros-tatic hyperplasia, hypotension, shock, inflamma-tory or obstructive bowel disorders, myasthenia gravis. Infants, neonates; Reduce dose in elderly or debilitated patients. May impair ability to drive or operate machinery. Lactation. Patients who have undergone thoracotomies & laparotomies.

AR: Dependence, withdrawal symptoms; nausea, vomiting, constipation; drowsiness, confusion; difficulty in micturition, ureteric or biliary spasms, urinary retention; dry mouth, dizziness, sweating, facial flushing, headache, vertigo, visual distur-bances, mental clouding, depression, sedation, weakness, faintness, bradycardia, tachycardia, palpitations, orthostatic hypotension, hypother-mia, restlessness, agitation, nervousness, mood changes, decreased libido or potency, hallucina-tion, miosis; raised intracranial pressure, muscle

PINK PAGES 2013-FINAL-July31.indd 60 8/15/2013 3:09:54 PM

Page 62: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

IMPORTANT DRUG NOTES 61 PN DEX 2013rigidity. Respiratory depression & hypotension, w/ circulatory failure & deepening coma (larger doses). Excitement & convulsions (especially in childn & infants). Rhabdomyolysis.

DI: Enhanced depressant effects w/ alcohol, anaesthetics, anxiolytics, tranquilizers, sedatives & hypnotics, TCAs, antipsychotics. Possible CNS depression or excitation w/ MAOIs. May alter effects of other compounds e.g. cyclizine, mexile-tine, cisapride, metoclopramide & domperidone.

• Fentanyl •

ใชบรรเท�อ�ก�รปวดป�นกล�งถงรนแรง เนองจ�กผปวยบ�งร�ยแพย�morphine ใชรวมกบย�ระงบคว�มรสกเพอก�รผ�ตด ใชบรรเท�อ�ก�รปวดหลงผ�ตดหรอก�รทำ�หตถก�รทกอใหเกดคว�มปวด

I: Moderate to severe pain for morphine hypersen-sitive patient. Adjunct to preoperative sedation. Relief of pain after operation.

CI: Hypersensitivity. Opioid non-tolerant patients. Acute or post-op pain, mild or intermittent chronic pain that can be managed w/ less potent anal-gesics. Transdermal: resp depression, especially when facilities for monitoring & resuscitation are unavailable. Acute or severe bronchial asthma; paralytic ileus. Intranasal spray: previous facial radiotherapy, recurrent episodes of epistaxis.

SP: Myasthaenia gravis. Head injury; increased-intracranial pressure; intracranial lesions; renal or hepatic impairment; neonates. Increased risk of resp depression in elderly, debilitated, cachectic patients, patient w/ hypoxia or hypercapnia. Hypo-thyroidism, prostatic hyperplasia, inflammatory bowel disorders, bradycardia or bradyarrhythmi-as. Rapid IV infusion may cause skeletal muscle & chest wall rigidity, impaired ventilation or resp distress/arrest. Pre-existing medical conditions that predispose patients to hypoventilation. Fever. Prolonged use may cause tolerance, psychologi-cal & physical dependence. Abrupt withdrawal after prolonged admin may lead to withdrawal symp-toms. Lactation. Pregnancy (avoid high doses or prolonged usage). Childn < 2 yr (parenteral), <16 yr (buccal lozenge), <18 yr (buccal tab).

AR: Nausea, vomiting; bradycardia, oedema, CNS depression, confusion, dizziness, drowsiness, headache, sedation, transient hypotension, periph-eral vasodilation; increased intracranial pressure.High IV dose may cause chest wall rigidity. Trans-dermal: Rash, erythema & itching. Resp depres-sion, trunk rigidity, reduced pulmonary compli-ance, apnoea, laryngospasm, bronchoconstriction. Buccal lozenges: dental decay including caries, tooth loss, gum line erosion.

DI: Depressant effects may be enhanced by other CNS depressants e.g. alcohol, anaesthet-ics, anxiolytics, hypnotics, TCAs & antipsychotics. Ammonium Cl may increase excretion of fentanyl. Phenothiazines may increase hypotensive effect of opioid analgesics. Serum levels may be increased by CYP3A4 inhibitors (e.g. azole antifungals, clarithromycin, diclofenac, doxycycline, erythromy-cin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, telithromy-cin & verapamil). May reduce the efficacy of pegvi-somant. Serum levels may be reduced by rifamycin derivatives. May increase serotonergic effect of SSRIs & sibutramine.

• Methadone •

บรรเท�อ�ก�รปวดป�นกล�งและรนแรง

I: Moderate to severe pain.

CI: Acute resp depression; acute bronchial asth-ma; acute alcoholism; risk of paralytic ileus; raised intracranial pressure or head injury. Lactation.

SP: Dose should be individualised. Prolonged QT interval; CV disease; hepatic impairment; elec-trolyte abnormalities; concommitant use of QT prolonging drug; resp disease; elderly. May impair ability to drive or operate machinery. Family history of sudden death. Pregnancy. Childn.

AR: Nausea; vomiting; constipation; anorexia; abdominal pain; drowsiness; resp depression; hypo-tension; bradycardia; euphoria; headache; dyspho-ria; urinary retention; miosis; visual disturbances; impotence; dizziness; sweating; pruritis; asthenia; arrythmias; QT prolongation. Cardiac arrest; resp arrest; shock. Pain at inj site, local tissue irritation & induration. Sleep apnoea. Pulmonary edema (overdosage), choreic movements (long-term use), hypoadrenalism (chronic addiction).

DI: Withdrawal symptoms may be experienced w/naloxone, naltrexone, pentazocine, nalbuphine, butorphanol, & buprenorphine. Increased clear-ance & possible reduced efficacy w/ some antiret-rovirals (abacavir, amprenavir, efavirenz, nelfinavir, nevirapine, ritonavir, lopinavir); rifampin; phenytoin; phenobarbital; carbamazepine. Decreased clear-ance & possibly increased toxicity w/ CYP3A4 inhibitors (e.g. ciprofloxacin, erythromycin, flucona-zole, ketoconazole, voriconazole, sertraline, fluox-etine, fluvoxamine). Increased chance of cardiac toxicity w/ other QT prolonging drugs &drugs that can cause electrolyte imbalance. Increased CNS depression w/ alcohol, other opioids or CNS depressants. Methadone may increase plasma levels of desipramine, zidovudine. Enhanced effect w/ cimetidine.

PINK PAGES 2013-FINAL-July31.indd 61 8/15/2013 3:09:54 PM

Page 63: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

62 IMPORTANT DRUG NOTES PN DEX 2013

• Morphine •

บรรเท�อ�ก�รปวดป�นกล�งถงปวดรนแรงในผปวยทตองรกษ�อ�ก�รปวดอย�งตอเนอง

I: Relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid therapy for an extended period of time.

CI: Resp depression, acute or severe asthma; para-lytic ileus; obstructive airway disease; acute liver disease; coma; increased intracranial pressure; acute alcoholism. Pulmonary oedema resulting from a chemical resp irritant. Phaeochromocytoma.

SP: Elderly & debilitated patients; hypothyroid-ism; renal & liver disease; head injury, intracranial lesions; toxic psychoses; hypotension, circulatory shock, MI; adrenocortical insufficiency; asthma; prostatic hyperplasia; inflammatory or obstructive bowel disease; myasthaenia gravis; childn < 18 yr, infants <3 mth; pregnancy, lactation; hypovolaemia, biliary tract disorders, ileus.

AR: Convulsions; muscle rigidity; nausea, vomiting, dry mouth, constipation; urinary retention; raised intracranial pressure, headache, vertigo; palpita-tions; hypothermia; pruritus, urticaria; tachycardia, bradycardia; blurred vision; miosis; dependence; drowsiness; confusion, restlessness, lightheaded-ness; dizziness; sweating; dysphoria; euphoria, mood changes, decreased libido, hallucinations. Respiratory depression; circulatory failure; hypo-tension; peripheral oedema; deepening coma; anaphylactic reactions. Hypogonadotrophic hypo-gonadism, adrenal insufficiency; growth hormone deficiency. Rectovaginal spasm (intrathecal). Myoclonus (high IV & spinal doses).

DI: Availability may be increased by TCAs; increased risk of serotonin syndrome w/ serotonergic drugs; risk of cardiac arrythmias w/ QT prolonging drugs; sedative effects may be increased by metoclopra-mide; antagonises efficacy of diuretics; morphine levels decreased by rifampicin. Increased CNS depression w/ other CNS depressants (e.g. other opioids, general anaesthetics, benzodiazepines, barbiturates), alcohol. Risk of severe hypotension w/ MAOIs. Increased concentration w/ cisapride.

• Pethidine •

ใชบรรเท�อ�ก�รปวดป�นกล�งถงปวดรนแรง ใชรวมกบย�ระงบคว�มรสกเพอก�รผ�ตดหรอก�รทำ�หตถก�รทกอใหเกดคว�มปวด

I: Moderate to severe acute pain. Adjunct to anaes-thesia.

SP: May impair ability to drive or operate machinery. Hypovolaemia, CV disease; adrenal insufficiency; biliary tract disorder; CNS depression or coma;

history of drug abuse or acute alcoholism; head injury, intracranial lesions, elevated intracranial pres-sure; hepatic or renal impairment; morbid obesity; prostatic hyperplasia; toxic psychoses; pre-existing resp compromise (hypoxia and/or hypercapnia), COPD or other obstructive airway disease; sickle-cell disease; supraventricular tachycardia; thyroid dysfunction. Elderly & debilitated patients. Withdraw gradually. Pregnancy (avoid prolonged use or high doses at term) & lactation. Phaeochromocytoma.

AR: Hypotension; fatigue, drowsiness, dizziness, nervousness, headache, restlessness, malaise, confusion, depression, hallucinations, tremors, muscle twitches, increased intracranial pres-sure, seizure, serotonin syndrome; rash, urticaria, erythema; nausea, vomiting, constipation, anorex-ia, stomach cramps, xerostomia, biliary spasm, paralytic ileus, sphincter of Oddi spasm; ureteral spasms, urinary retention; pain at inj site; weak-ness; dyspnoea; histamine release, physical & psychological dependence; cardiac arrhythmias, cardiac arrest, circulatory depression; increased plasma adrenaline concentrations.

DI: Increased pethidine metabolite levels w/ aciclo-vir, cimetidine, ritonavir. Reduced analgesic effects w/ phenytoin. Additive sedative and/or resp depres-sive effects w/ alcohol, barbiturates, benzodiaz-epines, phenothiazines, TCAs, other CNS depres-sants. Increased risk of serotonin syndrome w/ MAOIs (not be given concurrently or w/in 14 days of their discontinuation), serotonin agonists, serotonin reuptake inhibitors, sibutramine, TCAs. Aggravates adverse effects of isoniazid.

N3 - Narcotic Drug Schedule 3

• Codeine • (antitussive/analgesic)

บรรเท�อ�ก�รไอรนแรง บรรเท�อ�ก�รปวดเลกนอยถงปวดรนแรง

I: Severe cough. Mild to severe pain.

CI: Respiratory depression, obstructive airway disease, asthma. Severe CNS depression, acute alcoholism, convulsive disorders, head injuries, brain tumours, comatose patients, raised intracra-nial pressure. Pregnancy (prolonged use or high doses at term).

SP: Hypothyroidism, adrenocortical insufficiency; asthma, impaired hepatic or renal function, pros-tatic hyperplasia, hypotension, shock, inflamma-tory or obstructive bowel disorders, myasthenia gravis. Infants, neonates; Reduce dose in elderly or debilitated patients. May impair ability to drive or operate machinery. Lactation. Patients who have undergone thoracotomies & laparotomies.

PINK PAGES 2013-FINAL-July31.indd 62 8/16/2013 3:28:02 PM

Page 64: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

ÄRegistration expired

IMPORTANT DRUG NOTES 63 PN DEX 2013AR: Dependence, withdrawal symptoms; nausea, vomiting, constipation; drowsiness, confusion; difficulty in micturition, ureteric or biliary spasms, urinary retention; dry mouth, dizziness, sweating, facial flushing, headache, vertigo, visual distur-bances, mental clouding, depression, sedation, weakness, faintness, bradycardia, tachycardia, palpitations, orthostatic hypotension, hypother-mia, restlessness, agitation, nervousness, mood changes, decreased libido or potency, hallucina-tion, miosis; raised intracranial pressure, muscle rigidity. Respiratory depression & hypotension, w/ circulatory failure & deepening coma (larger doses). Excitement & convulsions (especially in childn & infants). Rhabdomyolysis.

DI: Enhanced depressant effects w/ alcohol, anaesthetics, anxiolytics, tranquilizers, sedatives & hypnotics, TCAs, antipsychotics. Possible CNS depression or excitation w/ MAOIs. May alter effects of other compounds e.g. cyclizine, mexile-tine, cisapride, metoclopramide & domperidone.

• ÄDextropropoxyphene •

บรรเท�ปวดระดบนอยถงป�นกล�ง

I: Mild to moderate pain.

CI: Hypersensitivity, chronic resp diseases, porphyria, pregnancy. Patients on MAOI treatment or w/in 2 wk of stopping treatment.

SP: Suicidal patients, hepatic or renal disease; lactation, elderly.

AR: Dizziness, drowsiness, sedation, weakness; nausea, vomiting, constipation; rash, urticaria; visual disturbances; physiological dependence. Convulsions in long-term therapy. Cardiac conduc-tion abnormalities & arrhythmias; liver impairment.

DI: Inhibits hepatic metabolism of benzodiaz-epines, b-blockers, carbamazepine, phenytoin & warfarin. Increased risk of toxicity when co-admin-istered w/ ritonavir. Potentiation of depressant effects when used w/ alcohol or CNS depressants. Accidental or intentional overdosage fatal (espe-cially if combined w/ alcohol, & analgesics e.g. paracetamol & aspirin).

• Diphenoxylate •

ชวยแกทองเสยเฉยบพลนและเรอรง

I: Acute & chronic diarrhoea.

CI: Infants & childn <4 yr. Jaundice, intestinal obstruction. Diarrhoea associated w/ pseudomem-branous colitis or enterotoxin-producing bacteria.

SP: Hepatic dysfunction, inflammatory bowel disease. Pregnancy, lactation; young children.

AR: Anorexia, nausea & vomiting, abdominal distention/discomfort, paralytic ileus, toxic megaco-lon, pancreatitis; headache, drowsiness, dizziness, restlessness, euphoria, depression, sedation, lethargy or insomnia, numbness of the extremi-ties; weakness, general malaise, resp depression, coma; hypersensitivity reactions, swelling of the gums.

DI: Potentiates effects of other CNS depressants (alcohol, barbiturates) & some anxiolytics. Theoreti-cal hypertensive crisis w/ MAOIs.

• Medicinal opium preparations •

บรรเท�ปวดไอและแกทองเสย

I: Analgesia. Cough. Diarrhoea.

CI: Severe hepatic & renal diseases; raised intrac-ranial pressure; acute resp depression or obstruc-tive airways disease; coma; prolonged use or high dosage near term.

SP: Hepatic or renal diseases; head injury, CNS depression, history of opioid agonist depend-ence; biliary tract or acute abdominal disorders; Addison’s disease; obesity; urinary difficulties; resp disease, resp depression, anoxia, hypercap-nia; thyroid disease; brain tumour, elevated CSF, seizures, acute alcoholism, delirium tremens, shock; infants<3 mth, debilitated patients & elderly; pregnancy.

AR: CNS depression, hypotension, dizziness, visu-al disturbances, mental clouding, sedation, coma, euphoria, weakness, faintness, agitation, restless-ness, nervousness, seizures, delirium, insomnia, drowsiness & palpitation, bradycardia; sweat-ing, flushing, pruritis, urticaria; malaise; urinary tract spasm & reduction in urination; constipation, nausea & vomiting; miosis. Severe resp depres-sion; increased intracranial pressure.

DI: Increased CNS depression w/ alcohol, other opiate agonists, general anaesthetics, tranquil-lizers, sedatives & hypnotics. However, some tranquillizers such as phenothiazines may antagonize the effect of opiate analgesia; opium prep may increase the effect of TCAs & MAOIs. Reduced effectiveness of diuretics in patients w/ CHF. Should not be given to patients bitten by Centruroides sculpturatus Ewing & C. gertschi Stahnke scorpions as opiate agonist may potenti-ate the effect of the venoms. May cause serotonin syndrome if used w/ MAOIs.

PINK PAGES 2013-FINAL-July31.indd 63 8/15/2013 3:09:54 PM

Page 65: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

P2

alprazolam

ALCELAM 0.25 mg 100ALCELAM 0.5 mg 259ALCELAM 1 mg 308ALLAM 0.25 mg 116ALLAM 0.5 mg 275ALLAM 1 mg 320ALNAX 0.25 mg 099ALNAX 0.5 mg 258ALNAX 1 mg 307ALPAZAM 0.25 mg 101ALPAZAM 0.5 mg 260ALPAZAM 1 mg 261ALPRALAN 0.25 mg 036ALPRALAN 0.5 mg 240ALPRAMED 0.25 mg 276ALPRAMED 0.5 mg 117ALPRAMED 1 mg 421ALPRAX 0.25 mg 161ALPRAX 0.5 mg 195ALPRAX 1 mg 052ALPRAXOL 0.25 mg 017ALPRAXOL 0.5 mg 235ALPRAZOLAM FRX

0.25 mg 122ALPRAZOLAM FRX

0.5 mg 282ANAX 0.25 mg 097ANAX 0.5 mg 256ANPRESS 0.25 mg 102ANPRESS 0.5 mg 274ANPRESS 1 mg 309ANZION 0.25 mg 098ANZION 0.5 mg 257ANZION 1 mg 306DIZOLAM 0.25 mg 103DIZOLAM 0.5 mg 262DIZOLAM 1 mg 324FARZOLAM 0.25 mg 104FARZOLAM 0.5 mg 263FARZOLAM 1 mg 310INZOLAM 0.25 mg 118INZOLAM 0.5 mg 277INZOLAM 1 mg 321

MANEX 0.25 mg 106MANEX 0.5 mg 264MANEX 1 mg 311MARZOLAM 0.25 mg 107MARZOLAM 0.5 mg 265MARZOLAM 1 mg 312MITRANAX 0.25 mg 119MITRANAX 0.5 mg 278MITRANAX 1 mg 322MOXINAX 0.25 mg 108MOXINAX 0.5 mg 266PHARNAX 0.25 mg 109PHARNAX 0.5 mg 267PHARNAX 1 mg 313PRAZOL 0.25 mg 110PRAZOL 0.5 mg 268PRAZOL 1 mg 314SIAMPRAXOL 0.25 mg 111SIAMPRAXOL 0.5 mg 269SIAMPRAXOL 1 mg 315SUNAX 0.25 mg 120SUNAX 0.5 mg 279XALAM 0.25 mg 112XALAM 0.5 mg 270XALAM 1 mg 316XANACINE 0.25 mg 113XANACINE 0.5 mg 271XANACINE 1 mg 317XANAX 0.25 mg 114XANAX 0.5 mg 272XANAX 1 mg 318XANAX XR 0.5 mg 372XANAX XR 1 mg 079XANAX XR 2 mg 381XIEMED 0.25 mg 121XIEMED 0.5 mg 280XIEMED 1 mg 323ZOLAM 0.25 mg 115ZOLAM 0.5 mg 273ZOLAM 1 mg 319

buprenorphine hydrochloride

BUPRINE 0.2 mg 001TEMGESIC

0.3 mg/mL x 1 mL 666TEMGESIC 0.2 mg 007

cathine

D-NORPSEUDOEPHEDRINE SR OSMOPHARM 20 mg 517

MIRAPRONT N 20 mg 516

diethylpropion hydrochloride

DIETIL RETARD 75 mg 096

PREFAMONE 75 mg 191

REGENON RETARD 75 mg 130

REGENON RETARD 75 mg 504

diethylpropion resinate

ATRACTIL 75 mg 505

ephedrine hydrochloride

EPHEDRINE GPO 30 mg/mL x 1 mL 632

flunitrazepam

ROHYPNOL 1 mg 423

flurazepam hydrochloride

DALMADORM 15 mg 512

ketamine hydrochloride

CALYPSOL 50 mg/mL x 10 mL 675

KETA-HAMELN 50 mg/mL x 10 mL 678

KETALAR 50 mg/mL x 10 mL 679

lormetazepam

LORAMET 1 mg 105

CONTROLLED SUBSTANCE CLASS INDEX

ดชนเภสชภณฑจดเรยงตามกลม/ประเภทของทะเบยน

Controlled Substance Class-Aug13.indd 64 8/14/2013 2:43:23 PM

Page 66: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

CONTROLLED SUBSTANCE CLASS INDEX 65PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

CO

NT

RO

LL

ED

SU

BS

TAN

CE

CL

AS

S IN

DE

X

methylphenidate hydrochloride

CONCERTA 18 mg 186CONCERTA 27 mg 439CONCERTA 36 mg 129METHYLPHENIDATE

HEXAL 10 mg 060RITALIN 10 mg 042RUBIFEN 10 mg 043

midazolam

DORMICUM 5 mg/mL x 1 mL 630

DORMICUM 15 mg/3 mL x 3 mL 631

DORMICUM 15 mg 379MIDAZ

5 mg/mL x 1 mL 644MIDAZ

5 mg/mL x 3 mL 645MIDAZOLAM HEXAL

5 mg/mL x 1 mL 646MIDAZOLAM HEXAL

5 mg/mL x 3 mL 647

nitrazepam

ALODORM 5 mg 090MOGADON 5 mg 091NITRADOS 5 mg 072

phentermine hydrochloride

PANBESY 15 mg 450PANBESY 30 mg 487PHENTERMINE

OSMOPHARM 15 mg 477

phentermine resinate

DUROMINE 15 mg 527DUROMINE 30 mg 521PHENTERMINE

TRENKER 15 mg 492PHENTERMINE

TRENKER 30 mg 451

phenylpropanolamine hydrochloride

PHENYLPROPANOLAMINE PHARMASANT 25 mg 157

pseudoephedrine hydrochloride

PSEUDOEPHEDRINE ASIAN PHARM 30 mg/5 mL x 60 mL 616

PSEUDOEPHEDRINE ASIAN PHARM 30 mg 158

PSEUDOEPHEDRINE ASIAN PHARM 60 mg 048

PSEUDOEPHEDRINE BJ BENJAOSOTH 30 mg/5 mL x 60 mL 617

PSEUDOEPHEDRINE BJ BENJAOSOTH 60 mg 152

PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 30 mg 049

PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 60 mg 050

PSEUDOEPHEDRINE GPO 30 mg 062

PSEUDOEPHEDRINE GPO 60 mg 063

PSEUDOEPHEDRINE MEDICINE PRODUCTS 60 mg 207

PSEUDOEPHEDRINE MILANO 30 mg/5 mL x 60 mL 618

PSEUDOEPHEDRINE MILANO 30 mg 153

PSEUDOEPHEDRINE MILANO 60 mg 046

temazepam

EUHYPNOS 20 20 mg 427

triazolam

HALCION 0.25 mg 378

TRIALAM 0.25 mg 185

TRYCAM 0.25 mg 376

zolpidem hemitartrate

STILNOX 10 mg 123

zolpidem tartrate

DACTIVE 10 10 mg 053

ZOLPIDEM TARTRATE RIVOPHARM 10 mg 124

ZOPIM 10 mg 125

P3

amobarbital

AMA† 159AMYTAL 0.5 g 674

meprobamate

REINBAMATE 400 mg 094

pentazocine

PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL 655

TAZCINE 30 mg/mL x 1 mL 665

TAZCINE 25 mg 066TAZCINE 50 mg 252

pentazocine lactate

FORTWIN 30 mg/mL x 1 mL 641

PANGON 30 mg/mL x 1 mL 654

SOSEGON 30 mg/mL x 1 mL 664

pentobarbital sodium

NEMBUTAL 54.7 mg/mL x 100 mL 680

P4

bromazepam

LEXOTAN 1.5 mg 080LEXOTAN 3 mg 254

butobarbital

BELLOID† 139

Controlled Substance Class-Aug13.indd 65 8/14/2013 2:43:23 PM

Page 67: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

66 CONTROLLED SUBSTANCE CLASS INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

CO

NT

RO

LL

ED

SU

BS

TAN

CE

CL

AS

S IN

DE

X

chlordiazepoxide

DIRAX† 413LIBRAX† 409

chlordiazepoxide hydrochloride

BENPINE 5 mg 435BENPINE 10 mg 526BENPINE 25 mg 218CEBARAX† 406CHLORDIAZEPOXIDE

ACDHON 10 mg 529CHLORDIAZEPOXIDE

CHAROEN BHAESAJ 10 mg 528

CHLORDIAZEPOXIDE MARCH PHARMA 25 mg 503

CHLORDIAZEPOXIDE T MAN 10 mg 401

CHLORDIBRAX† 407CHLORDIXIDE 5 mg 386CHLORDIXIDE 10 mg 220CHLORZEP 5 mg 387COMOBEN 5 mg 390COMOBEN 10 mg 510COZEP 10 mg 149COZEP 25 mg 202EPOXIDE 10 mg 211EPOXIDE 25 mg 217KENSPA† 251LICON† 410MED-ZEPOXIDE 5 mg 494MED-ZEPOXIDE 10 mg 059METAXIDE 10 mg 515MINOXIDE 10 mg 493MODURAX† 405POBRAX† 403PONDNEBIUM 5 mg 399PONDNEBIUM 10 mg 216RADIBRAX† 420TUMAX† 428UTORAX† 411ZEPOBRAX† 412ZEPOXIDE 5 mg 437ZEPOXIDE 10 mg 305ZEPOXIN 5 mg 230ZEPOXIN 10 mg 132

clobazam

FRISIUM 5 mg 038FRISIUM 10 mg 039

clonazepam

ANCORIL 0.5 mg 209CLONARIL 1 mg 370CLONARIL 2 mg 069CONVULSIL 2 mg 070POVANIL 0.5 mg 210POVANIL 1 mg 179POVANIL 2 mg 076PRENARPIL 0.5 mg 196PRENARPIL 1 mg 367PRENARPIL 2 mg 061RIVOTRIL

1 mg/mL x 1 mL 661RIVOTRIL 0.5 mg 197RIVOTRIL 2 mg 064

clorazepate dipotassium

ANXENE 5 mg 455ANXENE 10 mg 288ANXIELAX 5 mg 486CEXENE 5 mg 473CEXENE 10 mg 299CLORAMED 5 mg 456CLORAMED 10 mg 290CLORAXENE 5 mg 462CLORAZE 5 mg 458CLORAZE 10 mg 292CLOZENE 5 mg 446CLOZENE 10 mg 478CLOZEPATE 5 mg 466CONZEP 5 mg 480CONZEP 10 mg 447DEDA 5 mg 463DEDA 10 mg 291DIPOSEF 5 mg 453DIPOSEF 10 mg 284DIPOT 5 mg 459DOPAM 5 mg 148EXAN 5 mg 508EXAN 10 mg 511FLULIUM 5 mg 467FLULIUM 10 mg 300FREXENE 5 mg 441FREXENE 10 mg 445GAXENE 5 mg 474MANOTRAN 5 mg 461MANOTRAN 10 mg 289POLIZEP 5 mg 468POLIZEP 10 mg 294POMADOM 5 mg 481POMADOM 10 mg 449POSENE 5 mg 189

POSENE 10 mg 430SANOR 5 mg 454SANOR 10 mg 285SERENE MASA LAB

10 mg 286SERENE V S PHARMA

5 mg 457TAMYLAB-S 5 mg 469TENMED 5 mg 470TENMED 10 mg 296T-FIVE 5 mg 471TRANADON-S 5 mg 475TRANCAP 5 mg 496TRANCAP 10 mg 190TRANCLOR 5 mg 464TRANCLOR 10 mg 297TRANCON 5 mg 482TRANCON 10 mg 448TRANMED 5 mg 452TRANMED 10 mg 287TRANPATE 5 mg 442TRANPON 5 mg 472TRANSPON FORTE

10 mg 283TRANXENE 5 mg 465TRANXENE 10 mg 298TRANZEP 5 mg 460UPTRAN 10 mg 293UPZENE 5 mg 509ZETRAN 5 mg 476

diazepam

AZEPAM 2 mg 219AZEPAM 5 mg 326A-ZERAX 2 mg 479A-ZERAX 5 mg 489CALMIPAM 2 mg 388CALMIPAM 5 mg 302DIADON 5 mg 377DIAMED 2 mg 531DIAMED 5 mg 518DIANO 2 mg 010DIANO 5 mg 154DIAPAM 2 mg 396DIAPAM 5 mg 355DIAPINE

5 mg/mL x 1 mL 625DIAPINE

10 mg/2 mL x 2 mL 626DIAPINE CAPSULE

2 mg 499DIAPINE CAPSULE

5 mg 506

Controlled Substance Class-Aug13.indd 66 8/14/2013 2:43:23 PM

Page 68: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

CONTROLLED SUBSTANCE CLASS INDEX 67PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

CO

NT

RO

LL

ED

SU

BS

TAN

CE

CL

AS

S IN

DE

X

DIAPINE TABLET 2 mg 011

DIAPINE TABLET 5 mg 183

DIAPINE TABLET 10 mg 414

DIAZ 2 mg 071

DIAZ 5 mg 173

DIAZ 10 mg 369

DIAZA 2 mg 361

DIAZA 5 mg 162

DIAZA 10 mg/2 mL x 2 mL 627

DIAZEPAM ACDHON 2 mg 498

DIAZEPAM BJ BENJAOSOTH 2 mg 054

DIAZEPAM BJ BENJAOSOTH 5 mg 402

DIAZEPAM BJ BENJAOSOTH 10 mg 249

DIAZEPAM CHAROEN BHAESAJ 2 mg 362

DIAZEPAM GENERAL DRUGS HOUSE 2 mg 345

DIAZEPAM GENERAL DRUGS HOUSE 5 mg 163

DIAZEPAM GPO 10 mg/2 mL x 2 mL 628

DIAZEPAM GPO 2 mg 055

DIAZEPAM GPO 5 mg 164

DIAZEPAM GPO 10 mg 363

DIAZEPAM H K PHARM 2 mg 243

DIAZEPAM H K PHARM 5 mg 176

DIAZEPAM H K PHARM 10 mg 371

DIAZEPAM LERD SINGH 2 mg 075

DIAZEPAM LERD SINGH 5 mg 177

DIAZEPAM POND'S CHEMICAL 2 mg 395

DIAZEPAM POND'S CHEMICAL 5 mg 178

DIAZEPAM POND’S CHEMICAL 5 mg 242

DIAZEPAM SAMAKEEPHAESAJ 2 mg 391

DIAZEPAM SAMAKEEPHAESAJ 5 mg 155

DIAZEPAM SOMMAI BHAESAJ 5 mg 346

DIAZEPAM T MAN 2 mg 392

DIAZEPAM T MAN 5 mg 180

DIAZEPAM T MAN 5 mg 236

DIAZEPAM T MAN 10 mg 353

DIAZEPAM T P DRUG 10 mg/2 mL x 2 mL 629

DIAZEPAM T P DRUG 2 mg 012

DIAZEPAM T P DRUG 5 mg 165

DIAZEPAM T P DRUG 10 mg 364

DIAZEPAM VESCO 2 mg 351

DIAZEPAM VESCO 5 mg 147

DIAZEPION 2 mg 514

DIAZEPION 5 mg 500

DIAZEPION 10 mg 215

DILIUM 2 mg 200

DILIUM 5 mg 354

DIMED 2 mg 078

DIMED 5 mg 181

DIPAM 2 mg 037

DIPAM 5 mg 150

DIPAM 10 mg 357

DITRAN 2 mg 444

DITRAN 5 mg 501

DIVOPAN 2 mg 056

DIVOPAN 5 mg 166

DIZAN 2 mg 483

DIZAN 5 mg 443

DIZEP 2 mg 188

DIZEP 5 mg 214

DIZEPAM 2 mg 250

DIZEPAM 5 mg 167

DZP2 2 mg 497

LAYLIUM-10 10 mg/2 mL x 2 mL 642

MANODIAZO 2 mg 495

MANODIAZO 5 mg 530

MANODIAZO 10 mg 365

MANOLIUM 10 mg/2 mL x 2 mL 643

MED-ZEPAM 2 mg 041

MED-ZEPAM 5 mg 366

MONOZIDE 2 mg 525

MONOZIDE-10 10 mg/2 mL x 2 mL 648

PAM 5 mg 231

POPAM 2 mg 126

POPAM 5 mg 187

ROPAM 10 mg/2 mL x 2 mL 662

ROPAM 5 mg 174

S.CO ZEPAM 5 mg 246

SIPAM 10 mg/2 mL x 2 mL 663

SIPAM 2 mg 065

SIPAM 5 mg 168

SIPAM 10 mg 368

STESOLID 2 mg 431

STESOLID 5 mg 507

STESOLID 10 mg 513

TRANOLAN 10 mg/2 mL x 2 mL 667

TRANOLAN 2 mg 145

TRANOLAN 5 mg 201

V DAY ZEPAM 10 mg/2 mL x 2 mL 668

V DAY ZEPAM 2 mg 502

V DAY ZEPAM 5 mg 491

V DAY ZEPAM NL 10 mg/2 mL x 2 mL 669

VALAX 2 mg 032

VALAX 5 mg 146

VALAX 10 mg 349

VALENIUM 2 mg 077

VALENIUM 5 mg 169

VALIUM 10 mg/2 mL x 2 mL 670

VALIUM 5 mg 170

VASON 2 mg 425

VESCOPAM 10 mg/2 mL x 2 mL 671

VISPAM 2 mg 394

VISPAM 5 mg 239

VISPAM 10 mg 350

VOMED 2 mg 067

VOMED 5 mg 171

VORAPAM 2 mg 073

VORAPAM 5 mg 175

WINOPAM 2 mg 074

WINOPAM 5 mg 404

ZAM 2 mg 068

ZAM 5 mg 172

ZEPAM 10 mg/2 mL x 2 mL 672

ZEPAM 2 mg 429

ZEPAM 5 mg 382

Controlled Substance Class-Aug13.indd 67 8/14/2013 2:43:23 PM

Page 69: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

68 CONTROLLED SUBSTANCE CLASS INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

CO

NT

RO

LL

ED

SU

BS

TAN

CE

CL

AS

S IN

DE

X

ZEPAXID 10 mg/2 mL x 2 mL 673

ZEPAXID 2 mg 532ZEPAXID 5 mg 488ZOPAM 2 mg 051ZOPAM 5 mg 160ZOPAM 10 mg 359

ethyl loflazepate

MEILAX 1 mg 022MEILAX 2 mg 199VICTAN 2 mg 204

lorazepam

ANTA 0.5 mg 330ANTA 1 mg 018ANTA 2 mg 138ANXIRA 0.5 mg 327ANXIRA 1 mg 021ATIVAN 0.5 mg 332ATIVAN 1 mg 023ATIVAN 2 mg 141HAWKCOPAX 0.5 mg 348HAWKCOPAX 1 mg 393KEMORA 0.5 mg 434KEMORA 1 mg 024LIZAVAN 0.5 mg 333LIZAVAN 1 mg 025LONZA 0.5 mg 339LONZA 1 mg 020LORA 0.5 mg 397LORA 1 mg 040LORA 2 mg 244LORAMED 0.5 mg 334LORAMED 1 mg 026LORAMED 2 mg 237LORA-P 0.5 mg 347LORA-P 1 mg 013LORA-P 2 mg 137LORAPAM 0.5 mg 336LORAPAM 1 mg 027LORAPAM 2 mg 142LORAPINE 0.5 mg 340LORAPINE 1 mg 033LORAVAN 0.5 mg 329LORAVAN 1 mg 028LORAZE 1 mg 044LORAZENE 0.5 mg 328LORAZENE 1 mg 014LORAZENE 2 mg 143LORAZEP 0.5 mg 337

LORAZEP 1 mg 005

LORAZEP 2 mg 385

LORAZEPAM ACDHON 0.5 mg 344

LORAZEPAM ACDHON 1 mg 034

LORAZEPAM MACROPHAR 1 mg 400

LORAZIN 0.5 mg 352

LORAZIN 1 mg 045

LORAZIN 2 mg 253

LOZEPAM 0.5 mg 331

LOZEPAM 1 mg 193

ORA 0.5 mg 338

ORA 1 mg 029

ORA 2 mg 238

PORA 0.5 mg 398

PORA 1 mg 151

PORA 2 mg 241

RAZEPAM 0.5 mg 342

RAZEPAM 1 mg 031

RAZEPAM 2 mg 144

TRANAVAN 0.5 mg 335

TRANAVAN 1 mg 035

VEMED 0.5 mg 343

ZEDA 0.5 mg 016

ZEDA 1 mg 389

ZORA 0.5 mg 356

ZORA 2 mg 205

medazepam

CELIUM 5 mg 426MEDAZINE 5 mg 519MEDAZINE 10 mg 520

phenobarbital

BENERA† 433DONNATAL† 057MENOBARB 60 mg 208NEURAMIZONE† 432

phenobarbital sodium

BELLADONNA ALKALOIDS W/ PHENOBARBITAL† 247

BELLERGAL† 232

ELIXIR PHENOBARB 60 mL 556

GARDENAL 200 mg/4 mL 677

MENOBARB 15 mg/5 mL x 60 mL 563

MENOBARB 20 mg/5 mL x 60 mL 564

PHENOBARB 30 mg 233PHENOBARB 60 mg 047PHENOBARB ELIXIR

20 mg/5 mL x 60 mL 594PHENOBARBITAL

ACDHON 15 mg 384PHENOBARBITAL

ACDHON 30 mg 136PHENOBARBITAL

ACDHON 60 mg 030PHENOBARBITAL

ATLANTIC 16.25 mg 234PHENOBARBITAL

ATLANTIC 32.5 mg 436PHENOBARBITAL

ATLANTIC 65 mg 015PHENOBARBITAL

ATLANTIC 100 mg 303PHENOBARBITAL

CHEW BROTHERS 30 mg 341

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 30 mL 595

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL 596

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 120 mL 597

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL 598

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL 599

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL 600

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL 601

PHENOBARBITONE NEW LIFE PHARMA 30 mg 006

PHENOBARBITONE NEW LIFE PHARMA 60 mg 203

PHENOCO ELIXIR 20 mg/5 mL x 450 mL 602

PHENOCO ELIXIR 20 mg/5 mL x 3800 mL 603

PHENOCON 60 mg 255PHENOSIL ELIXIR

20 mg/5 mL x 60 mL 604

Controlled Substance Class-Aug13.indd 68 8/14/2013 2:43:23 PM

Page 70: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

CONTROLLED SUBSTANCE CLASS INDEX 69PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

CO

NT

RO

LL

ED

SU

BS

TAN

CE

CL

AS

S IN

DE

X

PHENOSIL ELIXIR 20 mg/5 mL x 450 mL 605

PHENOTAL ELIXIR 20 mg/5 mL x 60 mL 606

pinazepam

DOMAR 5 mg 490

prazepam

POZAPAM 5 mg 485POZAPAM 10 mg 192PRASEPINE 5 mg 484

tofisopam

GRANDAXIN 50 mg 058

N2

codeine phosphate

CODEINE GPO 15 mg 003

CODEINE GPO 30 mg 019

fentanyl

DUROGESIC PATCH 12 mcg/hr 681

DUROGESIC PATCH 25 mcg/hr 682

DUROGESIC PATCH 50 mcg/hr 683

DUROGESIC PATCH 100 mcg/hr 684

FENTADUR 25 mcg/hr 685

FENTANYL ANTIGEN 0.05 mg/mL x 2 mL 633

FENTANYL ANTIGEN 0.05 mg/mL x 10 mL 634

FENTANYL GPO 12 mcg/hr 686

FENTANYL GPO 25 mcg/hr 687

FENTANYL GPO 50 mcg/hr 688

FENTANYL HEXAL 12 mcg/hr 689

FENTANYL HEXAL 25 mcg/hr 690

FENTANYL HEXAL 50 mcg/hr 691

fentanyl citrate

FENTANYL JANSSEN-CILAG 0.05 mg/mL x 2 mL 635

FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL 636

FENTANYL SANDOZ 0.05 mg/mL x 2 mL 637

FENTANYL SANDOZ 500 mcg/10 mL 676

FENTANYL-HAMELN 50 mcg/mL x 2 mL 638

FENTANYL-HAMELN 50 mcg/mL x 10 mL 639

FENTANYL-SNS 50 mcg/mL x 2 mL 640

methadone hydrochloride

METHADONE GPO 10 mg/mL x 1000 mL 565

METHADONE GPO 5 mg 140

morphine

OPIUM TINCTURE GPO 1% x 450 mL 585

morphine sulfate

KAPANOL 20 mg 133KAPANOL 50 mg 134KAPANOL 100 mg 135MORPHINE

SALUTAS PHARMA 10 mg 438

MORPHINE SALUTAS PHARMA 30 mg 358

MORPHINE SALUTAS PHARMA 60 mg 245

MORPHINE SULFATE GPO 10 mg/5 mL 577

MORPHINE SULFATE GPO 10 mg 156

MORPHINE SULFATE INJ BLUE 10 mg/mL x 1 mL 649

MORPHINE SULFATE INJ PURPLE 10 mg/mL x 1 mL 650

MORPHINE T P DRUG 10 mg/mL x 1 mL 651

MORPHINE T P DRUG 10 mg/mL x 1 mL 652

MORPHINE T P DRUG 10 mg/mL x 1 mL 653

MST CONTINUS 10 mg 194

MST CONTINUS 30 mg 304

MST CONTINUS 60 mg 206

ORAMORPH 10 mg/5 mL x 250 mL 586

ORAMORPH 20 mg/mL x 30 mL 587

pethidine hydrochloride

PETHIDINE BIOLAB 100 mg/2 mL x 2 mL 656

PETHIDINE HAMELN 50 mg/mL 657

PETHIDINE M & H MANUFACTURING 50 mg/mL x 1 mL 658

PETHIDINE M & H MANUFACTURING 100 mg/2 mL x 2 mL 659

PETHIDINE T P DRUG 50 mg/mL x 1 mL 660

N3

camphorated opium tincture

BROWN MIXTURE GPO† 180 mL 538

BROWN MIXTURE GPO† 450 mL 539

BROWN MIXTURE OSOTH INTERLAB† 180 mL 540

CAMPHORATED OPIUM TINCTURE GPO 1000 mL 541

COUGH SYRUP GPO† 60 mL 553

MIST TUSSIS† 450 mL 567

MIST. SCILL AMMON. GPO† 180 mL 568

MIXTURE SCILLAE AMMON† 180 mL 569

Controlled Substance Class-Aug13.indd 69 8/14/2013 2:43:23 PM

Page 71: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

70 CONTROLLED SUBSTANCE CLASS INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

CO

NT

RO

LL

ED

SU

BS

TAN

CE

CL

AS

S IN

DE

X

MIXTURE TUSSIS† 30 mL 570

MIXTURE TUSSIS† 60 mL 571

MIXTURE TUSSIS† 120 mL 572

MIXTURE TUSSIS† 240 mL 573

MIXTURE TUSSIS† 450 mL 574

MIXTURE TUSSIS† 1800 mL 575

MIXTURE TUSSIS† 3600 mL 576

SQUILL AND AMMONIA

VIDHYASOM† 450 mL 619

codeine

CODIPRONT† 522CODIPRONT† 523CODIPRONT SYRUP†

60 mL 543

codeine phosphate

BENADRYL CD† 60 mL 533

BENADRYL CD† 1000 mL 534

BENYLIN CD† 60 mL 535BLUCO† 383BLUCON† 360BONADINE CD† 60 mL 536BROMTUSSIA DC†

60 mL 537BRONPECT† 325CEMOL CODEINE† 081CENTRODINE CD† 248CLINEPECT† 524CLINOPECT† 221CLINOPRONT† 408COCET† 082CO-COF† 182CODEE-C† 416CODENOL† 15 mg 422CODEPECT† 227CODESIA† 419CODESIA† 60 mL 542CODICET† 440CODICET BLUE 300† 380CODICET PINK† 15 mg 281CODIGESIC† 127CODYL COUGH LINCTUS†

60 mL 544

CODYL COUGH LINCTUS† 100 mL 545

CODYL COUGH LINCTUS† 1000 mL 546

CODYL COUGH LINCTUS† 4500 mL 547

COFCODYL† 60 mL 548COFCODYL† 100 mL 549COMODINE COUGH†

60 mL 550CONADYL† 60 mL 551CORYNIL† 225COSEDYL† 60 mL 552COTENOL† 085DECOS† 100 mL 554DIMETANE

EXPECTORANT DC† 2.5 L 555

HISEDYL† 60 mL 557HISEDYL† 120 mL 558MANTADYL COUGH†

60 mL 559MASADYL COUGH†

60 mL 560MASADYL COUGH†

100 mL 561MASADYL COUGH†

240 mL 562MASAPARA W/ CODEINE† 198MILA-CONO† 60 mL 566MILA-TERCON† 184NASA W/ CODEINE† 092NEO COUGH† 60 mL 578NEO COUGH† 100 mL 579NEO COUGH† 240 mL 580NEOCOD† 373NEO-CODEIN† 374NEOCOF† 212NEO-COPHEN 10 mg 222NEOPECT† 224NORDYL LINCTUS†

100 mL 581NORDYL LINCTUS†

500 mL 582NORTUSS LINCTUS†

100 mL 583NORTUSS LINCTUS†

500 mL 584PACOGESIC† 213PARA WITH CODEINE†

15 mg 083PARA WITH CODEINE†

30 mg 084PARA-CO 15 mg 375PARADEINE† 086PARADYL 8 mg 095PARAGEN CO† 128PARAMED-CO† 424

PARCOD† 089PARCONO† 093P-CODYL† 60 mL 588P-CODYL† 120 mL 589PERCIDYL COUGH†

100 mL 590PHENCODIN† 60 mL 591PHENCODIN† 500 mL 592PHENCODIN† 1000 mL 593PHENSEDYL OLIC†

100 mL 607PHENSODI† 60 mL 608PHENSODI† 120 mL 609PHENSODI† 1000 mL 610POLY-COF† 60 mL 611POLY-COF† 100 mL 612POLYDINE CD† 295PONDNADYL† 60 mL 613PONDNADYL† 100 mL 614PONDNADYL† 1000 mL 615ROLAR† 228ROPECT† 226ROTUSS† 229SECO† 417TENADRIN-C† 60 mL 620TERADENE† 60 mL 621TERADYL† 60 mL 622TERADYL† 1000 mL 623TERCO-C† 415TOCODYL† 418TUSSIDYL† 60 mL 624TYLENOL WITH

CODEINE† 087TYLENOL WITH

CODEINE† 088ZORITUSS 10 mg 223

dextropropoxyphene hydrochloride

DAVOL† 301

dextropropoxyphene napsylate

PARDEX 32.5 mg 131

diphenoxylate hydrochloride

DILOMIL† 002DITROPINE† 008LOMOTIL† 004SPASIL† 009

Controlled Substance Class-Aug13.indd 70 8/14/2013 2:43:24 PM

Page 72: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

2M (Med-Maker)2 เอม (เมด-เมเกอร)

ANPRESS 0.25 mg 102ANPRESS 1 mg 309CONVULSIL 2 mg 070XIEMED 0.5 mg 280

a N H Productsเอ เอน เอช โปรดคส

COMOBEN 5 mg 390COMOBEN 10 mg 510COMODINE COUGH†

60 mL 550DIVOPAN 2 mg 056DIVOPAN 5 mg 166

acdHoNแอคดอน

CHLORDIAZEPOXIDE ACDHON 10 mg 529

DIADON 5 mg 377DIAZEPAM

ACDHON 2 mg 498LORAZEPAM

ACDHON 0.5 mg 344LORAZEPAM

ACDHON 1 mg 034PHENOBARBITAL

ACDHON 15 mg 384PHENOBARBITAL

ACDHON 30 mg 136PHENOBARBITAL

ACDHON 60 mg 030PHENOBARBITAL

ELIXIR ACDHON 20 mg/5 mL x 30 mL 595

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL 596

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 120 mL 597

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL 598

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL 599

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL 600

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL 601

TRANADON-S 5 mg 475

all PlaNtsออลแพลนทส

PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL 655

alPHaPHarM/Fdaอลฟาฟารม/อย.

ALODORM 5 mg 090

TRIALAM 0.25 mg 185

aNtigeN/Fdaแอนตเจน/อย.

FENTANYL ANTIGEN 0.05 mg/mL x 2 mL 633

FENTANYL ANTIGEN 0.05 mg/mL x 10 mL 634

asiaN PHarMเอเชยนฟารมาซตคล

ALPRAXOL 0.25 mg 017

ALPRAXOL 0.5 mg 235

A-ZERAX 2 mg 479

A-ZERAX 5 mg 489

BROMTUSSIA DC† 60 mL 537

CODENOL† 15 mg 422

CODESIA† 419

CODESIA† 60 mL 542

DIPOT 5 mg 459

DITROPINE† 008

LORAZEP 0.5 mg 337

LORAZEP 1 mg 005

LORAZEP 2 mg 385

PHENOTAL ELIXIR 20 mg/5 mL x 60 mL 606

asiaN PHarM/Fdaเอเชยนฟารมาซตคล/อย.

PSEUDOEPHEDRINE ASIAN PHARM 30 mg 158

PSEUDOEPHEDRINE ASIAN PHARM 60 mg 048

PSEUDOEPHEDRINE ASIAN PHARM 30 mg/5 mL x 60 mL 616

atlaNtic labแอตแลนตค

AMA† 159BENPINE 5 mg 435BENPINE 10 mg 526BENPINE 25 mg 218DIAPINE

5 mg/mL x 1 mL 625DIAPINE

10 mg/2 mL x 2 mL 626DIAPINE CAPSULE

2 mg 499DIAPINE CAPSULE

5 mg 506DIAPINE TABLET

2 mg 011DIAPINE TABLET

5 mg 183DIAPINE TABLET

10 mg 414DIZOLAM 0.25 mg 103DIZOLAM 0.5 mg 262DIZOLAM 1 mg 324LORA 0.5 mg 397LORA 1 mg 040LORA 2 mg 244PHENOBARBITAL

ATLANTIC 16.25 mg 234PHENOBARBITAL

ATLANTIC 32.5 mg 436PHENOBARBITAL

ATLANTIC 65 mg 015PHENOBARBITAL

ATLANTIC 100 mg 303

aveNtisอเวนตส

FRISIUM 10 mg 039

MANUFACTURER’S INDEX

ดชนเภสชภณฑจดเรยงตามชอผผลต

MNF INDEX CLASS-FINAL-Aug13.indd 71 8/14/2013 2:48:37 PM

Page 73: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

72 MANUFACTURER’S INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

Ma

Nu

Fac

tu

re

r’s

iNd

eX

b l Huaบ เอล ฮว

BLUCON† 360CODICET† 440CODICET PINK† 15 mg 281TENADRIN-C† 60 mL 620TERADENE† 60 mL 621TERCO-C† 415

baNgkok lab & cosMeticบางกอกแลปแอนดคอสเมตค

ANZION 0.25 mg 098ANZION 0.5 mg 257ANZION 1 mg 306CLINEPECT† 524CLINOPECT† 221CLINOPRONT† 408CODIGESIC† 127COFCODYL† 60 mL 548COFCODYL† 100 mL 549DIAZ 2 mg 071DIAZ 5 mg 173DIAZ 10 mg 369LIZAVAN 0.5 mg 333LIZAVAN 1 mg 025PACOGESIC† 213ZEPOBRAX† 412

bard/Fdaบารด/อย.

MST CONTINUS 10 mg 194MST CONTINUS 30 mg 304MST CONTINUS 60 mg 206

beMed PHarMaบเมดฟารมา

CHLORZEP 5 mg 387

berliN PHarMเบอรลนฟารมาซตคอล

LORAZENE 0.5 mg 328LORAZENE 1 mg 014LORAZENE 2 mg 143

biolabไบโอแลป

SANOR 5 mg 454SANOR 10 mg 285STESOLID 5 mg 507STESOLID 10 mg 513

biolab/Fdaไบโอแลป/อย.

PETHIDINE BIOLAB 100 mg/2 mL x 2 mL 656

bJ beNJaosotHบเจ (เบญจโอสถ)

DAVOL† 301DIAZEPAM

BJ BENJAOSOTH 2 mg 054

DIAZEPAM BJ BENJAOSOTH 5 mg 402

DIAZEPAM BJ BENJAOSOTH 10 mg 249

MINOXIDE 10 mg 493

bJ beNJaosotH/Fdaบเจ (เบญจโอสถ)/อย.

PSEUDOEPHEDRINE BJ BENJAOSOTH 30 mg/5 mL x 60 mL 617

PSEUDOEPHEDRINE BJ BENJAOSOTH 60 mg 152

boeHriNger iNgelHeiM/Fdaเบอรงเกอร อนเกลไฮม/อย.

ORAMORPH 10 mg/5 mL x 250 mL 586

ORAMORPH 20 mg/mL x 30 mL 587

britisH disPeNsaryองกฤษตราง (แอล พ)

ZEDA 0.5 mg 016ZEDA 1 mg 389

cadila HealtHcare/Fdaคาดลา เฮลทแคร/อย.

DACTIVE 10 10 mg 053

cardiNal HealtH australiaคารดนล เฮลท ออสเตรเลย

ROPECT† 226ROTUSS† 229

ceNeXi/Fdaซนส/อย.

DORMICUM 5 mg/mL x 1 mL 630

ceva aNiMal HealtHซวา แอนมอล เฮลท

NEMBUTAL 54.7 mg/mL x 100 mL 680

cHalerMcHaiเฉลมชยเภสช

CALMIPAM 2 mg 388CALMIPAM 5 mg 302

cHaroeN bHaesaJ labเจรญเภสช

DIAZEPAM CHAROEN BHAESAJ 2 mg 362

CHLORDIAZEPOXIDE CHAROEN BHAESAJ 10 mg 528

PARADEINE† 086PHENSODI† 60 mL 608PHENSODI† 120 mL 609PHENSODI† 1000 mL 610

cHew brotHersจวบราเดอรส

DIAZEPION 2 mg 514DIAZEPION 5 mg 500DIAZEPION 10 mg 215PHENOBARBITAL

CHEW BROTHERS 30 mg 341REINBAMATE 400 mg 094ZEPOXIN 5 mg 230ZEPOXIN 10 mg 132

cMed Productsซเมด โปรดกส

VOMED 5 mg 171

deFeNce oF PHarMaceutical Factoryโรงงานเภสชกรรมทหาร

PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 30 mg 049

MNF INDEX CLASS-FINAL-Aug13.indd 72 8/14/2013 2:48:38 PM

Page 74: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

MANUFACTURER’S INDEX 73PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

Ma

Nu

Fac

tu

re

r’s

iNd

eX

PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 60 mg 050

deXo/Fdaเดคโซ/อย.

PREFAMONE 75 mg 191

douglas/Fdaดกลาส/อย.

DUROMINE 15 mg 527

DUROMINE 30 mg 521

NITRADOS 5 mg 072

TRYCAM 0.25 mg 376

duMeXดเมกซ

STESOLID 2 mg 431

egisอจส

GRANDAXIN 50 mg 058

eli lillyอไล ลลล

AMYTAL 0.5 g 674

gedeoN ricHterกเดยน รชเตอร

BELLOID† 139

gedeoN ricHter/Fdaกเดยน รชเตอร/อย.

CALYPSOL 50 mg/mL x 10 mL 675

geNeral drugs Houseเยนเนอรราลดรกสเฮาส

DIAZEPAM GENERAL DRUGS HOUSE 2 mg 345

DIAZEPAM GENERAL DRUGS HOUSE 5 mg 163

ZORA 0.5 mg 356

ZORA 2 mg 205

glaXosMitHkliNe/Fdaแกลกโซสมทไคลน/อย.

KAPANOL 20 mg 133KAPANOL 50 mg 134KAPANOL 100 mg 135

gold & silver bellโกลด แอนด ซลเวอรเบลล

ZORITUSS 10 mg 223

gPoองคการเภสชกรรม

BROWN MIXTURE GPO† 180 mL 538

BROWN MIXTURE GPO† 450 mL 539

CAMPHORATED OPIUM TINCTURE GPO 1000 mL 541

COUGH SYRUP GPO† 60 mL 553

DIAZEPAM GPO 10 mg/2 mL x 2 mL 628

DIAZEPAM GPO 2 mg 055DIAZEPAM GPO 5 mg 164DIAZEPAM GPO 10 mg 363MIST. SCILL AMMON.

GPO† 180 mL 568PSEUDOEPHEDRINE

GPO 30 mg 062PSEUDOEPHEDRINE

GPO 60 mg 063

gPo/Fdaองคการเภสชกรรม/อย.

CODEINE GPO 15 mg 003CODEINE GPO 30 mg 019EPHEDRINE GPO

30 mg/mL x 1 mL 632METHADONE GPO

10 mg/mL x 1000 mL 565METHADONE GPO 5 mg 140MORPHINE SULFATE

GPO 10 mg/5 mL 577MORPHINE SULFATE

GPO 10 mg 156OPIUM TINCTURE

GPO 1% x 450 mL 585

greater PHarMaเกรทเตอรฟารมา

DIAPAM 2 mg 396DIAPAM 5 mg 355

guardiaN drug Houseการเดยน ดรกเฮาส

GAXENE 5 mg 474

H k PHarMเอช เค ฟารมาซตคอล

ALLAM 0.25 mg 116ALLAM 0.5 mg 275ALLAM 1 mg 320DEDA 5 mg 463DEDA 10 mg 291DIAZEPAM

H K PHARM 2 mg 243DIAZEPAM

H K PHARM 5 mg 176DIAZEPAM

H K PHARM 10 mg 371

HaMelN/Fdaฮาเมลน/อย.

FENTANYL-HAMELN 50 mcg/mL x 2 mL 638

FENTANYL-HAMELN 50 mcg/mL x 10 mL 639

KETA-HAMELN 50 mg/mL x 10 mL 678

PETHIDINE HAMELN 50 mg/mL 657

HeXal ag/Fdaเฮกซาล เอจ/อย.

FENTANYL GPO 12 mcg/hr 686

FENTANYL GPO 25 mcg/hr 687

FENTANYL GPO 50 mcg/hr 688

FENTANYL HEXAL 12 mcg/hr 689

FENTANYL HEXAL 25 mcg/hr 690

FENTANYL HEXAL 50 mcg/hr 691

iNPac PHarMaอนแพคฟารมา

INZOLAM 0.25 mg 118INZOLAM 0.5 mg 277INZOLAM 1 mg 321LORAZIN 0.5 mg 352LORAZIN 1 mg 045

MNF INDEX CLASS-FINAL-Aug13.indd 73 8/14/2013 2:48:38 PM

Page 75: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

74 MANUFACTURER’S INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

Ma

Nu

Fac

tu

re

r’s

iNd

eX

LORAZIN 2 mg 253TENMED 5 mg 470TENMED 10 mg 296

iNtas PHarM/Fdaอนทสฟารมาซตคอล/อย.

MIDAZ 5 mg/mL x 1 mL 644MIDAZ 5 mg/mL x 3 mL 645

iNtertHaiอนเตอรไทย

CODIPRONT† 522TRANXENE 5 mg 465

JaNsseN PHarMa/Fdaแจนเซน ฟารมา/อย.

DUROGESIC PATCH 12 mcg/hr 681

DUROGESIC PATCH 25 mcg/hr 682

DUROGESIC PATCH 50 mcg/hr 683

DUROGESIC PATCH 100 mcg/hr 684

JaNsseN-cilag/Fdaแจนเซน-ซแลก/อย.

CONCERTA 18 mg 186CONCERTA 27 mg 439CONCERTA 36 mg 129FENTANYL

JANSSEN-CILAG 0.05 mg/mL x 2 mL 635

FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL 636

JeNaHeXal/Fdaจนาเฮกซาล/อย.

MIDAZOLAM HEXAL 5 mg/mL x 1 mL 646

MIDAZOLAM HEXAL 5 mg/mL x 3 mL 647

keNyakuเคนยาก

BRONPECT† 325KENSPA† 251LORAZE 1 mg 044PRAZOL 0.25 mg 110PRAZOL 0.5 mg 268

PRAZOL 1 mg 314VALENIUM 2 mg 077VALENIUM 5 mg 169

l. b. s.แอล บ เอส แลบบอเรตอร

DOPAM 5 mg 148HAWKCOPAX 0.5 mg 348HAWKCOPAX 1 mg 393PANGON 30 mg/mL x 1 mL 654PARA WITH CODEINE†

15 mg 083PARA WITH CODEINE†

30 mg 084ROPAM 10 mg/2 mL x 2 mL 662ROPAM 5 mg 174

lab rubio/Fdaแลบ รบโอ/อย.

RUBIFEN 10 mg 043

lacHMaNNแลชแมน

DIZAN 2 mg 483DIZAN 5 mg 443

laviPHarM/Fdaลาวฟารม/อย.

FENTADUR 25 mcg/hr 685

lerd siNgHเลศสงห

ALPRAMED 0.25 mg 276ALPRAMED 0.5 mg 117ALPRAMED 1 mg 421CHLORDIXIDE 5 mg 386CHLORDIXIDE 10 mg 220DIAZEPAM

LERD SINGH 2 mg 075DIAZEPAM

LERD SINGH 5 mg 177TRANPON 5 mg 472TRANSPON FORTE

10 mg 283

liFe coNcerNไลฟ คอนเซน

FREXENE 5 mg 441FREXENE 10 mg 445LICON† 410

liwiNNer PHarMaลวนเนอรฟารมา

WINOPAM 2 mg 074WINOPAM 5 mg 404

M & H MaNuFacturiNgเอม แอนด เอช แมนแฟคเจอรง

BLUCO† 383CODICET BLUE 300† 380TERADYL† 60 mL 622TERADYL† 1000 mL 623

M & H MaNuFacturiNg/Fdaเอม แอนด เอช แมนแฟคเจอรง/อย.

MORPHINE SULFATE INJ BLUE 10 mg/mL x 1 mL 649

MORPHINE SULFATE INJ PURPLE 10 mg/mL x 1 mL 650

PETHIDINE M & H MANUFACTURING 50 mg/mL x 1 mL 659

PETHIDINE M & H MANUFACTURING 100 mg/2 mL x 2 mL 658

Mackแมค

CODIPRONT SYRUP† 60 mL 543

Mack/Fdaแมค/อย.

MIRAPRONT N 20 mg 516

MacroPHarแมคโครฟาร

ANXIELAX 5 mg 486AZEPAM 2 mg 219AZEPAM 5 mg 326LORAZEPAM

MACROPHAR 1 mg 400

MarcH PHarMaแหลมทองการแพทย

CHLORDIAZEPOXIDE MARCH PHARMA 25 mg 503

MANODIAZO 2 mg 495MANODIAZO 5 mg 530MANODIAZO 10 mg 365

MNF INDEX CLASS-FINAL-Aug13.indd 74 8/14/2013 2:48:38 PM

Page 76: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

MANUFACTURER’S INDEX 75PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

Ma

Nu

Fac

tu

re

r’s

iNd

eX

MANOLIUM 10 mg/2 mL x 2 mL 643

MANOTRAN 5 mg 461MANOTRAN 10 mg 289MARZOLAM 0.25 mg 107MARZOLAM 0.5 mg 265MARZOLAM 1 mg 312

Masa labมาซาแลบ

CEBARAX† 406CONZEP 5 mg 480CONZEP 10 mg 447DIZEPAM 2 mg 250DIZEPAM 5 mg 167MASADYL COUGH†

60 mL 560MASADYL COUGH†

100 mL 561MASADYL COUGH†

240 mL 562MASAPARA W/ CODEINE† 198NEO COUGH† 60 mL 578NEO COUGH† 100 mL 579NEO COUGH† 240 mL 580NEOCOD† 373NEOCOF† 212NEOPECT† 224ORA 0.5 mg 338ORA 1 mg 029ORA 2 mg 238PARADYL 8 mg 095PHENOCON 60 mg 255SERENE

MASA LAB 10 mg 286ZETRAN 5 mg 476

Medical suPPlyเวชบรการ

MED-ZEPAM 2 mg 041MED-ZEPAM 5 mg 366MED-ZEPOXIDE 5 mg 494MED-ZEPOXIDE 10 mg 059

MedicaPเมดแคป

CORYNIL† 225

MediciNe Productsเมดซนโปรดกส

LONZA 0.5 mg 339LONZA 1 mg 020

XANACINE 0.25 mg 113XANACINE 0.5 mg 271XANACINE 1 mg 317ZAM 2 mg 068ZAM 5 mg 172

MediciNe Products/Fdaเมดซนโปรดกส/อย.

PSEUDOEPHEDRINE MEDICINE PRODUCTS 60 mg 207

MedicPHarMaสหแพทยเภสช

CODEE-C† 416CODYL COUGH

LINCTUS† 60 mL 544CODYL COUGH

LINCTUS† 100 mL 545CODYL COUGH

LINCTUS† 1000 mL 546CODYL COUGH

LINCTUS† 4500 mL 547DIAMED 2 mg 531DIAMED 5 mg 518DIMED 2 mg 078DIRAX† 413FARZOLAM 0.25 mg 104MEDAZINE 5 mg 520MEDAZINE 10 mg 519PARA-CO 15 mg 375PARAMED-CO† 424PRENARPIL 0.5 mg 196PRENARPIL 1 mg 367PRENARPIL 2 mg 061TRANMED 5 mg 452TRANMED 10 mg 287UPZENE 5 mg 509ZOLAM 0.25 mg 115ZOLAM 0.5 mg 273ZOLAM 1 mg 319

MediFiveเมดไฟว

CLORAMED 5 mg 456CLORAMED 10 mg 290LORAMED 0.5 mg 334

Mega liFescieNcesเมกา ไลฟไซแอนซ

CODEPECT† 227ROLAR† 228

MeiJiเมจ

MEILAX 1 mg 022

MEILAX 2 mg 199

MilaNoมลาโน

DIANO 2 mg 010

DIANO 5 mg 154

MENOBARB 15 mg/5 mL x 60 mL 563

MENOBARB 20 mg/5 mL x 60 mL 564

MENOBARB 60 mg 208

MILA-CONO† 60 mL 566

MILA-TERCON† 184

PARCONO† 093

MilaNo/Fdaมลาโน/อย.

PSEUDOEPHEDRINE MILANO 30 mg/5 mL x 60 mL 618

PSEUDOEPHEDRINE MILANO 30 mg 153

PSEUDOEPHEDRINE MILANO 60 mg 046

MilliMedมลลเมด

ANAX 0.25 mg 097

ANAX 0.5 mg 256

CO-COF† 182

NASA W/ CODEINE† 092

POLY-COF† 60 mL 611

POLY-COF† 100 mL 612

VASON 2 mg 425

ModerN MaNuโมเดอรนแมน

CLORAZE 5 mg 458

CLORAZE 10 mg 292

MOXINAX 0.25 mg 108

MOXINAX 0.5 mg 266

ZEPAM 10 mg/2 mL x 2 mL 672

ZEPAM 2 mg 429

ZEPAM 5 mg 382

MNF INDEX CLASS-FINAL-Aug13.indd 75 8/14/2013 2:48:38 PM

Page 77: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

76 MANUFACTURER’S INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

Ma

Nu

Fac

tu

re

r’s

iNd

eX

New liFe PHarMaนวไลฟฟารมา

CLOZEPATE 5 mg 466COCET† 082DIPAM 2 mg 037DIPAM 5 mg 150DIPAM 10 mg 357LOZEPAM 0.5 mg 331LOZEPAM 1 mg 193PHENOBARBITONE

NEW LIFE PHARMA 30 mg 006

PHENOBARBITONE NEW LIFE PHARMA 60 mg 203

XALAM 0.25 mg 112XALAM 0.5 mg 270XALAM 1 mg 316

Novartisโนวารตส

BELLERGAL† 232

Novartis/Fdaโนวารตส/อย.

RITALIN 10 mg 042

olaN-keMedโอลน-เคมเมด

ALPRALAN 0.25 mg 036ALPRALAN 0.5 mg 240KEMORA 0.5 mg 434KEMORA 1 mg 024LORAMED 1 mg 026LORAMED 2 mg 237TRANOLAN

10 mg/2 mL x 2 mL 667TRANOLAN 2 mg 145TRANOLAN 5 mg 201

olicโอลค

ALPRAZOLAM FRX 0.25 mg 122

ALPRAZOLAM FRX 0.5 mg 282

BENADRYL CD† 60 mL 533

BENADRYL CD† 1000 mL 534

BENYLIN CD† 60 mL 535

CODIPRONT† 523LIBRAX† 409LOMOTIL† 004PHENSEDYL OLIC†

100 mL 607PRASEPINE 5 mg 484TYLENOL WITH

CODEINE† 087TYLENOL WITH

CODEINE† 088VALIUM 5 mg 170

osMoPHarM/Fdaออสโมฟารม/อย.

D-NORPSEUDOEPHEDRINE SR OSMOPHARM 20 mg 517

PANBESY 15 mg 450PANBESY 30 mg 487PHENTERMINE

OSMOPHARM 15 mg 477

osotH iNterlabโอสถอนเตอร

BROWN MIXTURE OSOTH INTERLAB† 180 mL 540

HISEDYL† 60 mL 557HISEDYL† 120 mL 558MIXTURE

SCILLAE AMMON† 180 mL 569

PARAGEN CO† 128P-CODYL† 60 mL 588P-CODYL† 120 mL 589

P P labพ พ แลบอราตอรส

EPOXIDE 10 mg 211EPOXIDE 25 mg 217LORA-P 0.5 mg 347LORA-P 1 mg 013LORA-P 2 mg 137PHENOBARB 30 mg 233PHENOBARB 60 mg 047PHENOBARB ELIXIR

20 mg/5 mL x 60 mL 594V DAY ZEPAM

10 mg/2 mL x 2 mL 668V DAY ZEPAM 2 mg 502V DAY ZEPAM 5 mg 491V DAY ZEPAM NL

10 mg/2 mL x 2 mL 669

PaNdrugsแพนดรกส

TRANZEP 5 mg 460

Parke-davis/Fdaพารคเดวส/อย.

KETALAR 50 mg/mL x 10 mL 679

PFizerไฟเซอร

XANAX 0.25 mg 114XANAX 0.5 mg 272XANAX 1 mg 318XANAX XR 0.5 mg 372XANAX XR 1 mg 079XANAX XR 2 mg 381

PHarMacia/Fdaฟารมาเซย/อย.

HALCION 0.25 mg 378

PHarMasaNt labฟารมาสนต แลบ

ALCELAM 0.25 mg 100ALCELAM 0.5 mg 259ALCELAM 1 mg 308ANTA 0.5 mg 330ANTA 1 mg 018ANTA 2 mg 138BONADINE CD† 60 mL 536CEMOL CODEINE† 081CENTRODINE CD† 248COZEP 10 mg 149COZEP 25 mg 202DZP2 2 mg 497FLULIUM 5 mg 467FLULIUM 10 mg 300POBRAX† 403POLYDINE CD† 295POMADOM 5 mg 481POMADOM 10 mg 449POPAM 2 mg 126POPAM 5 mg 187POVANIL 0.5 mg 210POVANIL 1 mg 179POVANIL 2 mg 076POZAPAM 5 mg 485POZAPAM 10 mg 192RADIBRAX† 420ZOPAM 2 mg 051

MNF INDEX CLASS-FINAL-Aug13.indd 76 8/14/2013 2:48:39 PM

Page 78: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

MANUFACTURER’S INDEX 77PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

Ma

Nu

Fac

tu

re

r’s

iNd

eX

ZOPAM 5 mg 160ZOPAM 10 mg 359

PHarMasaNt lab/Fdaฟารมาสนต แลบ/อย.

PHENYLPROPANOLAMINE PHARMASANT 25 mg 157

PHarMiNarฟารมนา

FARZOLAM 0.5 mg 263FARZOLAM 1 mg 310

PoliPHarMโปลฟารม

DOMAR 5 mg 490MITRANAX 0.25 mg 119MITRANAX 0.5 mg 278MITRANAX 1 mg 322POLIZEP 5 mg 468POLIZEP 10 mg 294TRANAVAN 0.5 mg 335TRANAVAN 1 mg 035

PoNd's cHeMicalพอนดเคมคอล

ALNAX 0.25 mg 099ALNAX 0.5 mg 258ALNAX 1 mg 307DIAZEPAM

POND'S CHEMICAL 2 mg 395

DIAZEPAM POND'S CHEMICAL 5 mg 242

DIAZEPAM POND'S CHEMICAL 5 mg 178

NEO-CODEIN† 374NEO-COPHEN 10 mg 222PERCIDYL COUGH†

100 mL 590PONDNADYL† 60 mL 613PONDNADYL† 100 mL 614PONDNADYL† 1000 mL 615PONDNEBIUM 5 mg 399PONDNEBIUM 10 mg 216PORA 0.5 mg 398PORA 1 mg 151PORA 2 mg 241TAMYLAB-S 5 mg 469

r P scHerer/Fdaอาร พ เชอเรอร/อย.

EUHYPNOS 20 20 mg 427

raNbaXy uNicHeMแรนแบกซ

FORTWIN 30 mg/mL x 1 mL 641

reckitt beNckiser/Fdaเรกคทท เบนคเซอร/อย.

TEMGESIC 0.3 mg/mL x 1 mL 666

TEMGESIC 0.2 mg 007

rivoPHarM/Fdaรโวฟารม/อย.

ZOLPIDEM TARTRATE RIVOPHARM 10 mg 124

rocHeโรช

LEXOTAN 1.5 mg 080LEXOTAN 3 mg 254RIVOTRIL

1 mg/mL x 1 mL 661RIVOTRIL 0.5 mg 197RIVOTRIL 2 mg 064VALIUM

10 mg/2 mL x 2 mL 670

rocHe/Fdaโรช/อย.

DALMADORM 15 mg 512DORMICUM

15 mg/3 mL x 3 mL 631DORMICUM 15 mg 379MOGADON 5 mg 091ROHYPNOL 1 mg 423

roseMoNt PHarMโรสมอนท ฟารมซตคอล

NORDYL LINCTUS† 100 mL 581

NORDYL LINCTUS† 500 mL 582

NORTUSS LINCTUS† 100 mL 583

NORTUSS LINCTUS† 500 mL 584

s co PHarMaเอส โค ฟารมา

S.CO ZEPAM 5 mg 246

salutas PHarMa/Fdaซาลทส ฟารมา/อย.

METHYLPHENIDATE HEXAL 10 mg 060

MORPHINE SALUTAS PHARMA 10 mg 438

MORPHINE SALUTAS PHARMA 30 mg 358

MORPHINE SALUTAS PHARMA 60 mg 245

saMakeePHaesaJ (uNioN drug lab)สามคคเภสช

BELLADONNA ALKALOIDS W/ PHENOBARBITAL† 247

DIAZEPAM SAMAKEEPHAESAJ 2 mg 391

DIAZEPAM SAMAKEEPHAESAJ 5 mg 155

saNdoz caNada/Fdaแซนดอส แคนาดา/อย.

FENTANYL SANDOZ 0.05 mg/mL x 2 mL 637

FENTANYL SANDOZ 500 mcg/10 mL 676

saNoFi-aveNtisซาโนฟ-อเวนตส

FRISIUM 5 mg 038GARDENAL 200 mg/4 mL 677

saNoFi-syNtHelaboซาโนฟ-ซนเตลาโบ

SOSEGON 30 mg/mL x 1 mL 664

TRANXENE 10 mg 298VICTAN 2 mg 204

saNoFi-wiNtHroP/Fdaซาโนฟ-วนทรอป/อย.

STILNOX 10 mg 123

MNF INDEX CLASS-FINAL-Aug13.indd 77 8/14/2013 2:48:39 PM

Page 79: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

78 MANUFACTURER’S INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

Ma

Nu

Fac

tu

re

r’s

iNd

eX

seNg tHaiแสงไทย

DIAZA 10 mg/2 mL x 2 mL 627

DIAZA 2 mg 361DIAZA 5 mg 162

seveN starsหางขายยาตราเจดดาว

DILIUM 2 mg 200DILIUM 5 mg 354

siaM bHeasacHสยามเภสช

DILOMIL† 002LORAPAM 0.5 mg 336LORAPAM 1 mg 027LORAPAM 2 mg 142SIAMPRAXOL 0.25 mg 111SIAMPRAXOL 0.5 mg 269SIAMPRAXOL 1 mg 315SIPAM 10 mg/2 mL x 2 mL 663SIPAM 2 mg 065SIPAM 5 mg 168SIPAM 10 mg 368TRANCLOR 5 mg 464TRANCLOR 10 mg 297

siaM bHeasacH/Fdaสยามเภสช/อย.

BUPRINE 0.2 mg 001

siaM Medicareสยามเมดแคร

POSENE 5 mg 189POSENE 10 mg 430

siloM Medicalสลมการแพทย

PHENOSIL ELIXIR 20 mg/5 mL x 60 mL 604

PHENOSIL ELIXIR 20 mg/5 mL x 450 mL 605

sNs/Fdaเอสเอนเอส/อย.

FENTANYL-SNS 50 mcg/mL x 2 mL 640

soMMai bHaesaJสมหมายเภสช

DIAZEPAM SOMMAI BHAESAJ 5 mg 346

sriPrasit PHarMaเภสชกรรมศรประสทธ

DECOS† 100 mL 554NEURAMIZONE† 432PARDEX 32.5 mg 131SECO† 417SPASIL† 009TUMAX† 428

suPHoNg bHaesaJสพงษเภสช

DIZEP 2 mg 188DIZEP 5 mg 214ELIXIR PHENOBARB

60 mL 556LORAVAN 0.5 mg 329LORAVAN 1 mg 028MIXTURE TUSSIS† 30 mL 570MIXTURE TUSSIS† 60 mL 571MIXTURE TUSSIS† 120 mL 572MIXTURE TUSSIS† 240 mL 573MIXTURE TUSSIS† 450 mL 574MIXTURE TUSSIS† 1800 mL 575MIXTURE TUSSIS† 3600 mL 576SUNAX 0.25 mg 120SUNAX 0.5 mg 279

t M N iMPeXท เอม เอน อมแพกซ

CEXENE 5 mg 473CEXENE 10 mg 299LORAPINE 0.5 mg 340VALAX 2 mg 032VALAX 10 mg 349

t P drugท พ ดรก

COSEDYL† 60 mL 552COTENOL† 085DIAZEPAM T P DRUG

10 mg/2 mL x 2 mL 629DIAZEPAM

T P DRUG 2 mg 012DIAZEPAM

T P DRUG 5 mg 165DIAZEPAM

T P DRUG 10 mg 364

TRANCAP 5 mg 496TRANCAP 10 mg 190ZEPOXIDE 5 mg 437ZEPOXIDE 10 mg 305

t P drug/Fdaท พ ดรก/อย.

MORPHINE T P DRUG 10 mg/mL x 1 mL 651

MORPHINE T P DRUG 10 mg/mL x 1 mL 652

MORPHINE T P DRUG 10 mg/mL x 1 mL 653

PETHIDINE T P DRUG 50 mg/mL x 1 mL 660

t s PHarMaท เอส ฟารมา

T-FIVE 5 mg 471

t v PHarMท ว ฟารมาซตคอล

PAM 5 mg 231

t. MaN PHarMaท แมน ฟารมา

CHLORDIAZEPOXIDE T MAN 10 mg 401

DIAZEPAM T MAN 2 mg 392DIAZEPAM T MAN 5 mg 180DIAZEPAM T MAN 5 mg 236DIAZEPAM T MAN 10 mg 353MANEX 0.25 mg 106MANEX 0.5 mg 264MANEX 1 mg 311MANTADYL COUGH†

60 mL 559PARCOD† 089TRANPATE 5 mg 442

t. o. cHeMicalsท โอ เคมคอลส

BENERA† 433CLORAXENE 5 mg 462CONADYL† 60 mL 551PHENOCO ELIXIR

20 mg/5 mL x 450 mL 602PHENOCO ELIXIR

20 mg/5 mL x 3800 mL 603TOCODYL† 418

MNF INDEX CLASS-FINAL-Aug13.indd 78 8/14/2013 2:48:39 PM

Page 80: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

MANUFACTURER’S INDEX 79PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

Ma

Nu

Fac

tu

re

r’s

iNd

eX

taiwaN biotecH/Fdaไตหวน ไบโอเทค/อย.

ZOPIM 10 mg 125

taNaPat bHaesaJธนพฒนเภสช

DIMED 5 mg 181

teMMler/Fdaเทมเลอร/อย.

REGENON RETARD 75 mg 504REGENON RETARD 75 mg 130

tHai NakorN PataNaไทยนครพฒนา

ALPAZAM 0.25 mg 101ALPAZAM 0.5 mg 260ALPAZAM 1 mg 261RAZEPAM 0.5 mg 342RAZEPAM 1 mg 031RAZEPAM 2 mg 144

tHai P d cHeMicalsไทย พ ด เคมคอลส

MONOZIDE 2 mg 525MONOZIDE-10

10 mg/2 mL x 2 mL 648

tHaiPHarMed 1942หางยาไทย 1942

DITRAN 2 mg 444DITRAN 5 mg 501

torreNtทอรเรนท

ALPRAX 0.25 mg 161ALPRAX 0.5 mg 195ALPRAX 1 mg 052

treNker/Fdaเทรนเกอร/อย.

ATRACTIL 75 mg 505DIETIL RETARD 75 mg 096PHENTERMINE TRENKER

15 mg 492PHENTERMINE TRENKER

30 mg 451

udoMPHoN (PHiHalab)อดมพร (ฟฮาแลบ)

METAXIDE 10 mg 515TAZCINE

30 mg/mL x 1 mL 665TAZCINE 25 mg 066TAZCINE 50 mg 252ZEPAXID

10 mg/2 mL x 2 mL 673ZEPAXID 2 mg 532ZEPAXID 5 mg 488

uMedaยเมดา

CLOZENE 5 mg 446CLOZENE 10 mg 478LAYLIUM-10

10 mg/2 mL x 2 mL 642

uNisoNยนซน

DIPOSEF 5 mg 453DIPOSEF 10 mg 284EXAN 5 mg 508EXAN 10 mg 511

uPsoNอพซน

UPTRAN 10 mg 293

utoPiaNยโทเปยน

ANCORIL 0.5 mg 209ANPRESS 0.5 mg 274ANXENE 5 mg 455ANXENE 10 mg 288ANXIRA 0.5 mg 327ANXIRA 1 mg 021CELIUM 5 mg 426CHLORDIBRAX† 407CLONARIL 1 mg 370CLONARIL 2 mg 069LORAPINE 1 mg 033MODURAX† 405TRANCON 5 mg 482TRANCON 10 mg 448UTORAX† 411VALAX 5 mg 146VEMED 0.5 mg 343VISPAM 2 mg 394VISPAM 5 mg 239

VISPAM 10 mg 350

VOMED 2 mg 067

XIEMED 0.25 mg 121

XIEMED 1 mg 323

v s PHarMa

ว เอส ฟารมา

PHARNAX 0.25 mg 109

PHARNAX 0.5 mg 267

PHARNAX 1 mg 313

PHENCODIN† 60 mL 591

PHENCODIN† 500 mL 592

PHENCODIN† 1000 mL 593

SERENE V S PHARMA 5 mg 457

TUSSIDYL† 60 mL 624

VORAPAM 2 mg 073

VORAPAM 5 mg 175

vesco PHarMa

เวสโกฟารมาซตคอล

DIAZEPAM VESCO 2 mg 351

DIAZEPAM VESCO 5 mg 147

VESCOPAM 10 mg/2 mL x 2 mL 671

vidHyasoM

วทยาศรม

MIST TUSSIS† 450 mL 567

SQUILL AND AMMONIA VIDHYASOM† 450 mL 619

wHiteHall

ไวทฮอลล

DIMETANE EXPECTORANT DC† 2.5 L 555

DONNATAL† 057

wyetH

ไวเอท (ประเทศไทย)

ATIVAN 0.5 mg 332

ATIVAN 1 mg 023

ATIVAN 2 mg 141

wyetH-ayerst/Fda

ไวเอท-เอเยรสท/อย.

LORAMET 1 mg 105

MNF INDEX CLASS-FINAL-Aug13.indd 79 8/16/2013 3:36:12 PM

Page 81: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

- ALPRAX 0.5 mg - 195

- ALPRAX 1 mg - 052

- ALPRAXOL 0.25 mg - 017

- ALPRAXOL 0.5 mg - 235

- ALPRAZOLAM FRX 0.25 mg - 122

- ALPRAZOLAM FRX 0.5 mg - 282

- ANAX 0.25 mg - 097

- ANAX 0.5 mg - 256

- ANPRESS 0.25 mg - 102

- ANPRESS 0.5 mg - 274

- ANPRESS 1 mg - 309

- ANZION 0.25 mg - 098

- ANZION 0.5 mg - 257

- ANZION 1 mg - 306

- DIZOLAM 0.25 mg - 103

- DIZOLAM 0.5 mg - 262

- DIZOLAM 1 mg - 324

- FARZOLAM 0.25 mg - 104

- FARZOLAM 0.5 mg - 263

- FARZOLAM 1 mg - 310

- INZOLAM 0.25 mg - 118

- INZOLAM 0.5 mg - 277

- INZOLAM 1 mg - 321

- MANEX 0.25 mg - 106

- MANEX 0.5 mg - 264

- MANEX 1 mg - 311

- MARZOLAM 0.25 mg - 107

- MARZOLAM 0.5 mg - 265

- MARZOLAM 1 mg - 312

- MITRANAX 0.25 mg - 119

- MITRANAX 0.5 mg - 278

- MITRANAX 1 mg - 322

- MOXINAX 0.25 mg - 108

- MOXINAX 0.5 mg - 266

- PHARNAX 0.25 mg - 109

- PHARNAX 0.5 mg - 267

- PHARNAX 1 mg - 313

- PRAZOL 0.25 mg - 110

- PRAZOL 0.5 mg - 268

- PRAZOL 1 mg - 314

- SIAMPRAXOL 0.25 mg - 111

AALCELAM 0.25 mg - 100ALCELAM 0.5 mg - 259ALCELAM 1 mg - 308ALLAM 0.25 mg - 116ALLAM 0.5 mg - 275ALLAM 1 mg - 320ALNAX 0.25 mg - 099ALNAX 0.5 mg - 258ALNAX 1 mg - 307ALODORM 5 mg - 090ALPAZAM 0.25 mg - 101ALPAZAM 0.5 mg - 260ALPAZAM 1 mg - 261ALPRALAN 0.25 mg - 036ALPRALAN 0.5 mg - 240ALPRAMED 0.25 mg - 276ALPRAMED 0.5 mg - 117ALPRAMED 1 mg - 421ALPRAX 0.25 mg - 161ALPRAX 0.5 mg - 195ALPRAX 1 mg - 052ALPRAXOL 0.25 mg - 017ALPRAXOL 0.5 mg - 235

alprazolam:

- ALCELAM 0.25 mg - 100

- ALCELAM 0.5 mg - 259

- ALCELAM 1 mg - 308

- ALLAM 0.25 mg - 116

- ALLAM 0.5 mg - 275

- ALLAM 1 mg - 320

- ALNAX 0.25 mg - 099

- ALNAX 0.5 mg - 258

- ALNAX 1 mg - 307

- ALPAZAM 0.25 mg - 101

- ALPAZAM 0.5 mg - 260

- ALPAZAM 1 mg - 261

- ALPRALAN 0.25 mg - 036

- ALPRALAN 0.5 mg - 240

- ALPRAMED 0.25 mg - 276

- ALPRAMED 0.5 mg - 117

- ALPRAMED 1 mg - 421

- ALPRAX 0.25 mg - 161

Registration No. Frame No. Registration No. Frame No.

BRAND & GENERIC NAME INDEX

ดชนรวมชอการคาและชอสามญ

B&G Name Index-FINAL-Aug13.indd 80 8/14/2013 2:45:17 PM

Page 82: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 81PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

- SIAMPRAXOL 0.5 mg - 269

- SIAMPRAXOL 1 mg - 315

- SUNAX 0.25 mg - 120

- SUNAX 0.5 mg - 279

- XALAM 0.25 mg - 112

- XALAM 0.5 mg - 270

- XALAM 1 mg - 316

- XANACINE 0.25 mg - 113

- XANACINE 0.5 mg - 271

- XANACINE 1 mg - 317

- XANAX 0.25 mg - 114

- XANAX 0.5 mg - 272

- XANAX 1 mg - 318

- XANAX XR 0.5 mg - 372

- XANAX XR 1 mg - 079

- XANAX XR 2 mg - 381

- XIEMED 0.25 mg - 121

- XIEMED 0.5 mg - 280

- XIEMED 1 mg - 323

- ZOLAM 0.25 mg - 115

- ZOLAM 0.5 mg - 273

- ZOLAM 1 mg - 319

ALPRAZOLAM FRX 0.25 mg - 122

ALPRAZOLAM FRX 0.5 mg - 282

AMA† P2A 20/55 159

amobarbital:

- AMA† P2A 20/55 159

- AMYTAL 0.5 g - 674

AMYTAL 0.5 g - 674ANAX 0.25 mg - 097ANAX 0.5 mg - 256ANCORIL 0.5 mg P1A 14/51 209ANPRESS 0.25 mg - 102ANPRESS 0.5 mg - 274ANPRESS 1 mg - 309ANTA 0.5 mg P1A 36/53 330ANTA 1 mg P1A 12/54 018ANTA 2 mg P1A 29/52 138ANXENE 5 mg - 455ANXENE 10 mg - 288ANXIELAX 5 mg - 486ANXIRA 0.5 mg P1A 24/52 327ANXIRA 1 mg P1A 25/52 021ANZION 0.25 mg - 098ANZION 0.5 mg - 257ANZION 1 mg - 306ATIVAN 0.5 mg - 332ATIVAN 1 mg - 023ATIVAN 2 mg - 141

ATRACTIL 75 mg - 505AZEPAM 2 mg - 219AZEPAM 5 mg - 326A-ZERAX 2 mg P1A 37/52 479A-ZERAX 5 mg P1A 38/52 489

BBELLADONNA ALKALOIDS W/

PHENOBARBITAL† - 247BELLERGAL† - 232BELLOID† - 139BENADRYL CD†

60 mL - 533BENADRYL CD†

1000 mL - 534BENERA† - 433BENPINE 5 mg P1A 32/54 435BENPINE 10 mg P1A 17/54 526BENPINE 25 mg P1A 1/49 218BENYLIN CD† 60 mL - 535BLUCO† - 383BLUCON† - 360BONADINE CD† 60 mL - 536

bromazepam:

- LEXOTAN 1.5 mg P1C 26/55 080

- LEXOTAN 3 mg P1C 27/55 254

BROMTUSSIA DC† 60 mL - 537

BRONPECT† - 325BROWN MIXTURE

GPO† 180 mL N2A 7/56 538BROWN MIXTURE

GPO† 450 mL N2A 7/56 539BROWN MIXTURE

OSOTH INTERLAB† 180 mL N2A 13/53 540

buprenorphine hydrochloride:

- BUPRINE 0.2 mg - 001

- TEMGESIC 0.3 mg/mL x 1 mL - 666

- TEMGESIC 0.2 mg - 007

BUPRINE 0.2 mg - 001

butobarbital:

- BELLOID† - 139

CCALMIPAM 2 mg - 388CALMIPAM 5 mg - 302CALYPSOL

50 mg/mL x 10 mL - 675CAMPHORATED

OPIUM TINCTURE GPO 1000 mL N2A 6/53 541

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 81 8/14/2013 2:45:17 PM

Page 83: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

82 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

camphorated opium tincture:

- BROWN MIXTURE GPO† 180 mL N2A 7/56 538

- BROWN MIXTURE GPO† 450 mL N2A 7/56 539

- BROWN MIXTURE OSOTH INTERLAB† 180 mL N2A 13/53 540

- CAMPHORATED OPIUM TINCTURE GPO 1000 mL N2A 6/53 541

- COUGH SYRUP GPO† 60 mL - 553

- MIST TUSSIS† 450 mL - 567

- MIST. SCILL AMMON. GPO† 180 mL - 568

- MIXTURE SCILLAE AMMON† 180 mL - 569

- MIXTURE TUSSIS† 30 mL N2A 11/55 570

- MIXTURE TUSSIS† 60 mL N2A 11/55 571

- MIXTURE TUSSIS† 120 mL N2A 11/55 572

- MIXTURE TUSSIS† 240 mL N2A 11/55 573

- MIXTURE TUSSIS† 450 mL N2A 11/55 574

- MIXTURE TUSSIS† 1800 mL - 575

- MIXTURE TUSSIS† 3600 mL - 576

- SQUILL AND AMMONIA VIDHYASOM† 450 mL - 619

cathine:

- D-NORPSEUDOEPHEDRINE SR OSMOPHARM 20 mg - 517

- MIRAPRONT N 20 mg - 516

CEBARAX† P2A 22/51 406CELIUM 5 mg P1A 27/54 426CEMOL CODEINE† - 081CENTRODINE CD† N2A 11/47 248CEXENE 5 mg - 473CEXENE 10 mg - 299

chlordiazepoxide:

- DIRAX† P2A 31/54 413

- LIBRAX† P2A 3/55 409

CHLORDIAZEPOXIDE ACDHON 10 mg - 529

CHLORDIAZEPOXIDE CHAROEN BHAESAJ 10 mg - 528

chlordiazepoxide hydrochloride:

- BENPINE 5 mg P1A 32/54 435

- BENPINE 10 mg P1A 17/54 526

- BENPINE 25 mg P1A 1/49 218

- CEBARAX† P2A 22/51 406

- CHLORDIAZEPOXIDE ACDHON 10 mg - 529

- CHLORDIAZEPOXIDE CHAROEN BHAESAJ 10 mg - 528

- CHLORDIAZEPOXIDE MARCH PHARMA 25 mg - 503

- CHLORDIAZEPOXIDE T MAN 10 mg P1A 21/55 401

- CHLORDIBRAX† - 407

- CHLORDIXIDE 5 mg - 386

- CHLORDIXIDE 10 mg - 220

- CHLORZEP 5 mg - 387

- COMOBEN 5 mg P1A 1/55 390

- COMOBEN 10 mg P1A 2/55 510

- COZEP 10 mg P1A 3/50 149

- COZEP 25 mg P1A 39/53 202

- EPOXIDE 10 mg - 211

- EPOXIDE 25 mg - 217

- KENSPA† P2A 36/52 251

- LICON† - 410

- MED-ZEPOXIDE 5 mg - 494

- MED-ZEPOXIDE 10 mg - 059

- METAXIDE 10 mg - 515

- MINOXIDE 10 mg P1A 44/52 493

- MODURAX† - 405

- POBRAX† - 403

- PONDNEBIUM 5 mg - 399

- PONDNEBIUM 10 mg - 216

- RADIBRAX† - 420

- TUMAX† P2A 25/55 428

- UTORAX† - 411

- ZEPOBRAX† - 412

- ZEPOXIDE 5 mg - 437

- ZEPOXIDE 10 mg P1A 35/52 305

- ZEPOXIN 5 mg - 230

- ZEPOXIN 10 mg - 132

CHLORDIAZEPOXIDE MARCH PHARMA 25 mg - 503

CHLORDIAZEPOXIDE T MAN 10 mg P1A 21/55 401

CHLORDIBRAX† - 407CHLORDIXIDE 5 mg - 386CHLORDIXIDE 10 mg - 220CHLORZEP 5 mg - 387CLINEPECT† - 524CLINOPECT† - 221

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 82 8/14/2013 2:45:17 PM

Page 84: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 83PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

CLINOPRONT† N2A 1/50 408

clobazam:

- FRISIUM 5 mg P1C 12/53, P1B 13/53 038

- FRISIUM 10 mg - 039

CLONARIL 1 mg P1A 15/51 370CLONARIL 2 mg P1A 16/51 069

clonazepam:

- ANCORIL 0.5 mg P1A 14/51 209

- CLONARIL 1 mg P1A 15/51 370

- CLONARIL 2 mg P1A 16/51 069

- CONVULSIL 2 mg P1A 18/53 070

- POVANIL 0.5 mg P1A 33/52 210

- POVANIL 1 mg P1A 13/54 179

- POVANIL 2 mg P1A 34/52 076

- PRENARPIL 0.5 mg P1A 4/55 196

- PRENARPIL 1 mg P1A 5/55 367

- PRENARPIL 2 mg P1A 6/55 061

- RIVOTRIL 1 mg/mL x 1 mL - 661

- RIVOTRIL 0.5 mg P1A 6/53 197

- RIVOTRIL 2 mg P1A 7/53 064

CLORAMED 5 mg - 456CLORAMED 10 mg - 290CLORAXENE 5 mg P1A 33/54 462CLORAZE 5 mg P1A 24/55 458CLORAZE 10 mg - 292CLOZENE 5 mg - 446CLOZENE 10 mg - 478CLOZEPATE 5 mg - 466COCET† - 082CO-COF† N2A 6/51 182CODEE-C† N2A 6/52 416

clorazepate dipotassium:

- ANXENE 5 mg - 455

- ANXENE 10 mg - 288

- ANXIELAX 5 mg - 486

- CEXENE 5 mg - 473

- CEXENE 10 mg - 299

- CLORAMED 5 mg - 456

- CLORAMED 10 mg - 290

- CLORAXENE 5 mg P1A 33/54 462

- CLORAZE 5 mg P1A 24/55 458

- CLORAZE 10 mg - 292

- CLOZENE 5 mg - 446

- CLOZENE 10 mg - 478

- CLOZEPATE 5 mg - 466

- CONZEP 5 mg - 480

- CONZEP 10 mg - 447

- DEDA 5 mg - 463

- DEDA 10 mg - 291

- DIPOSEF 5 mg - 453

- DIPOSEF 10 mg - 284

- DIPOT 5 mg P1A 40/52 459

- DOPAM 5 mg - 148

- EXAN 5 mg - 508

- EXAN 10 mg - 511

- FLULIUM 5 mg P1A 28/55 467

- FLULIUM 10 mg - 300

- FREXENE 5 mg - 441

- FREXENE 10 mg - 445

- GAXENE 5 mg - 474

- MANOTRAN 5 mg - 461

- MANOTRAN 10 mg - 289

- POLIZEP 5 mg P1A 23/50 468

- POLIZEP 10 mg - 294

- POMADOM 5 mg - 481

- POMADOM 10 mg - 449

- POSENE 5 mg - 189

- POSENE 10 mg - 430

- SANOR 5 mg - 454

- SANOR 10 mg - 285

- SERENE MASA LAB 10 mg - 286

- SERENE V S PHARMA 5 mg - 457

- TAMYLAB-S 5 mg - 469

- TENMED 5 mg P1A 47/52 470

- TENMED 10 mg - 296

- T-FIVE 5 mg - 471

- TRANADON-S 5 mg - 475

- TRANCAP 5 mg - 496

- TRANCAP 10 mg - 190

- TRANCLOR 5 mg - 464

- TRANCLOR 10 mg - 297

- TRANCON 5 mg P1A 20/53 482

- TRANCON 10 mg - 448

- TRANMED 5 mg P1A 39/52 452

- TRANMED 10 mg - 287

- TRANPATE 5 mg - 442

- TRANPON 5 mg - 472

- TRANSPON FORTE 10 mg - 283

- TRANXENE 5 mg P1A 14/54 465

- TRANXENE 10 mg - 298

- TRANZEP 5 mg - 460

- UPTRAN 10 mg - 293

- UPZENE 5 mg - 509

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 83 8/14/2013 2:45:17 PM

Page 85: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

84 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

- ZETRAN 5 mg - 476

codeine:

- CODIPRONT† - 522

- CODIPRONT† N2A 9/51 523

- CODIPRONT SYRUP† 60 mL - 543

CODEINE GPO 15 mg - 003CODEINE GPO 30 mg - 019

codeine phosphate:

- BENADRYL CD† 60 mL - 533

- BENADRYL CD† 1000 mL - 534

- BENYLIN CD† 60 mL - 535

- BLUCO† - 383

- BLUCON† - 360

- BONADINE CD† 60 mL - 536

- BROMTUSSIA DC† 60 mL - 537

- BRONPECT† - 325

- CEMOL CODEINE† - 081

- CENTRODINE CD† N2A 11/47 248

- CLINEPECT† - 524

- CLINOPECT† - 221

- CLINOPRONT† N2A 1/50 408

- COCET† - 082

- CO-COF† N2A 6/51 182

- CODEE-C† N2A 6/52 416

- CODEINE GPO 15 mg - 003

- CODEINE GPO 30 mg - 019

- CODENOL† 15 mg N2A 1/56 422

- CODEPECT† N2A 10/55 227

- CODESIA† N2A 6/55 419

- CODESIA† 60 mL N2A 5/55 542

- CODICET† - 440

- CODICET BLUE 300† N2A 10/51 380

- CODICET PINK† 15 mg N2A 1/52 281

- CODIGESIC† N2A 3/50 127

- CODYL COUGH LINCTUS† 60 mL N2A 3/55 544

- CODYL COUGH LINCTUS† 100 mL N2A 3/55 545

- CODYL COUGH LINCTUS† 1000 mL - 546

- CODYL COUGH LINCTUS† 4500 mL - 547

- COFCODYL† 60 mL N2A 1/54 548

- COFCODYL† 100 mL N2A 1/54 549

- COMODINE COUGH† 60 mL - 550

- CONADYL† 60 mL - 551

- CORYNIL† - 225

- COSEDYL† 60 mL - 552

- COTENOL† - 085

- DECOS† 100 mL N2A 2/55 554

- DIMETANE EXPECTORANT DC† 2.5 L - 555

- HISEDYL† 60 mL - 557

- HISEDYL† 120 mL - 558

- MANTADYL COUGH† 60 mL - 559

- MASADYL COUGH† 60 mL - 560

- MASADYL COUGH† 100 mL - 561

- MASADYL COUGH† 240 mL - 562

- MASAPARA W/ CODEINE† N2A 7/55 198

- MILA-CONO† 60 mL - 566

- MILA-TERCON† - 184

- NASA W/ CODEINE† N2A 4/51 092

- NEO COUGH† 60 mL - 578

- NEO COUGH† 100 mL - 579

- NEO COUGH† 240 mL - 580

- NEOCOD† - 373

- NEO-CODEIN† - 374

- NEOCOF† - 212

- NEO-COPHEN 10 mg - 222

- NEOPECT† N2A 11/52 224

- NORDYL LINCTUS† 100 mL - 581

- NORDYL LINCTUS† 500 mL - 582

- NORTUSS LINCTUS† 100 mL - 583

- NORTUSS LINCTUS† 500 mL - 584

- PACOGESIC† - 213

- PARA WITH CODEINE† 15 mg N2A 4/56 083

- PARA WITH CODEINE† 30 mg N2A 5/56 084

- PARA-CO 15 mg N2A 7/52 375

- PARADEINE† N2A 2/54 086

- PARADYL 8 mg - 095

- PARAGEN CO† - 128

- PARAMED-CO† - 424

- PARCOD† - 089

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 84 8/14/2013 2:45:17 PM

Page 86: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 85PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

- PARCONO† - 093

- P-CODYL† 60 mL - 588

- P-CODYL† 120 mL - 589

- PERCIDYL COUGH† 100 mL - 590

- PHENCODIN† 60 mL - 591

- PHENCODIN† 500 mL - 592

- PHENCODIN† 1000 mL - 593

- PHENSEDYL OLIC† 100 mL - 607

- PHENSODI† 60 mL - 608

- PHENSODI† 120 mL - 609

- PHENSODI† 1000 mL - 610

- POLY-COF† 60 mL N2A 5/51 611

- POLY-COF† 100 mL N2A 5/51 612

- POLYDINE CD† - 295

- PONDNADYL† 60 mL - 613

- PONDNADYL† 100 mL - 614

- PONDNADYL† 1000 mL - 615

- ROLAR† N2A 9/55 228

- ROPECT† N2A 1/55 226

- ROTUSS† N2C 9/52 229

- SECO† N2A 4/55 417

- TENADRIN-C† 60 mL - 620

- TERADENE† 60 mL - 621

- TERADYL† 60 mL - 622

- TERADYL† 1000 mL - 623

- TERCO-C† N2A 11/53 415

- TOCODYL† - 418

- TUSSIDYL† 60 mL - 624

- TYLENOL WITH CODEINE† N2A 9/53 087

- TYLENOL WITH CODEINE† - 088

- ZORITUSS 10 mg - 223

CODENOL† 15 mg N2A 1/56 422CODEPECT† N2A 10/55 227CODESIA† N2A 6/55 419CODESIA† 60 mL N2A 5/55 542CODICET† - 440CODICET BLUE 300† N2A 10/51 380CODICET PINK†

15 mg N2A 1/52 281CODIGESIC† N2A 3/50 127CODIPRONT† - 522CODIPRONT† N2A 9/51 523CODIPRONT SYRUP†

60 mL - 543CODYL COUGH

LINCTUS† 60 mL N2A 3/55 544

CODYL COUGH LINCTUS† 100 mL N2A 3/55 545

CODYL COUGH LINCTUS† 1000 mL - 546

CODYL COUGH LINCTUS† 4500 mL - 547

COFCODYL† 60 mL N2A 1/54 548COFCODYL† 100 mL N2A 1/54 549COMOBEN 5 mg P1A 1/55 390COMOBEN 10 mg P1A 2/55 510COMODINE COUGH†

60 mL - 550CONADYL† 60 mL - 551CONCERTA 18 mg - 186CONCERTA 27 mg - 439CONCERTA 36 mg - 129CONVULSIL 2 mg P1A 18/53 070CONZEP 5 mg - 480CONZEP 10 mg - 447CORYNIL† - 225COSEDYL† 60 mL - 552COTENOL† - 085COUGH SYRUP GPO†

60 mL - 553COZEP 10 mg P1A 3/50 149COZEP 25 mg P1A 39/53 202

DDACTIVE 10 10 mg - 053DALMADORM 15 mg - 512DAVOL† - 301DECOS† 100 mL N2A 2/55 554DEDA 5 mg - 463DEDA 10 mg - 291

dextropropoxyphene hydrochloride:

- DAVOL† - 301

dextropropoxyphene napsylate:

- PARDEX 32.5 mg - 131

DIADON 5 mg - 377DIAMED 2 mg P1A 14/53 531DIAMED 5 mg P1A 15/53 518DIANO 2 mg P1A 5/54 010DIANO 5 mg P1A 6/54 154DIAPAM 2 mg P1A 15/54 396DIAPAM 5 mg P1A 16/54 355DIAPINE

5 mg/mL x 1 mL P1A 10/55 626DIAPINE

10 mg/2 mL x 2 mL P1A 10/55 625DIAPINE

CAPSULE 2 mg P1A 47/53 499DIAPINE

CAPSULE 5 mg P1A 48/53 506

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 85 8/14/2013 2:45:18 PM

Page 87: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

86 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

DIAPINE TABLET 2 mg P1A 33/53 011

DIAPINE TABLET 5 mg P1A 34/53 183

DIAPINE TABLET 10 mg P1A 35/53 414

DIAZ 2 mg - 071DIAZ 5 mg - 173DIAZ 10 mg - 369DIAZA

10 mg/2 mL x 2 mL - 627DIAZA 2 mg - 361DIAZA 5 mg - 162diazepam:

- AZEPAM 2 mg - 219

- AZEPAM 5 mg - 326

- A-ZERAX 2 mg P1A 37/52 479

- A-ZERAX 5 mg P1A 38/52 489

- CALMIPAM 2 mg - 388

- CALMIPAM 5 mg - 302

- DIADON 5 mg - 377

- DIAMED 2 mg P1A 14/53 531

- DIAMED 5 mg P1A 15/53 518

- DIANO 2 mg P1A 5/54 010

- DIANO 5 mg P1A 6/54 154

- DIAPAM 2 mg P1A 15/54 396

- DIAPAM 5 mg P1A 16/54 355

- DIAPINE 5 mg/mL x 1 mL P1A 10/55 626

- DIAPINE 10 mg/2 mL x 2 mL P1A 10/55 625

- DIAPINE CAPSULE 2 mg P1A 47/53 499

- DIAPINE CAPSULE 5 mg P1A 48/53 506

- DIAPINE TABLET 2 mg P1A 33/53 011

- DIAPINE TABLET 5 mg P1A 34/53 183

- DIAPINE TABLET 10 mg P1A 35/53 414

- DIAZ 2 mg - 071

- DIAZ 5 mg - 173

- DIAZ 10 mg - 369

DIAZA 10 mg/2 mL x 2 mL - 627

- DIAZA 2 mg - 361

- DIAZA 5 mg - 162

- DIAZEPAM ACDHON 2 mg - 498

- DIAZEPAM BJ BENJAOSOTH 10 mg - 249

- DIAZEPAM BJ BENJAOSOTH 2 mg - 054

- DIAZEPAM BJ BENJAOSOTH 5 mg P1A 44/54 402

- DIAZEPAM CHAROEN BHAESAJ 2 mg - 362

- DIAZEPAM GENERAL DRUGS HOUSE 2 mg P1A 44/53 345

- DIAZEPAM GENERAL DRUGS HOUSE 5 mg P1A 8/54 163

- DIAZEPAM GPO 10 mg/2 mL x 2 mL - 628

- DIAZEPAM GPO 2 mg - 055

- DIAZEPAM GPO 5 mg - 164

- DIAZEPAM GPO 10 mg - 363

- DIAZEPAM H K PHARM 2 mg P1A 51/54 243

- DIAZEPAM H K PHARM 5 mg P1A 52/54 176

- DIAZEPAM H K PHARM 10 mg P1A 53/54 371

- DIAZEPAM LERD SINGH 2 mg P1A 25/54 075

- DIAZEPAM LERD SINGH 5 mg P1A 26/54 177

- DIAZEPAM POND'S CHEMICAL 2 mg P1A 40/53 395

- DIAZEPAM POND'S CHEMICAL 5 mg P1A 41/53 242

- DIAZEPAM POND'S CHEMICAL 5 mg - 178

- DIAZEPAM SAMAKEEPHAESAJ 2 mg - 391

- DIAZEPAM SAMAKEEPHAESAJ 5 mg - 155

- DIAZEPAM SOMMAI BHAESAJ 5 mg - 346

- DIAZEPAM T MAN 2 mg P1A 24/53 392

- DIAZEPAM T MAN 5 mg P1A 42/54 236

- DIAZEPAM T MAN 5 mg P1A 42/54 180

- DIAZEPAM T MAN 10 mg - 353

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 86 8/14/2013 2:45:18 PM

Page 88: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 87PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

- DIAZEPAM T P DRUG 10 mg/2 mL x 2 mL P1A 47/54 629

- DIAZEPAM T P DRUG 2 mg - 012

- DIAZEPAM T P DRUG 5 mg - 165

- DIAZEPAM T P DRUG 10 mg - 364

- DIAZEPAM VESCO 2 mg P1A 8/55 351

- DIAZEPAM VESCO 5 mg P1A 9/55 147

- DIAZEPION 2 mg - 514

- DIAZEPION 5 mg - 500

- DIAZEPION 10 mg - 215

- DILIUM 2 mg - 200

- DILIUM 5 mg - 354

- DIMED 2 mg - 078

- DIMED 5 mg - 181

- DIPAM 2 mg - 037

- DIPAM 5 mg - 150

- DIPAM 10 mg - 357

- DITRAN 2 mg P1A 16/53 444

- DITRAN 5 mg - 501

- DIVOPAN 2 mg P1A 42/53 056

- DIVOPAN 5 mg P1A 43/53 166

- DIZAN 2 mg - 483

- DIZAN 5 mg - 443

- DIZEP 2 mg P1A 54/54 188

- DIZEP 5 mg P1A 55/54 214

- DIZEPAM 2 mg P1A 45/53 250

- DIZEPAM 5 mg P1A 46/53 167

- DZP2 2 mg - 497

- LAYLIUM-10 10 mg/2 mL x 2 mL - 642

- MANODIAZO 2 mg P1A 9/56 495

- MANODIAZO 5 mg P1A 10/56 530

- MANODIAZO 10 mg P1A 11/55 365

- MANOLIUM 10 mg/2 mL x 2 mL P1A 11/54 643

- MED-ZEPAM 2 mg - 041

- MED-ZEPAM 5 mg - 366

- MONOZIDE 2 mg - 525

- MONOZIDE-10 10 mg/2 mL x 2 mL - 648

- PAM 5 mg - 231

- POPAM 2 mg - 126

- POPAM 5 mg - 187

- ROPAM 10 mg/2 mL x 2 mL P1A 49/53 662

- ROPAM 5 mg - 174

- S.CO ZEPAM 5 mg - 246

- SIPAM 10 mg/2 mL x 2 mL P1A 26/53 663

- SIPAM 2 mg P1A 12/56 065

- SIPAM 5 mg P1A 13/56 168

- SIPAM 10 mg - 368

- STESOLID 2 mg - 431

- STESOLID 5 mg - 507

- STESOLID 10 mg - 513

- TRANOLAN 10 mg/2 mL x 2 mL P1A 41/52 667

- TRANOLAN 2 mg P1A 9/54 145

- TRANOLAN 5 mg P1A 10/54 201

- V DAY ZEPAM 10 mg/2 mL x 2 mL - 668

- V DAY ZEPAM 2 mg - 502

- V DAY ZEPAM 5 mg - 491

- V DAY ZEPAM NL 10 mg/2 mL x 2 mL - 669

- VALAX 2 mg - 032

- VALAX 5 mg - 146

- VALAX 10 mg - 349

- VALENIUM 2 mg - 077

- VALENIUM 5 mg - 169

- VALIUM 10 mg/2 mL x 2 mL - 670

- VALIUM 5 mg - 170

- VASON 2 mg P1A 25/53 425

- VESCOPAM 10 mg/2 mL x 2 mL P1A 50/53 671

- VISPAM 2 mg - 394

- VISPAM 5 mg - 239

- VISPAM 10 mg - 350

- VOMED 2 mg - 067

- VOMED 5 mg - 171

- VORAPAM 2 mg P1A 45/54 073

- VORAPAM 5 mg P1A 46/54 175

- WINOPAM 2 mg - 074

- WINOPAM 5 mg - 404

- ZAM 2 mg P1A 1/51 068

- ZAM 5 mg P1A 2/51 172

- ZEPAM 10 mg/2 mL x 2 mL - 672

- ZEPAM 2 mg - 429

- ZEPAM 5 mg - 382

- ZEPAXID 10 mg/2 mL x 2 mL - 673

- ZEPAXID 2 mg - 532

- ZEPAXID 5 mg P1A 21/50 488

- ZOPAM 2 mg P1A 31/53 051

- ZOPAM 5 mg P1A 32/53 160

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 87 8/14/2013 2:45:18 PM

Page 89: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

88 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

- ZOPAM 10 mg P1A 8/53 359

DIAZEPAM ACDHON 2 mg - 498

DIAZEPAM BJ BENJAOSOTH 2 mg - 054

DIAZEPAM BJ BENJAOSOTH 5 mg P1A 44/54 402

DIAZEPAM CHAROEN BHAESAJ 2 mg - 362

DIAZEPAM GENERAL DRUGS HOUSE 2 mg P1A 44/53 345

DIAZEPAM GENERAL DRUGS HOUSE 5 mg P1A 8/54 163

DIAZEPAM GPO 10 mg/2 mL x 2 mL - 628

DIAZEPAM GPO 2 mg - 055

DIAZEPAM GPO 5 mg - 164

DIAZEPAM GPO 10 mg - 363

DIAZEPAM H K PHARM 2 mg P1A 51/54 243

DIAZEPAM H K PHARM 5 mg P1A 52/54 176

DIAZEPAM H K PHARM 10 mg P1A 53/54 371

DIAZEPAM LERD SINGH 2 mg P1A 25/54 075

DIAZEPAM LERD SINGH 5 mg P1A 26/54 177

DIAZEPAM POND'S CHEMICAL 2 mg P1A 40/53 395

DIAZEPAM POND’S CHEMICAL 5 mg - 178

DIAZEPAM POND'S CHEMICAL 5 mg P1A 41/53 242

DIAZEPAM SAMAKEEPHAESAJ 2 mg - 391

DIAZEPAM SAMAKEEPHAESAJ 5 mg - 155

DIAZEPAM SOMMAI BHAESAJ 5 mg - 346

DIAZEPAM T MAN 2 mg P1A 24/53 392

DIAZEPAM T MAN 5 mg P1A 42/54 180

DIAZEPAM T MAN 5 mg P1A 42/54 236

DIAZEPAM T MAN 10 mg - 353

DIAZEPAM T P DRUG 10 mg/2 mL x 2 mL P1A 47/54 629

DIAZEPAM T P DRUG 2 mg - 012

DIAZEPAM T P DRUG 5 mg - 165

DIAZEPAM T P DRUG 10 mg - 364

DIAZEPAM VESCO 2 mg P1A 8/55 351

DIAZEPAM VESCO 5 mg P1A 9/55 147

DIAZEPION 2 mg - 514DIAZEPION 5 mg - 500DIAZEPION 10 mg - 215

diethylpropion hydrochloride:

- DIETIL RETARD 75 mg - 096

- PREFAMONE 75 mg - 191

- REGENON RETARD 75 mg - 504

- REGENON RETARD 75 mg - 130

diethylpropion resinate:

- ATRACTIL 75 mg - 505

DIETIL RETARD 75 mg - 096DILIUM 2 mg - 200DILIUM 5 mg - 354DILOMIL† - 002DIMED 2 mg - 078DIMED 5 mg - 181DIMETANE

EXPECTORANT DC† 2.5 L - 555

DIPAM 2 mg - 037DIPAM 5 mg - 150DIPAM 10 mg - 357

diphenoxylate hydrochloride:

- DILOMIL† - 002

- DITROPINE† - 008

- LOMOTIL† N2A 12/53 004

- SPASIL† N2A 2/51 009

DIPOSEF 5 mg - 453DIPOSEF 10 mg - 284DIPOT 5 mg P1A 40/52 459DIRAX† P2A 31/54 413DITRAN 2 mg P1A 16/53 444DITRAN 5 mg - 501DITROPINE† - 008DIVOPAN 2 mg P1A 42/53 056DIVOPAN 5 mg P1A 43/53 166

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 88 8/14/2013 2:45:18 PM

Page 90: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 89PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

DIZAN 2 mg - 483DIZAN 5 mg - 443DIZEP 2 mg P1A 54/54 188DIZEP 5 mg P1A 55/54 214DIZEPAM 2 mg P1A 45/53 250DIZEPAM 5 mg P1A 46/53 167DIZOLAM 0.25 mg - 103DIZOLAM 0.5 mg - 262DIZOLAM 1 mg - 324D-NORPSEUDOEPHEDRINE

SR OSMOPHARM 20 mg - 517DOMAR 5 mg P1A 5/52 490DONNATAL† - 057DOPAM 5 mg - 148DORMICUM

5 mg/mL x 1 mL - 630DORMICUM

15 mg/3 mL x 3 mL - 631DORMICUM 15 mg - 379DUROGESIC

PATCH 12 mcg/hr - 681DUROGESIC

PATCH 25 mcg/hr - 682DUROGESIC

PATCH 50 mcg/hr - 683DUROGESIC PATCH

100 mcg/hr - 684DUROMINE 15 mg - 527DUROMINE 30 mg - 521DZP2 2 mg - 497

EELIXIR PHENOBARB

60 mL - 556EPHEDRINE GPO

30 mg/mL x 1 mL - 632

ephedrine hydrochloride:

- EPHEDRINE GPO 30 mg/mL x 1 mL - 632

EPOXIDE 10 mg - 211EPOXIDE 25 mg - 217

ethyl loflazepate:

- MEILAX 1 mg - 022

- MEILAX 2 mg - 199

- VICTAN 2 mg - 204

EUHYPNOS 20 20 mg - 427EXAN 5 mg - 508EXAN 10 mg - 511

FFARZOLAM 0.25 mg - 104FARZOLAM 0.5 mg - 263FARZOLAM 1 mg - 310

FENTADUR 25 mcg/hr - 685

fentanyl:

- DUROGESIC PATCH 12 mcg/hr - 681

- DUROGESIC PATCH 25 mcg/hr - 682

- DUROGESIC PATCH 50 mcg/hr - 683

- DUROGESIC PATCH 100 mcg/hr - 684

- FENTADUR 25 mcg/hr - 685

- FENTANYL ANTIGEN 0.05 mg/mL x 2 mL - 633

- FENTANYL ANTIGEN 0.05 mg/mL x 10 mL - 634

- FENTANYL GPO 12 mcg/hr - 686

- FENTANYL GPO 25 mcg/hr - 687

- FENTANYL GPO 50 mcg/hr - 688

- FENTANYL HEXAL 12 mcg/hr - 689

- FENTANYL HEXAL 25 mcg/hr - 690

- FENTANYL HEXAL 50 mcg/hr - 691

FENTANYL ANTIGEN 0.05 mg/mL x 2 mL - 633

FENTANYL ANTIGEN 0.05 mg/mL x 10 mL - 634

fentanyl citrate:

- FENTANYL JANSSEN-CILAG 0.05 mg/mL x 2 mL - 635

- FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL - 636

- FENTANYL SANDOZ 0.05 mg/mL x 2 mL - 637

- FENTANYL SANDOZ 500 mcg/10 mL - 676

- FENTANYL-HAMELN 50 mcg/mL x 2 mL - 638

- FENTANYL-HAMELN 50 mcg/mL x 10 mL - 639

- FENTANYL-SNS 50 mcg/mL x 2 mL - 640

FENTANYL GPO 12 mcg/hr - 686

FENTANYL GPO 25 mcg/hr - 687

FENTANYL GPO 50 mcg/hr - 688

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 89 8/14/2013 2:45:18 PM

Page 91: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

90 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

FENTANYL HEXAL 12 mcg/hr - 689

FENTANYL HEXAL 25 mcg/hr - 690

FENTANYL HEXAL 50 mcg/hr - 691

FENTANYL JANSSEN-CILAG 0.05 mg/mL x 2 mL - 635

FENTANYL JANSSEN-CILAG 0.05 mg/mL x 10 mL - 636

FENTANYL SANDOZ 0.05 mg/mL x 2 mL - 637

FENTANYL SANDOZ 500 mcg/10 mL - 676

FENTANYL-HAMELN 50 mcg/mL x 2 mL - 638

FENTANYL-HAMELN 50 mcg/mL x 10 mL - 639

FENTANYL-SNS 50 mcg/mL x 2 mL - 640

FLULIUM 5 mg P1A 28/55 467FLULIUM 10 mg - 300

flunitrazepam:

- ROHYPNOL 1 mg - 423

flurazepam hydrochloride:

- DALMADORM 15 mg - 512

FORTWIN 30 mg/mL x 1 mL - 641

FREXENE 5 mg - 441FREXENE 10 mg - 445FRISIUM 5 mg P1C 12/53,

P1B 13/53 038FRISIUM 10 mg - 039

GGARDENAL

200 mg/4 mL P1C 1/50 677GAXENE 5 mg - 474GRANDAXIN 50 mg P1C 27/53 058

HHALCION 0.25 mg - 378HAWKCOPAX 0.5 mg P1A 7/55 348HAWKCOPAX 1 mg - 393HISEDYL† 60 mL - 557HISEDYL† 120 mL - 558

IINZOLAM 0.25 mg - 118INZOLAM 0.5 mg - 277INZOLAM 1 mg - 321

KKAPANOL 20 mg - 133KAPANOL 50 mg - 134KAPANOL 100 mg - 135KEMORA 0.5 mg P1A 48/54 434KEMORA 1 mg P1A 49/54 024KENSPA† P2A 36/52 251KETA-HAMELN

50 mg/mL x 10 mL - 678KETALAR

50 mg/mL x 10 mL - 679

ketamine hydrochloride:

- CALYPSOL 50 mg/mL x 10 mL - 675

- KETA-HAMELN 50 mg/mL x 10 mL - 678

- KETALAR 50 mg/mL x 10 mL - 679

LLAYLIUM-10

10 mg/2 mL x 2 mL - 642LEXOTAN 1.5 mg P1C 26/55 080LEXOTAN 3 mg P1C 27/55 254LIBRAX† P2A 3/55 409LICON† - 410LIZAVAN 0.5 mg - 333LIZAVAN 1 mg - 025LOMOTIL† N2A 12/53 004LONZA 0.5 mg P1A 1/54 339LONZA 1 mg P1A 2/54 020LORA 0.5 mg P1A 28/54 397LORA 1 mg P1A 29/54 040LORA 2 mg P1A 30/54 244LORAMED 0.5 mg - 334LORAMED 1 mg - 026LORAMED 2 mg P1A 50/54 237LORAMET 1 mg - 105LORA-P 0.5 mg - 347LORA-P 1 mg - 013LORA-P 2 mg - 137LORAPAM 0.5 mg - 336LORAPAM 1 mg - 027LORAPAM 2 mg - 142LORAPINE 0.5 mg - 340LORAPINE 1 mg - 033LORAVAN 0.5 mg P1A 22/50 329LORAVAN 1 mg - 028LORAZE 1 mg P1A 31/51 044LORAZENE 0.5 mg - 328LORAZENE 1 mg - 014LORAZENE 2 mg - 143

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 90 8/14/2013 2:45:18 PM

Page 92: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 91PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

LORAZEP 0.5 mg P1A 51/53 337LORAZEP 1 mg P1A 52/53 005LORAZEP 2 mg P1A 53/53 385

lorazepam:

- ANTA 0.5 mg P1A 36/53 330

- ANTA 1 mg P1A 12/54 018

- ANTA 2 mg P1A 29/52 138

- ANXIRA 0.5 mg P1A 24/52 327

- ANXIRA 1 mg P1A 25/52 021

- ATIVAN 0.5 mg - 332

- ATIVAN 1 mg - 023

- ATIVAN 2 mg - 141

- HAWKCOPAX 0.5 mg P1A 7/55 348

- HAWKCOPAX 1 mg - 393

- KEMORA 0.5 mg P1A 48/54 434

- KEMORA 1 mg P1A 49/54 024

- LIZAVAN 0.5 mg - 333

- LIZAVAN 1 mg - 025

- LONZA 0.5 mg P1A 1/54 339

- LONZA 1 mg P1A 2/54 020

- LORA 0.5 mg P1A 28/54 397

- LORA 1 mg P1A 29/54 040

- LORA 2 mg P1A 30/54 244

- LORAMED 0.5 mg - 334

- LORAMED 1 mg - 026

- LORAMED 2 mg P1A 50/54 237

- LORA-P 0.5 mg - 347

- LORA-P 1 mg - 013

- LORA-P 2 mg - 137

- LORAPAM 0.5 mg - 336

- LORAPAM 1 mg - 027

- LORAPAM 2 mg - 142

- LORAPINE 0.5 mg - 340

- LORAPINE 1 mg - 033

- LORAVAN 0.5 mg P1A 22/50 329

- LORAVAN 1 mg - 028

- LORAZE 1 mg P1A 31/51 044

- LORAZENE 0.5 mg - 328

- LORAZENE 1 mg - 014

- LORAZENE 2 mg - 143

- LORAZEP 0.5 mg P1A 51/53 337

- LORAZEP 1 mg P1A 52/53 005

- LORAZEP 2 mg P1A 53/53 385

- LORAZEPAM ACDHON 0.5 mg - 344

- LORAZEPAM ACDHON 1 mg - 034

- LORAZEPAM MACROPHAR 1 mg - 400

- LORAZIN 0.5 mg P1A 26/52 352

- LORAZIN 1 mg P1A 27/52 045

- LORAZIN 2 mg P1A 28/52 253

- LOZEPAM 0.5 mg - 331

- LOZEPAM 1 mg - 193

- ORA 0.5 mg P1A 12/51 338

- ORA 1 mg P1A 13/51 029

- ORA 2 mg - 238

- PORA 0.5 mg - 398

- PORA 1 mg - 151

- PORA 2 mg - 241

- RAZEPAM 0.5 mg - 342

- RAZEPAM 1 mg - 031

- RAZEPAM 2 mg - 144

- TRANAVAN 0.5 mg P1A 22/55 335

- TRANAVAN 1 mg P1A 23/55 035

- VEMED 0.5 mg - 343

- ZEDA 0.5 mg P1A 8/52 016

- ZEDA 1 mg P1A 9/52 389

- ZORA 0.5 mg P1A 3/54 356

- ZORA 2 mg P1A 4/54 205

LORAZEPAM ACDHON 0.5 mg - 344

LORAZEPAM ACDHON 1 mg - 034

LORAZEPAM MACROPHAR 1 mg - 400

LORAZIN 0.5 mg P1A 26/52 352LORAZIN 1 mg P1A 27/52 045LORAZIN 2 mg P1A 28/52 253

lormetazepam:

- LORAMET 1 mg - 105

LOZEPAM 0.5 mg - 331LOZEPAM 1 mg - 193

MMANEX 0.25 mg - 106MANEX 0.5 mg - 264MANEX 1 mg - 311MANODIAZO 2 mg P1A 9/56 495MANODIAZO 5 mg P1A 10/56 530MANODIAZO 10 mg P1A 11/55 365MANOLIUM

10 mg/2 mL x 2 mL P1A 11/54 643MANOTRAN 5 mg - 461MANOTRAN 10 mg - 289MANTADYL COUGH†

60 mL - 559MARZOLAM 0.25 mg - 107MARZOLAM 0.5 mg - 265MARZOLAM 1 mg - 312MASADYL COUGH†

60 mL - 560

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 91 8/14/2013 2:45:18 PM

Page 93: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

92 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

MASADYL COUGH† 100 mL - 561

MASADYL COUGH† 240 mL - 562

MASAPARA W/ CODEINE† N2A 7/55 198

medazepam:

- CELIUM 5 mg P1A 27/54 426

- MEDAZINE 5 mg P1A 30/50 520

- MEDAZINE 10 mg P1A 31/50 519

MEDAZINE 5 mg P1A 30/50 520MEDAZINE 10 mg P1A 31/50 519MED-ZEPAM 2 mg - 041MED-ZEPAM 5 mg - 366MED-ZEPOXIDE 5 mg - 494MED-ZEPOXIDE 10 mg - 059MEILAX 1 mg - 022MEILAX 2 mg - 199MENOBARB

15 mg/5 mL x 60 mL - 563MENOBARB

20 mg/5 mL x 60 mL - 564MENOBARB 60 mg - 208

meprobamate:

- REINBAMATE 400 mg - 094

METAXIDE 10 mg - 515METHADONE GPO

10 mg/mL x 1000 mL - 565METHADONE GPO 5 mg - 140

methadone hydrochloride:

- METHADONE GPO 10 mg/mL x 1000 mL - 565

- METHADONE GPO 5 mg - 140

METHYLPHENIDATE HEXAL 10 mg - 060

methylphenidate hydrochloride:

- CONCERTA 18 mg - 186

- CONCERTA 27 mg - 439

- CONCERTA 36 mg - 129

- METHYLPHENIDATE HEXAL 10 mg - 060

- RITALIN 10 mg - 042

- RUBIFEN 10 mg - 043

MIDAZ 5 mg/mL x 1 mL - 644MIDAZ 5 mg/mL x 3 mL - 645

midazolam:

- DORMICUM 5 mg/mL x 1 mL - 630

- DORMICUM 15 mg/3 mL x 3 mL - 631

- DORMICUM 15 mg - 379

- MIDAZ 5 mg/mL x 1 mL - 644

- MIDAZ 5 mg/mL x 3 mL - 645

- MIDAZOLAM HEXAL 5 mg/mL x 1 mL - 646

- MIDAZOLAM HEXAL 5 mg/mL x 3 mL - 647

MIDAZOLAM HEXAL 5 mg/mL x 1 mL - 646

MIDAZOLAM HEXAL 5 mg/mL x 3 mL - 647

MILA-CONO† 60 mL - 566MILA-TERCON† - 184MINOXIDE 10 mg P1A 44/52 493MIRAPRONT N 20 mg - 516MIST TUSSIS† 450 mL - 567MIST. SCILL AMMON.

GPO† 180 mL - 568MITRANAX 0.25 mg - 119MITRANAX 0.5 mg - 278MITRANAX 1 mg - 322MIXTURE SCILLAE

AMMON† 180 mL - 569MIXTURE TUSSIS†

30 mL N2A 11/55 570MIXTURE TUSSIS†

60 mL N2A 11/55 571MIXTURE TUSSIS†

120 mL N2A 11/55 572MIXTURE TUSSIS†

240 mL N2A 11/55 573MIXTURE TUSSIS†

450 mL N2A 11/55 574MIXTURE TUSSIS†

1800 mL - 575MIXTURE TUSSIS†

3600 mL - 576MODURAX† - 405MOGADON 5 mg - 091MONOZIDE 2 mg - 525MONOZIDE-10

10 mg/2 mL x 2 mL - 648

morphine:

- OPIUM TINCTURE GPO 1% x 450 mL - 585

MORPHINE SALUTAS PHARMA 10 mg - 438

MORPHINE SALUTAS PHARMA 30 mg - 358

MORPHINE SALUTAS PHARMA 60 mg - 245

morphine sulfate:

- KAPANOL 20 mg - 133

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 92 8/14/2013 2:45:18 PM

Page 94: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 93PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

- KAPANOL 50 mg - 134

- KAPANOL 100 mg - 135

- MORPHINE SALUTAS PHARMA 10 mg - 438

- MORPHINE SALUTAS PHARMA 30 mg - 358

- MORPHINE SALUTAS PHARMA 60 mg - 245

- MORPHINE SULFATE GPO 10 mg/5 mL - 577

- MORPHINE SULFATE GPO 10 mg - 156

- MORPHINE SULFATE INJ BLUE 10 mg/mL x 1 mL - 649

- MORPHINE SULFATE INJ PURPLE 10 mg/mL x 1 mL - 650

- MORPHINE T P DRUG 10 mg/mL x 1 mL - 651

- MORPHINE T P DRUG 10 mg/mL x 1 mL - 652

- MORPHINE T P DRUG 10 mg/mL x 1 mL - 653

- MST CONTINUS 10 mg - 194

- MST CONTINUS 30 mg - 304

- MST CONTINUS 60 mg - 206

- ORAMORPH 10 mg/5 mL x 250 mL - 586

- ORAMORPH 20 mg/mL x 30 mL - 587

MORPHINE SULFATE GPO 10 mg/5 mL - 577

MORPHINE SULFATE GPO 10 mg - 156

MORPHINE SULFATE INJ BLUE 10 mg/mL x 1 mL - 649

MORPHINE SULFATE INJ PURPLE 10 mg/mL x 1 mL - 650

MORPHINE T P DRUG 10 mg/mL x 1 mL - 651

MORPHINE T P DRUG 10 mg/mL x 1 mL - 652

MORPHINE T P DRUG 10 mg/mL x 1 mL - 653

MOXINAX 0.25 mg - 108

MOXINAX 0.5 mg - 266

MST CONTINUS 10 mg - 194

MST CONTINUS 30 mg - 304

MST CONTINUS 60 mg - 206

NNASA W/ CODEINE† N2A 4/51 092NEMBUTAL

54.7 mg/mL x 100 mL P1F 2/50 680NEO COUGH† 60 mL - 578NEO COUGH† 100 mL - 579NEO COUGH† 240 mL - 580NEOCOD† - 373NEO-CODEIN† - 374NEOCOF† - 212NEO-COPHEN 10 mg - 222NEOPECT† N2A 11/52 224NEURAMIZONE† P2A 7/54 432NITRADOS 5 mg - 072

nitrazepam:

- ALODORM 5 mg - 090

- MOGADON 5 mg - 091

- NITRADOS 5 mg - 072

NORDYL LINCTUS† 100 mL - 581

NORDYL LINCTUS† 500 mL - 582

NORTUSS LINCTUS† 100 mL - 583

NORTUSS LINCTUS† 500 mL - 584

OOPIUM TINCTURE GPO

1% x 450 mL - 585ORA 0.5 mg P1A 12/51 338ORA 1 mg P1A 13/51 029ORA 2 mg - 238ORAMORPH

10 mg/5 mL x 250 mL - 586ORAMORPH 20 mg/mL x 30 mL - 587

PPACOGESIC† - 213PAM 5 mg - 231PANBESY 15 mg - 450PANBESY 30 mg - 487PANGON

30 mg/mL x 1 mL P1A 19/53 654PARA WITH CODEINE†

15 mg N2A 4/56 083PARA WITH CODEINE†

30 mg N2A 5/56 084PARA-CO 15 mg N2A 7/52 375PARADEINE† N2A 2/54 086

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 93 8/14/2013 2:45:19 PM

Page 95: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

94 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

PARADYL 8 mg - 095PARAGEN CO† - 128PARAMED-CO† - 424PARCOD† - 089PARCONO† - 093PARDEX 32.5 mg - 131P-CODYL† 60 mL - 588P-CODYL† 120 mL - 589

pentazocine:

- PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL - 655

- TAZCINE 30 mg/mL x 1 mL - 665

- TAZCINE 25 mg - 066

- TAZCINE 50 mg - 252

PENTAZOCINE ALL PLANTS 30 mg/mL x 1 mL - 655

pentazocine lactate:

- FORTWIN 30 mg/mL x 1 mL - 641

- PANGON 30 mg/mL x 1 mL P1A 19/53 654

- SOSEGON 30 mg/mL x 1 mL - 664

pentobarbital sodium:

- NEMBUTAL 54.7 mg/mL x 100 mL P1F 2/50 680

PERCIDYL COUGH† 100 mL - 590

PETHIDINE BIOLAB 100 mg/2 mL x 2 mL - 656

PETHIDINE HAMELN 50 mg/mL - 657

pethidine hydrochloride:

- PETHIDINE BIOLAB 100 mg/2 mL x 2 mL - 656

- PETHIDINE HAMELN 50 mg/mL - 657

- PETHIDINE M & H MANUFACTURING 50 mg/mL x 1 mL - 658

- PETHIDINE M & H MANUFACTURING 100 mg/2 mL x 2 mL - 659

- PETHIDINE T P DRUG 50 mg/mL x 1 mL - 660

PETHIDINE M & H MANUFACTURING 50 mg/mL x 1 mL - 658

PETHIDINE M & H MANUFACTURING 100 mg/2 mL x 2 mL - 659

PETHIDINE T P DRUG 50 mg/mL x 1 mL - 660

PHARNAX 0.25 mg - 109PHARNAX 0.5 mg - 267PHARNAX 1 mg - 313PHENCODIN† 60 mL - 591PHENCODIN† 500 mL - 592PHENCODIN†

1000 mL - 593PHENOBARB 30 mg - 233PHENOBARB 60 mg - 047PHENOBARB ELIXIR

20 mg/5 mL x 60 mL - 594

phenobarbital:

- BENERA† - 433

- DONNATAL† - 057

- MENOBARB 60 mg - 208

- NEURAMIZONE† P2A 7/54 432

PHENOBARBITAL ACDHON 15 mg - 384

PHENOBARBITAL ACDHON 30 mg - 136

PHENOBARBITAL ACDHON 60 mg - 030

PHENOBARBITAL ATLANTIC 16.25 mg - 234

PHENOBARBITAL ATLANTIC 32.5 mg P1A 33/51 436

PHENOBARBITAL ATLANTIC 65 mg P1A 34/51 015

PHENOBARBITAL ATLANTIC 100 mg P1A 35/51 303

PHENOBARBITAL CHEW BROTHERS 30 mg - 341

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 30 mL - 595

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL - 596

PHENOBARBITAL | ELIXIR ACDHON 20 mg/5 mL x 120 mL - 597

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL - 598

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL - 599

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL - 600

PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL - 601

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 94 8/14/2013 2:45:19 PM

Page 96: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 95PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

phenobarbital sodium:

- BELLADONNA ALKALOIDS W/ PHENOBARBITAL† - 247

- BELLERGAL† - 232

- ELIXIR PHENOBARB 60 mL - 556

- GARDENAL 200 mg/4 mL P1C 1/50 677

- MENOBARB 15 mg/5 mL x 60 mL - 563

- MENOBARB 20 mg/5 mL x 60 mL - 564

- PHENOBARB 30 mg - 233

- PHENOBARB 60 mg - 047

- PHENOBARBITAL ACDHON 15 mg - 384

- PHENOBARBITAL ACDHON 30 mg - 136

- PHENOBARBITAL ACDHON 60 mg - 030

- PHENOBARBITAL ATLANTIC 16.25 mg - 234

- PHENOBARBITAL ATLANTIC 32.5 mg P1A 33/51 436

- PHENOBARBITAL ATLANTIC 65 mg P1A 34/51 015

- PHENOBARBITAL ATLANTIC 100 mg P1A 35/51 303

- PHENOBARBITAL CHEW BROTHERS 30 mg - 341

- PHENOBARB ELIXIR 20 mg/5 mL x 60 mL - 594

- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 30 mL - 595

- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 60 mL - 596

- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 120 mL - 597

- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 240 mL - 598

- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 450 mL - 599

- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 500 mL - 600

- PHENOBARBITAL ELIXIR ACDHON 20 mg/5 mL x 1000 mL - 601

- PHENOBARBITONE NEW LIFE PHARMA 30 mg - 006

- PHENOBARBITONE NEW LIFE PHARMA 60 mg - 203

- PHENOCO ELIXIR 20 mg/5 mL x 450 mL - 602

- PHENOCO ELIXIR 20 mg/5 mL x 3800 mL - 603

- PHENOCON 60 mg - 255

- PHENOSIL ELIXIR 20 mg/5 mL x 60 mL - 604

- PHENOSIL ELIXIR 20 mg/5 mL x 450 mL - 605

- PHENOTAL ELIXIR 20 mg/5 mL x 60 mL P1A 16/52 606

PHENOBARBITONE NEW LIFE PHARMA 30 mg - 006

PHENOBARBITONE NEW LIFE PHARMA 60 mg - 203

PHENOCO ELIXIR 20 mg/5 mL x 450 mL - 602

PHENOCO ELIXIR 20 mg/5 mL x 3800 mL - 603

PHENOCON 60 mg - 255PHENOSIL ELIXIR

20 mg/5 mL x 60 mL - 604PHENOSIL ELIXIR

20 mg/5 mL x 450 mL - 605PHENOTAL ELIXIR

20 mg/5 mL x 60 mL P1A 16/52 606PHENSEDYL OLIC†

100 mL - 607PHENSODI† 60 mL - 608PHENSODI† 120 mL - 609PHENSODI† 1000 mL - 610

phentermine hydrochloride:

- PANBESY 15 mg - 450

- PANBESY 30 mg - 487

- PHENTERMINE OSMOPHARM 15 mg - 477

PHENTERMINE OSMOPHARM 15 mg - 477

phentermine resinate:

- DUROMINE 15 mg - 527

- DUROMINE 30 mg - 521

- PHENTERMINE TRENKER 15 mg - 492

- PHENTERMINE TRENKER 30 mg - 451

PHENTERMINE TRENKER 15 mg - 492

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 95 8/14/2013 2:45:19 PM

Page 97: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

96 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

PHENTERMINE TRENKER 30 mg - 451

phenylpropanolamine hydrochloride:

- CLINEPECT† - 524

- DIMETANE EXPECTORANT DC† 2.5 L - 555

- PHENYLPROPANOLAMINE PHARMASANT 25 mg - 157

PHENYLPROPANOLAMINE PHARMASANT 25 mg - 157

pinazepam:

- DOMAR 5 mg P1A 5/52 490

POBRAX† - 403POLIZEP 5 mg P1A 23/50 468POLIZEP 10 mg - 294POLY-COF† 60 mL N2A 5/51 611POLY-COF† 100 mL N2A 5/51 612POLYDINE CD† - 295POMADOM 5 mg - 481POMADOM 10 mg - 449PONDNADYL† 60 mL - 613PONDNADYL† 100 mL - 614PONDNADYL† 1000 mL - 615PONDNEBIUM 5 mg - 399PONDNEBIUM 10 mg - 216POPAM 2 mg - 126POPAM 5 mg - 187PORA 0.5 mg - 398PORA 1 mg - 151PORA 2 mg - 241POSENE 5 mg - 189POSENE 10 mg - 430POVANIL 0.5 mg P1A 33/52 210POVANIL 1 mg P1A 13/54 179POVANIL 2 mg P1A 34/52 076POZAPAM 5 mg P1A 23/52 485POZAPAM 10 mg P1A 39/51 192PRASEPINE 5 mg - 484

prazepam:

- POZAPAM 5 mg P1A 23/52 485

- POZAPAM 10 mg P1A 39/51 192

- PRASEPINE 5 mg - 484

PRAZOL 0.25 mg - 110PRAZOL 0.5 mg - 268PRAZOL 1 mg - 314PREFAMONE 75 mg - 191PRENARPIL 0.5 mg P1A 4/55 196PRENARPIL 1 mg P1A 5/55 367PRENARPIL 2 mg P1A 6/55 061PSEUDOEPHEDRINE

ASIAN PHARM 30 mg/5 mL x 60 mL - 616

PSEUDOEPHEDRINE ASIAN PHARM 30 mg - 158

PSEUDOEPHEDRINE ASIAN PHARM 60 mg - 048

PSEUDOEPHEDRINE BJ BENJAOSOTH 30 mg/5 mL x 60 mL - 617

PSEUDOEPHEDRINE BJ BENJAOSOTH 60 mg - 152

PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 30 mg - 049

PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 60 mg - 050

PSEUDOEPHEDRINE GPO 30 mg - 062

PSEUDOEPHEDRINE GPO 60 mg - 063

pseudoephedrine hydrochloride:

- BLUCO† - 383

- BLUCON† - 360

- PSEUDOEPHEDRINE ASIAN PHARM 30 mg/5 mL x 60 mL - 616

- PSEUDOEPHEDRINE ASIAN PHARM 30 mg - 158

- PSEUDOEPHEDRINE ASIAN PHARM 60 mg - 048

- PSEUDOEPHEDRINE BJ BENJAOSOTH 30 mg/5 mL x 60 mL - 617

- PSEUDOEPHEDRINE BJ BENJAOSOTH 60 mg - 152

- PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 30 mg - 049

- PSEUDOEPHEDRINE DEFENCE OF PHARMACEUTICAL FACTORY 60 mg - 050

- PSEUDOEPHEDRINE GPO 30 mg - 062

- PSEUDOEPHEDRINE GPO 60 mg - 063

- PSEUDOEPHEDRINE MEDICINE PRODUCTS 60 mg - 207

- PSEUDOEPHEDRINE MILANO 30 mg/5 mL x 60 mL - 618

- PSEUDOEPHEDRINE MILANO 30 mg - 153

- PSEUDOEPHEDRINE MILANO 60 mg - 046

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 96 8/14/2013 2:45:19 PM

Page 98: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

BRAND & GENERIC NAME INDEX 97PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

SQUILL AND AMMONIA VIDHYASOM† 450 mL - 619

STESOLID 2 mg - 431STESOLID 5 mg - 507STESOLID 10 mg - 513STILNOX 10 mg - 123SUNAX 0.25 mg - 120SUNAX 0.5 mg - 279

TTAMYLAB-S 5 mg - 469TAZCINE 30 mg/mL x 1 mL - 665TAZCINE 25 mg - 066TAZCINE 50 mg - 252

temazepam:

- EUHYPNOS 20 20 mg - 427

TEMGESIC 0.3 mg/mL x 1 mL - 666

TEMGESIC 0.2 mg - 007TENADRIN-C† 60 mL - 620TENMED 5 mg P1A 47/52 470TENMED 10 mg - 296TERADENE† 60 mL - 621TERADYL† 1000 mL - 623TERADYL† 60 mL - 622TERCO-C† N2A 11/53 415T-FIVE 5 mg - 471TOCODYL† - 418

tofisopam:

- GRANDAXIN 50 mg P1C 27/53 058

TRANADON-S 5 mg - 475TRANAVAN 0.5 mg P1A 22/55 335TRANAVAN 1 mg P1A 23/55 035TRANCAP 5 mg - 496TRANCAP 10 mg - 190TRANCLOR 5 mg - 464TRANCLOR 10 mg - 297TRANCON 5 mg P1A 20/53 482TRANCON 10 mg - 448TRANMED 5 mg P1A 39/52 452TRANMED 10 mg - 287TRANOLAN

10 mg/2 mL x 2 mL P1A 41/52 667TRANOLAN 2 mg P1A 9/54 145TRANOLAN 5 mg P1A 10/54 201TRANPATE 5 mg - 442TRANPON 5 mg - 472TRANSPON FORTE

10 mg - 283TRANXENE 5 mg P1A 14/54 465TRANXENE 10 mg - 298TRANZEP 5 mg - 460TRIALAM 0.25 mg - 185

- TERADENE† 60 mL - 621

PSEUDOEPHEDRINE MEDICINE PRODUCTS 60 mg - 207

PSEUDOEPHEDRINE MILANO 30 mg/5 mL x 60 mL - 618

PSEUDOEPHEDRINE MILANO 30 mg - 153

PSEUDOEPHEDRINE MILANO 60 mg - 046

RRADIBRAX† - 420RAZEPAM 0.5 mg - 342RAZEPAM 1 mg - 031RAZEPAM 2 mg - 144REGENON RETARD

75 mg - 130REGENON RETARD

75 mg - 504REINBAMATE 400 mg - 094RITALIN 10 mg - 042RIVOTRIL

1 mg/mL x 1 mL - 661RIVOTRIL 0.5 mg P1A 6/53 197RIVOTRIL 2 mg P1A 7/53 064ROHYPNOL 1 mg - 423ROLAR† N2A 9/55 228ROPAM

10 mg/2 mL x 2 mL P1A 49/53 662ROPAM 5 mg - 174ROPECT† N2A 1/55 226ROTUSS† N2C 9/52 229RUBIFEN 10 mg - 043

SS.CO ZEPAM 5 mg - 246SANOR 5 mg - 454SANOR 10 mg - 285SECO† N2A 4/55 417SERENE

MASA LAB 10 mg - 286SERENE

V S PHARMA 5 mg - 457SIAMPRAXOL 0.25 mg - 111SIAMPRAXOL 0.5 mg - 269SIAMPRAXOL 1 mg - 315SIPAM 10 mg/2 mL x 2 mL P1A 26/53 663SIPAM 2 mg P1A 12/56 065SIPAM 5 mg P1A 13/56 168SIPAM 10 mg - 368SOSEGON

30 mg/mL x 1 mL - 664SPASIL† N2A 2/51 009

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 97 8/14/2013 2:45:19 PM

Page 99: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

98 BRAND & GENERIC NAME INDEX PN DEX 2013

¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics†Indicates brands that contain more than one ingredient

BR

AN

D &

GE

NE

RIC

NA

ME

IND

EX

XANACINE 0.25 mg - 113XANACINE 0.5 mg - 271XANACINE 1 mg - 317XANAX 0.25 mg - 114XANAX 0.5 mg - 272XANAX 1 mg - 318XANAX XR 0.5 mg - 372XANAX XR 1 mg - 079XANAX XR 2 mg - 381XIEMED 0.25 mg - 121XIEMED 0.5 mg - 280XIEMED 1 mg - 323

ZZAM 2 mg P1A 1/51 068ZAM 5 mg P1A 2/51 172ZEDA 0.5 mg P1A 8/52 016ZEDA 1 mg P1A 9/52 389ZEPAM

10 mg/2 mL x 2 mL - 672ZEPAM 2 mg - 429ZEPAM 5 mg - 382ZEPAXID

10 mg/2 mL x 2 mL - 673ZEPAXID 2 mg - 532ZEPAXID 5 mg P1A 21/50 488ZEPOBRAX† - 412ZEPOXIDE 5 mg - 437ZEPOXIDE 10 mg P1A 35/52 305ZEPOXIN 5 mg - 230ZEPOXIN 10 mg - 132ZETRAN 5 mg - 476ZOLAM 0.25 mg - 115ZOLAM 0.5 mg - 273ZOLAM 1 mg - 319

zolpidem hemitartrate:

- STILNOX 10 mg - 123

zolpidem tartrate:

- DACTIVE 10 10 mg - 053

- ZOLPIDEM TARTRATE RIVOPHARM 10 mg - 124

- ZOPIM 10 mg - 125

ZOLPIDEM TARTRATE RIVOPHARM 10 mg - 124

ZOPAM 2 mg P1A 31/53 051ZOPAM 5 mg P1A 32/53 160ZOPAM 10 mg P1A 8/53 359ZOPIM 10 mg - 125ZORA 0.5 mg P1A 3/54 356ZORA 2 mg P1A 4/54 205ZORITUSS 10 mg - 223

triazolam:

- HALCION 0.25 mg - 378

- TRIALAM 0.25 mg - 185

- TRYCAM 0.25 mg - 376

TRYCAM 0.25 mg - 376TUMAX† P2A 25/55 428TUSSIDYL† 60 mL - 624TYLENOL WITH

CODEINE† N2A 9/53 087TYLENOL WITH CODEINE† - 088

UUPTRAN 10 mg - 293UPZENE 5 mg - 509UTORAX† - 411

VV DAY ZEPAM

10 mg/2 mL x 2 mL - 668V DAY ZEPAM 2 mg - 502V DAY ZEPAM 5 mg - 491V DAY ZEPAM NL

10 mg/2 mL x 2 mL - 669VALAX 2 mg - 032VALAX 5 mg - 146VALAX 10 mg - 349VALENIUM 2 mg - 077VALENIUM 5 mg - 169VALIUM

10 mg/2 mL x 2 mL - 670VALIUM 5 mg - 170VASON 2 mg P1A 25/53 425VEMED 0.5 mg - 343VESCOPAM

10 mg/2 mL x 2 mL P1A 50/53 671VICTAN 2 mg - 204VISPAM 2 mg - 394VISPAM 5 mg - 239VISPAM 10 mg - 350VOMED 2 mg - 067VOMED 5 mg - 171VORAPAM 2 mg P1A 45/54 073VORAPAM 5 mg P1A 46/54 175

WWINOPAM 2 mg - 074WINOPAM 5 mg - 404

XXALAM 0.25 mg - 112XALAM 0.5 mg - 270XALAM 1 mg - 316

Registration No. Frame No. Registration No. Frame No.

B&G Name Index-FINAL-Aug13.indd 98 8/14/2013 2:45:19 PM

Page 100: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

Çѵ¶ØÍÍ¡Ä·¸Ôì»ÃÐàÀ· 2 (P2)

Generic Nameª×èÍÊÒÁÑÞ

Manufacturer¼ÙŒ¼ÅÔµ

Brand Nameª×èÍ¡ÒäŒÒ

Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ

ephedrine hydrochloride GPO Ephedrine GPO Inj (amp) 30 mg/mL x 1 mL.

fl unitrazepam Roche Rohypnol Tab 1 mg.

ketamine hydrochloride Gedeon Richter Calypsol Inj (vial) 50 mg/mL x 10 mL.

methylphenidate hydrochloride

Janssen-Cilag Concerta Tab 18 mg. 27 mg. 36 mg.

Lab Rubio Rubifen Tab 10 mg.

Novartis Ritalin Tab 10 mg.

18 mg

27 mg

36 mg

(¢ŒÍÁÙŶ֧à´×͹ ¡.¤. 2556)

List of Products Sold by FDAÃÒ¡ÒÃÂÒ·Õè¨íÒ˹‹ÒÂâ´Â¡ÅØ‹Áà§Ô¹·Ø¹ËÁعàÇÕ¹ÂÒàʾµÔ´

PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 99 8/14/2013 6:01:28 PM

Page 101: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

100 PRODUCTS SOLD BY FDA PN DEX 2013

Çѵ¶ØÍÍ¡Ä·¸Ôì»ÃÐàÀ· 2 (P2)

Generic Nameª×èÍÊÒÁÑÞ

Manufacturer¼ÙŒ¼ÅÔµ

Brand Nameª×èÍ¡ÒäŒÒ

Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ

methylphenidate hydrochloride(continued)

Salutas Pharma Methylphenidate Hexal

Tab 10 mg.

midazolam Cenexi Dormicum Inj (amp) 5 mg/mL x 1 mL.

Jenahexal Midazolam Hexal Inj (amp) 5 mg/mL x 1 mL, 3 mL.

Roche Dormicum Tab 15 mg.

nitrazepam Alphapharm Alodorm Tab 5 mg.

phentermine hydrochloride Osmopharm Panbesy Cap 15 mg. 30 mg.

phentermine resinate Douglas Duromine Cap 15 mg. 30 mg.

zolpidem hemitartrate Sanofi -Winthrop Stilnox Tab 10 mg.

1 mL 3 mL

15 mg

30 mg

15 mg

30 mg

PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 100 8/14/2013 6:01:28 PM

Page 102: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

PRODUCTS SOLD BY FDA 101PN DEX 2013

Çѵ¶ØÍÍ¡Ä·¸Ôì»ÃÐàÀ· 2 (P2)

Generic Nameª×èÍÊÒÁÑÞ

Manufacturer¼ÙŒ¼ÅÔµ

Brand Nameª×èÍ¡ÒäŒÒ

Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ

zolpidem tartrate

Cadila Healthcare Dactive 10 Tab 10 mg.

Rivopharm Zolpidem Tartrate Rivopharm

Tab 10 mg.

Taiwan Biotech Zopim Tab 10 mg.

ÂÒàʾµÔ´ãËŒâ·É»ÃÐàÀ· 2 (N2)

Generic Nameª×èÍÊÒÁÑÞ

Manufacturer¼ÙŒ¼ÅÔµ

Brand Nameª×èÍ¡ÒäŒÒ

Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ

codeine phosphate GPO Codeine GPO Tab 15 mg. 30 mg.

15 mg

30 mg

fentanyl Hexal AG Fentanyl Hexal TTS 12 mcg/hr. 25 mcg/hr. 50 mcg/hr.

25 mcg/hr

12 mcg/hr

50 mcg/hr

PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 101 8/14/2013 6:01:28 PM

Page 103: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

102 PRODUCTS SOLD BY FDA PN DEX 2013

ÂÒàʾµÔ´ãËŒâ·É»ÃÐàÀ· 2 (N2)

Generic Nameª×èÍÊÒÁÑÞ

Manufacturer¼ÙŒ¼ÅÔµ

Brand Nameª×èÍ¡ÒäŒÒ

Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ

fentanyl(continued)

Janssen Pharma Durogesic Patch TTS 12 mcg/hr. 25 mcg/hr. 50 mcg/hr.

12 mcg/hr

25 mcg/hr

50 mcg/hr

Lavipharm Fentadur TTS 25 mcg/hr.

fentanyl citrate Hameln Fentanyl-Hameln Inj (amp) 0.05 mg/mL x 2 mL, 10 mL.

2 mL 10 mL

Janssen-Cilag Fentanyl Janssen-Cilag

Inj (amp) 0.05 mg/mL x 2 mL, 10 mL.

2 mL 10 mL

SNS Fentanyl-SNS Inj (amp) 0.05 mg/mL x 2 mL.

PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 102 8/14/2013 6:01:29 PM

Page 104: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

PRODUCTS SOLD BY FDA 103PN DEX 2013

ÂÒàʾµÔ´ãËŒâ·É»ÃÐàÀ· 2 (N2)

Generic Nameª×èÍÊÒÁÑÞ

Manufacturer¼ÙŒ¼ÅÔµ

Brand Nameª×èÍ¡ÒäŒÒ

Presentation & PackingÃٻẺ-¢¹Ò´-ºÃèØ

fentanyl citrate(continued)

Sandoz Canada Fentanyl Sandoz Inj 0.05 mg/mL x 2 mL, 10 mL.

2 mL 10 mL

methadone hydrochloride

GPO Methadone GPO Tab 5 mg. Soln 10 mg/mL x 1,000 mL.

Tab

Soln

morphine sulfate Bard MST Continus Tab 10 mg. 30 mg. 60 mg.

10 mg

10 mg. 30 mg. 60 mg.

30 mg

60 mg

GlaxoSmithKline Kapanol Cap 20 mg. 50 mg. 100 mg.

20 mg

50 mg

100 mg

GPO Morphine Sulfate GPO

Tab 10 mg. Oral soln 10 mg/5 mL.

Tab

Oral soln

PNDEX 2013 - DRUG LIST SOLD BY FDA-Aug14.indd 103 8/14/2013 6:01:30 PM

Page 105: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ

104_MIMS PNDEX.pdf 1 8/17/13 5:12 PM

Page 106: 5th Edition › sites › NRF › Shared Documents... · 5th Edition ชื่อหนังสือ รูปแบบเภสัชภัณฑ์วัตถุออกฤทธิ์และยาเสพติดให้โทษ